Skip to main content

MATERIALES POROSOS INTELIGENTES MULTIFUNCIONALES Y DISPOSITIVOS ELECTRONICOS PARA LA LIBERACION DE FARMACOS, DETECCION DE DROGAS Y BIOMARCADORES Y COMUNICACION A NANOESCALA

RTI2018-100910-B-C41

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 84
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Oligonucleotide-capped nanoporous anodic alumina biosensor as diagnostic tool for rapid and accurate detection of Candida auris in clinical samples

  • Pla, Luis
  • Santiago-Felipe, Sara
  • Tormo-Mas, María Ángeles
  • Ruiz-Gaitán, Alba
  • Peman, Javier
  • Valentín, Eulogio
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Candida auris has arisen as an important multidrug-resistant fungus because of several nosocomial outbreaks and elevated rates of mortality. Accurate and rapid diagnosis of C. auris is highly desired; nevertheless, current methods often present severe limitations and produce misidentification. Herein a sensitive, selective, and time-competitive biosensor based on oligonucleotide-gated nanomaterials for effective detection of C. auris is presented. In the proposed design, a nanoporous anodic alumina scaffold is filled with the fluorescent indicator rhodamine B and the pores blocked with different oligonucleotides capable of specifically recognize C. auris genomic DNA. Gate opening modulation and cargo delivery is controlled by successful DNA recognition. C. auris is detected at a concentration as low as 6 CFU/mL allowing obtaining a diagnostic result in clinical samples in one hour with no prior DNA extraction or amplification steps., The authors want to thank the Spanish Government (project RTI2018-100910-B-C41 (MCIU/AEI/FEDER, UE)), the Generalitat Valenciana (project PROMETEO/2018/024), Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (AURISGATE project) and Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (NANOPATH AND CANDI-EYE projects) for support. L.P thanks MINECO for his predoctoral fellowship. S.S. thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support "Sara Borrell" (CD16/000237).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy

  • Hernández Teruel, Adrián
  • Gonzalez-Alvarez, Isabel
  • Bermejo, Marival
  • Merino Sanjuán, Virginia
  • Gonzalez-Alvarez, Marta
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Colonic Drug Delivery Systems (CDDS) are especially advantageous for local treatment of inflammatory bowel diseases (IBD). Site-targeted drug release allows to obtain a high drug concentration in injured tissues and less systemic adverse effects, as consequence of less/null drug absorption in small intestine. This review focused on the reported contributions in the last four years to improve the effectiveness of treatments of inflammatory bowel diseases. The work concludes that there has been an increase in the development of CDDS in which pH, specific enzymes, reactive oxygen species (ROS), or a combination of all of these triggers the release. These delivery systems demonstrated a therapeutic improvement with fewer adverse effects. Future perspectives to the treatment of this disease include the elucidation of molecular basis of IBD diseases in order to design more specific treatments, and the performance of more in vivo assays to validate the specificity and stability of the obtained systems., The authors want to thank the Spanish Government (project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE)) and the Generalitat Valenciana (project PROMETEO/2018/024) for support. This work was also supported by the project "MODELOS IN VITRO DE EVALUACION BIOFARMACEUTICA" SAF2016-78756(AEI/FEDER, EU) funded by Agencia Estatal Investigacion and European Union, through FEDER (Fondo Europeo de Desarrollo Regional).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Capítulo o parte de un libro (BookPart)

Novel Probes and Carriers to Target Senescent Cells

  • Lozano-Torres, Beatriz
  • Blandez, Juan F.
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
Detecting senescent cells has become a task of increasing importance in recent years. The implication of cellular senescence in a variety of physiological processes as well as in various diseases is the main reason why potential diagnostic tools for senescent cells are sought. This chapter clearly and concisely addresses the discussion of the published tools (molecular based probes and nanocarriers) to carry out the diagnosis of senescent cells both in vitro and in vivo and in tissues. The comprehensive reading of this chapter will allow the reader to overview the advances in the area of the detection of cellular senescence using probes and carriers as diagnostic methods.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Nanosensor for Sensitive Detection of the New Psychedelic Drug 25I-NBOMe

  • Garrido-García, Eva María
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Alfonso-Navarro, María
  • Díaz de Greñu-Puertas, Borja
  • Lozano-Torres, Beatriz
  • Parra Álvarez, Margarita
  • Gaviña, Pablo
[EN] This work reports the synthesis, characterization, and sensing behavior of a hybrid nanodevice for the detection of the potent abuse drug 25I-NBOMe. The system is based on mesoporous silica nanoparticles, loaded with a fluorescent dye, functionalized with a serotonin derivative and capped with the 5-HT2A receptor antibody. In the presence of 25I-NBOMe the capping antibody is displaced, leading to pore opening and rhodamine B release. This delivery was ascribed to 5-HT2A receptor antibody detachment from the surface due to its stronger coordination with 25I-NBOMe present in the solution. The prepared nanodevice allowed the sensitive (limit of detection of 0.6 mm) and selective recognition of the 25I-NBOMe drug (cocaine, heroin, mescaline, lysergic acid diethylamide, MDMA, and morphine were unable to induce pore opening and rhodamine B release). This nanodevice acts as a highly sensitive and selective fluorometric probe for the 25I-NBOMe illicit drug in artificial saliva and in sweets., The authors thank the Spanish Government (projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and CTQ2017-87954-P) and the Generalitat Valencia (PROMETEO/2018/024) for support. E.G. is grateful to the Spanish MEC for her FPU grant. The authors also thank the Electron Microscopy Service at the UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Biocompatibility and internalization assessment of bare and functionalised mesoporous silica nanoparticles

  • Garrido-Cano, Iris
  • Herrera, Guadalupe
  • Cejalvo, Juan Miguel
  • Lluch, Ana
  • Eroles, Pilar
  • Candela-Noguera, Vicente
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We report herein an evaluation of the effect of several mesoporous silica nanoparticles (MSNs) on the cellular uptake and in vitro cytotoxicity in human cells. Bare MSNs and MSNs functionalized with polyethylene glycol or hyaluronic acid are employed to evaluate uptake efficiency and mechanisms of endocytosis in cancer (MDA-MB-231) and non-cancer (MCF10A) cells. Moreover, changes in viability, cell cycle, oxidative stress, and mitochondrial membrane potential are evaluated. Our results confirm that MSNs are internalized efficiently by human cells and that uptake mechanisms differ for cell types and particles. We also confirm that MSNs are biocompatible materials that do not induce ROS/RNS production, nor changes on mitochondrial membrane potential or cell cycle., The authors want to thank the Spanish Government RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and PI18/01219 (ISCIII), the Generalitat Valenciana (PROMETEO/2018/024 and ACIF/2016/030), and CIBER-BBN (CB07/01/2012) and CIBER-ONC (CB16/12/00481) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic

  • Galiana, Irene
  • Lozano-Torres, Beatriz
  • Sancho, Mónica
  • Alfonso-Navarro, María
  • Bisbal, Viviana
  • Serrano, Manuel
  • Orzaez, Mar
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The induction of senescence produces a stable cell cycle arrest in cancer cells, thereby inhibiting tumor growth; however, the incomplete immune cell-mediated clearance of senescent cells may favor tumor relapse, limiting the long-term anti-tumorigenic effect of such drugs. A combination of senescence induction and the elimination of senescent cells may, therefore, represent an efficient means to inhibit tumor relapse. In this study, we explored the antitumor efficacy of a combinatory senogenic and targeted senolytic therapy in an immunocompetent orthotopic mouse model of the aggressive triple negative breast cancer subtype. Following palbociclib-induced senogenesis and senolysis by treatment with nano-encapsulated senolytic agent navitoclax, we observed inhibited tumor growth, reduced metastases, and a reduction in the systemic toxicity of navitoclax. We believe that this combination treatment approach may have relevance to other senescence-inducing chemotherapeutic drugs and additional tumor types. Significance: While the application of senescence inducers represents a successful treatment strategy in breast cancer patients, some patients still relapse, perhaps due to the subsequent accumulation of senescent cells in the body that can promote tumor recurrence. We now demonstrate that a combination treatment of a senescence inducer and a senolytic nanoparticle selectively eliminates senescent cells, delays tumor growth, and reduces metastases in a mouse model of aggressive breast cancer. Collectively, our results support targeted senolysis as a new therapeutic opportunity to improve outcomes in breast cancer patients., The M.O. laboratory members thank the financial support from the Spanish Government (project SAF2017-84689-R (MINECO/AEI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO/2019/065). The R.M. laboratory members thank the financial support from the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/FEDER, EU) and the Generalitat Valenciana (project PROMETEO 2018/024). Both I.G. and B.L-T. are grateful to the Generalitat Valenciana and the Spanish Ministry of Economy, respectively, for their Ph.D. grants. I.G. would like to thank I. Borreda and J. Forteza and the Instituto Valenciano de Patologia for their special collaboration and F. Sancenon for his appreciated help
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A gated material as immunosensor for in-tissue detection of IDH1-R132H mutation in gliomas

  • Pla, Luis
  • Prat-Acín, Ricardo
  • Galeano-Senabre, Inmaculada
  • Botello-Marabotto, Marina Dolores
  • Palanca-Suela, Sarai
  • Santiago Felipe, Sara
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] A nanodevice consisted on nanoporous anodic alumina (NAA) supports functionalized with specific and selective antibody-based gatekeepers for the detection of IDH1-R132H mutant enzyme is here reported. Molecular profile and tissue mutations of the tumours (such as IDH1/IDH2 mutations in gliomas) are a great source of information that already make a difference in terms of prognosis and prediction of response to combined therapy. However, standardized methodologies to determine this mutation are time-consuming and cannot provide information before or during surgical intervention, which significantly limits their utility in terms of intraoperative decisionmaking. To solve this limitation, our sensing system, in the presence of the target IDH1-R132H mutant enzyme triggers the delivery of a fluorescent reporter from the antibody-capped NAA that is easily detected using a standard fluorimeter in less than 1 h. Good capabilities of the sensor in terms of sensitivity (limit of detection as low as 0.01 ng/mL) and selectivity are determined. The biosensor is validated in seventeen human glioma tissue samples, also analysed by standardized methodologies, showing significant differences between IDH1 wild-type and IDH1-R132H mutant gliomas (p < 0.01) with high sensitivity, specificity and accuracy (87.5/88.9/88.2) for IDH1-R132H mutational status classification in human glioma tissues. This new detection system might play an important role in surgical interventions, anticipating mutational status information in gliomas and supporting thus decision making and patient survival., This study was supported by the Spanish Government (project RTI2018-100910-B-C41 MCUI/AEI/FEDER, UE), the Generalitat Valenciana (project PROMETEO/2018/024), the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (GLIOVIEW-IDH and GLIOVIEWIDH_2.0 project) and CIBER-BBN (NANOPATH AND CANDI-EYE projects). S.S. thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support "Sara Borrell" (CD16/000237). L.P. thanks to Ministerio de Economia, Industria y Competitividad for his FPI grant. We also a knowledge service provided by Biobanco La Fe of Instituto de Investigacion Sanitaria La Fe, Val`encia, Spain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lipofuscin labeling through biorthogonal strain-promoted azide-alkyne cycloaddition for the detection of senescent cells

  • Lozano-Torres, Beatriz
  • Blandez, Juan F.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] A new method for senescent cell detection is described, which is based on lipofuscin labeling with a fluorescent reporter through a biorthogonal strain-promoted azide-alkyne cycloaddition. The sensing protocol involves a first step where the interaction of lipofuscin with a Sudan Black B derivative containing an azide moiety (SBB-N3 ) is carried out. In the final step, the azide moiety reacts with a fluorophore containing a cyclooctene ring (BODIPY). The efficacy of this two-step protocol is assessed in senescent melanoma SK-MEL-103 cells, senescent triple-negative breast cancer MDA-MB-231 cells and senescent WI-38 fibroblasts. In all cases, a clear fluorescence pattern was observed in senescent cells, compared to proliferative cells, only when the SBB-N3 -BODIPY probe was formed. Our results provide an alternative tool for the detection of senescent cells, based on an in situ bio-orthogonal reaction for lipofuscin labeling, RM laboratory members are grateful for financial support from the FEDER foundation of European Union (IDIFEDER/2021/044), the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22) and the Generalitat Valenciana (project PROMETEO 2018/024). BL-T and AG-F acknowledge their current Margarita Salas postdoctoral fellowship from UPV-MIU and 'Next Generation EU' program. JF-B is grateful for his Sara Borrell postdoctoral fellowship (CD19/00038).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Purely Covalent Molecular Cages and Containers for Guest Encapsulation

  • Montà-González, Giovanni|||0000-0002-0739-9937
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
[EN] Cage compounds offer unique binding pockets similar to enzyme-binding sites, which can be customized in terms of size, shape, and functional groups to point toward the cavity and many other parameters. Different synthetic strategies have been developed to create a toolkit of methods that allow preparing tailor-made organic cages for a number of distinct applications, such as gas separation, molecular recognition, molecular encapsulation, hosts for catalysis, etc. These examples show the versatility and high selectivity that can be achieved using cages, which is impossible by employing other molecular systems. This review explores the progress made in the field of fully organic molecular cages and containers by focusing on the properties of the cavity and their application to encapsulate guests., V.M.-C. acknowledges the financial support from project CIDEGENT/2020/031 funded by the Generalitat Valenciana and project PID2020-113256RA-I00 funded by MCIN/AEI/10.13039/501100011033. R.M.-M. and F.S. acknowledge the financial support from project PROMETEO 2018/024 from the Generalitat Valenciana and project RTI2018-100910-B-C41 funded by MCIN/AEI/10.13039/501100011033/and FEDER A way to make Europe. Funding for open access charge: CRUE-Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Surfactant-Triggered Molecular Gate Tested on Different Mesoporous Silica Supports for Gastrointestinal Controlled Delivery

  • Poyatos-Racionero, Elisa
  • González-Álvarez, Isabel
  • González-Álvarez, Marta
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Aznar, Elena|||0000-0003-0361-3876
[EN] In recent decades, the versatility of mesoporous silica particles and their relevance to develop controlled release systems have been demonstrated. Within them, gated materials able to modulate payload delivery represent great advantages. However, the role played by the porous matrix in this kind of systems is scarce. In this work, different mesoporous silica materials (MCM-41, MCM-48, SBA-15 and UVM-7) are functionalized with oleic acid as a molecular gate. All systems are fully characterized and their ability to confine the entrapped cargo and release it in the presence of bile salts is validated with release assays and in vitro digestion experiments. The cargo release profile of each synthesized support is studied, paying attention to the inorganic scaffold. Obtained release profiles fit to Korsmeyer-Peppas model, which explains the differences among the studied supports. Based on the results, UVM-7 material was the most appropriate system for duodenal delivery and was tested in an in vivo model of the Wistar rat. Payload confinement and its complete release after gastric emptying is achieved, establishing the possible use of mesoporous silica particles as protection and direct release agents into the duodenum and, hence, demonstrating that these systems could serve as an alternative to the administration methods employed until now., This research was funded by the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22-AR (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO/2018/024 and ACIF/2016/023 grant).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Two-Photon Probe Based on Naphthalimide-Styrene Fluorophore for the In Vivo Tracking of Cellular Senescence

  • Lozano-Torres, Beatriz
  • Blandez, Juan F.
  • Galiana, Irene
  • Lopez-Dominguez, Jose Alberto
  • Rovira, Miguel
  • Páez-Ribes, Marta
  • González-Gualda, Estela
  • Muñoz-Espín, Daniel
  • Serrano, Manuel
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cellular senescence is a state of stable cell cycle arrest that can negatively affect the regenerative capacities of tissues and can contribute to inflammation and the progression of various aging-related diseases. Advances in the in vivo detection of cellular senescence are still crucial to monitor the action of senolytic drugs and to assess the early onset or accumulation of senescent cells. Here, we describe a naphthalimide-styrene-based probe (HeckGal) for the detection of cellular senescence both in vitro and in vivo. HeckGal is hydrolyzed by the increased lysosomal beta-galactosidase activity of senescent cells, resulting in fluorescence emission. The probe was validated in vitro using normal human fibroblasts and various cancer cell lines undergoing senescence induced by different stress stimuli. Remarkably, HeckGal was also validated in vivo in an orthotopic breast cancer mouse model treated with senescence-inducing chemotherapy and in a renal fibrosis mouse model. In all cases, HeckGal allowed the unambiguous detection of senescence in vitro as well as in tissues and tumors in vivo. This work is expected to provide a potential technology for senescence detection in aged or damaged tissues., R.M. laboratory members thank the financial support from the Spanish Government (project RTI2018-100910-B-C41) and the Generalitat Valenciana (project PROMETEO 2018/024). B.L.-T. is grateful to the Spanish Ministry of Economy for their PhD grants (FPU15/02707). I.G. thanks her contract from IDM. J.F.-B. thanks to his postdoctoral fellowship (CD19/00038). J.A.L.-D. thanks the financial support from the Ministry of Science/MICINN (IJCI-2017-33047). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Economy cofunded by the European Regional Development Fund (ERDF) (SAF201348256-R), the European Research Council (ERC-2014-AdG/669622), and the "laCaixa" Foundation. The D.M.-E. laboratory is supported by the Cancer Research U.K. (CRUK), Cambridge Centre Early Detection Programme, by a CRUK Early Detection OHSU project award (C62187/A26989), by a Medical Research Council (MRC) New Investigators Research Grant (NIRG, MR/R000530/1).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A fluorogenic capped mesoporous aptasensor for gluten detection

  • Pla, Luis
  • Santiago Felipe, Sara
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Celiac disease is a complex and autoimmune disorder caused by the ingestion of gluten affecting almost 1% of global population. Nowadays an effective treatment does not exist, and the only way to manage the disease is the removal of gluten from the diet. Owing the key role played by gluten, clear and regulated labelling of foodstuff and smart methods for gluten detection are needed to fight frauds on food industry and to avoid the involuntary ingestion of this protein by celiac patients. On that scope, the development of a novel detection system of gluten is here presented. The sensor consists of nanoporous anodic alumina films loaded with a fluorescent dye and capped with an aptamer that recognizes gliadin (gluten's soluble proteins). In the presence of gliadin, aptamer sequences displace from the surface of anodic alumina resulting in pore opening and dye delivery. The dispositive shows a limit of detection (LOD) of 100 mu g kg(-1) of gliadin, good selectivity and a detection time of approximately 60 min. Moreover, the sensor is validated in real food samples. This novel probe allows fast gluten detection through a simple signalling process with potential use for food control. (C) 2020 Elsevier B.V. All rights reserved., The authors want to thank the Spanish Government RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and the Generalitat Valenciana (project PROMETEO/2018/024) for support. L.P. thanks to Ministerio de Economia, Industria y Competitividad for his FPI grant. S.S.-F. thanks CIBER and ISCIII for her Sara Borrell contract. The authors also thank the Electron Microscopy Service at the UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Smart microdevices for nutraceutical-controlled delivery

  • Poyatos Racionero, Elisa
[ES] La presente tesis doctoral, titulada "Microportadores inteligentes para la liberación controlada de sustancias de interés nutracéutico", se centra en el diseño y evaluación de sistemas híbridos orgánico-inorgánicos para proteger y liberar controladamente compuestos bioactivos. Dichos sistemas están basados en (i) materiales de sílice, principalmente partículas mesoporosas, como soporte inorgánico para almacenar y proteger la carga bioactiva; y (ii) una capa externa de biomoléculas como puerta molecular, que regula la liberación de la carga ante ciertos estímulos. En el primer capítulo de la tesis se describe el ácido oleico como puerta molecular. Este capítulo se subdivide en tres artículos diferentes, con distintos objetivos. En el primer artículo se emplea por primera vez el ácido oleico como puerta molecular de un soporte mesoporoso, cargado con la molécula modelo rodamina B. El material preparado es capaz de proteger la carga en las condiciones presentes en la boca y en el estómago, e inducir su liberación en el intestino con la acción surfactante de las sales biliares. El sistema se ha empleado para la liberación de vitamina B2, demostrando así la utilidad del diseño para la protección y liberación controlada de nutracéuticos. El segundo artículo evalúa la efectividad de esta puerta molecular en diferentes tipos de partículas mesoporosas de sílice, con diversos tamaños y estructuras de poro (MCM-41, MCM-48, SBA-15 y UVM-7). En todos los sistemas estudiados, la puerta molecular es capaz de mantener protegidas las moléculas cargadas, y liberarlas ante la presencia de sales biliares. El sólido basado en la estructura de UVM-7 se validó in vivo, observándose un retraso en la absorción intestinal de la rodamina gracias a su encapsulación. Por último, el tercer artículo incluido en este capítulo ha estudiado la posibilidad de incorporar puertas moleculares en filosilicatos. Se ha conseguido la protección y liberación controlada de biomoléculas de gran tamaño implicadas en el metabolismo humano (vitamina B12 y hematina) empleando filosilicatos funcionalizados con ácido oleico como puerta molecular. El segundo capítulo describe por primera vez el uso de la proteína zeína (prolamina de maíz) como puerta molecular. La presencia de la prolamina de maíz inhibe la salida de los compuestos antimicrobianos encapsulados (timol, carvacrol y cinamaldehído) liberándolos en presencia de las enzimas proteolíticas excretadas durante el crecimiento bacteriano. De todos los materiales desarrollados, el sistema cargado con cinamaldehído ha demostrado una inhibición del crecimiento de E. coli superior a la del compuesto libre. Finalmente, el tercer capítulo estudia la efectividad de la lactosa como puerta molecular para proteger aceites esenciales y liberarlos solo en las condiciones presentes en el intestino. Se han preparado tres materiales diferentes basados en MCM-41, cargados con timol, eugenol y cinamaldehído, y funcionalizados con lactosa para inhibir la salida de los compuestos. La acción enzimática de la lactasa secretada en el intestino es capaz de hidrolizar la puerta molecular en los correspondientes monosacáridos, liberando la carga a lo largo del lumen intestinal. Los microdispositivos diseñados han sido validados in vitro con células Caco-2, donde se ha observado el aumento de la capacidad citotóxica del cinamaldehído y la disminución de la permeabilidad a través del modelo de membrana intestinal gracias a su encapsulación. Finalmente, el microdispositivo cargado con cinamaldehído se ha validado in vivo ratificándose la disminución de la permeabilidad del compuesto y su mayor permanencia en el lumen intestinal. Así, la presente tesis doctoral ha demostrado la posibilidad de emplear biomoléculas sencillas de grado alimentario como puertas moleculares sobre diversos materiales de sílice. Estos nuevos sistemas han permitido proteger y liberar control, [CA] La present tesi doctoral, titulada "Microportadors intel·ligents per a l'alliberament controlat de substàncies d'interès nutracèutic", se centra en el disseny i avaluació de sistemes híbrids orgànic-inorgànics per a la protecció i alliberament controlat de compostos bioactius. Aquests sistemes estan basats en (i) materials de sílice, principalment partícules mesoporoses, com a suport inorgànic per emmagatzemar i protegir la càrrega bioactiva; i (ii) una capa externa de biomolècules com a porta molecular, que regula l'alliberament d'aquesta càrrega davant de determinats estímuls. En el primer capítol de la tesi es descriu l'àcid oleic com a porta molecular. Aquest capítol se subdivideix en tres articles diferents, amb objectius diferents. En el primer article s'empra per primera vegada l'àcid oleic com a porta molecular d'un suport mesoporós, carregat amb la molècula model rodamina B. El material preparat és capaç de protegir la càrrega en les condicions presents a la boca i a l'estómac, i induir el seu alliberament a l'intestí amb l'acció surfactant de les sals biliars. El sistema s'ha emprat per a l'alliberament de vitamina B2, demostrant així la utilitat del disseny per a la protecció i alliberament controlat de nutracèutics. El segon article avalua l'efectivitat d'aquesta porta molecular en diferents tipus de partícules mesoporoses de sílice, amb diverses mides i estructures de porus (MCM-41, MCM-48, SBA-15 i UVM-7). En tots els sistemes estudiats, la porta molecular és capaç de mantindre protegides les molècules carregades, i alliberar-les davant la presència de sals biliars. El sòlid basat en l'estructura de UVM-7 es validà in vivo, observant-se un retard en l'absorció intestinal de la rodamina gràcies a la seua encapsulació. Finalment, en el tercer article inclòs en aquest capítol s'ha estudiat la possibilitat d'incorporar portes moleculars en fil·losilicats. S'ha aconseguit la protecció i alliberament controlat de biomolècules de grans dimensions implicades en el metabolisme humà (vitamina B12 i hematina) emprant fil·losilicats funcionalitzats amb àcid oleic com a porta molecular. El segon capítol descriu per primera vegada l'ús de la proteïna zeïna (prolamina de dacsa) com a porta molecular. La presència de la prolamina de dacsa inhibeix la sortida dels compostos antimicrobians encapsulats (timol, carvacrol i cinamaldèhid) alliberant-los en presència dels enzims proteolítics excretades durant el creixement bacterià. De tots els materials desenvolupats, el sistema carregat amb cinamaldèhid ha demostrat una inhibició de l'creixement d'E. coli superior a la del compost lliure. Finalment, el tercer capítol estudia l'efectivitat de la lactosa com a porta molecular per protegir olis essencials i alliberar-los només en les condicions presents a l'intestí. S'han preparat tres materials diferents basats en MCM-41, carregats amb timol, eugenol i cinamaldèhid, i funcionalitzats amb lactosa per inhibir l'eixida dels compostos. L'acció enzimàtica de la lactasa secretada a l'intestí és capaç d'hidrolitzar la porta molecular en els corresponents monosacàrids, alliberant la càrrega al llarg del lumen intestinal. Els microdispositius dissenyats s'han validat in vitro amb cèl·lules Caco-2, on s'observà l'augment de la capacitat citotòxica del cinamaldèhid i la disminució de la permeabilitat a través del model de membrana intestinal gràcies a la seua encapsulació. Finalment, el microdispositiu carregat amb cinamaldèhid s'ha validat in vivo ratificant la disminució de la permeabilitat del compost i la seua major permanència al lumen intestinal. Així, la present tesi doctoral ha demostrat la possibilitat d'emprar biomolècules senzilles de grau alimentari com portes moleculars sobre diversos materials de sílice. Aquests nous sistemes han permès protegir i alliberar controladament diferents nutracèutics, millorant així la seua biodisponibilitat., [EN] This PhD thesis, entitled "Smart microdevices for nutraceutical-delivery", is focused on the design and evaluation of organic-inorganic hybrid systems for the protection and controlled release of bioactive molecules. These systems are based on (i) silica materials, mainly mesoporous particles, as inorganic support to store and protect the bioactive cargo; and (ii) an outer layer of biomolecules that regulate the payload release triggered by certain stimuli. In the first chapter of the thesis oleic acid is described as a molecular gate. This chapter is subdivided into three different articles, with different objectives. In the first article, oleic acid is used for the first time as molecular gate of a mesoporous support, loaded with the rhodamine B model molecule. The designed material is capable of protecting the cargo under the conditions present in the mouth and stomach, and inducing its release in the small intestine with the surfactant action of bile salts. The system has been used for the release of vitamin B2, thus demonstrating the validity of the design for the protection and controlled release of nutraceuticals. The second article evaluates the effectiveness of this molecular gate in different types of mesoporous silica particles, with different sizes and pore structures (MCM-41, MCM-48, SBA-15 and UVM-7). In all the systems studied, the molecular gate is capable of keeping cargo molecules protected and releasing them in the presence of bile salts. The solid based on the structure of UVM-7 was validated in vivo, observing a delay in the intestinal absorption of rhodamine thanks to its encapsulation. Lastly, the third article included in this chapter has studied the possibility of incorporating molecular gates onto phyllosilicates. The protection and controlled release of large biomolecules involved in human metabolism (vitamin B12 and hematin) have been achieved using phyllosilicates functionalized with oleic acid as molecular gate. The second chapter describes for the first time the use of the protein zein (corn prolamine) as a molecular gate. The presence of corn prolamine inhibits the release of encapsulated antimicrobial compounds (thymol, carvacrol and cinnamaldehyde) releasing them in the presence of the proteolytic enzymes excreted during bacterial growth. Among all the materials developed, the cinnamaldehyde-loaded system has shown greater inhibition of E. coli growth than the free compound. Finally, the third chapter studies the effectiveness of lactose as a molecular gate to protect essential oils and release them only under the conditions present in the intestine. Three different materials based on MCM-41 loaded with thymol, eugenol, and cinnamaldehyde, and functionalized with lactose to inhibit the release of the compounds have been prepared. The enzymatic action of the lactase secreted in the intestine is capable of hydrolyzing the molecular gate into the corresponding monosaccharides, thus releasing the cargo along the intestinal lumen. The designed microdevices have been validated in vitro with Caco-2 cells, where an increase in the cytotoxic capacity of cinnamaldehyde and a decrease in permeability through the intestinal membrane model have been observed thanks to its encapsulation. Finally, the cinnamaldehyde-loaded microdevice has been validated in vivo, confirming the decrease in the permeability of the compound and its greater permanence in the intestinal lumen. Thus, the present PhD thesis has demonstrated the possibility of using simple food-grade biomolecules as gatekeepers on various silica materials. These new systems have allowed the protection and controlled release of different nutraceuticals, thus improving their bioavailability., The authors also thank the Electron Microscopy Service at the UPV for support. The authors also thank Prof. Pedro Amorós for his explanations and guidance on the knowledge of phyllosilicates.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A new 8-oxo-7,8-2 &apos, deoxyguanosine nanoporous anodic alumina aptasensor for colorectal cancer diagnosis in blood and urine

  • Pla, Luis
  • Bañuls, Celia
  • Estañ, Nuria
  • Botello-Marabotto, Marina Dolores
  • Sáez, Guillermo
  • Santiago-Felipe, Sara
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Many important human diseases, and especially cancer, have been related to the overproduction of 8-oxo-7,8-dihydro-2 '-deoxyguanosine (8-oxo-dG). This molecule is a product of oxidative stress processes over nucleophilic bases in DNA. In this work, an aptasensor for the rapid, selective and accurate detection of this oncomarker is presented. The aptasensor consists of a nanoporous anodic alumina material loaded with a dye and is functionalized with an aptamer-based "molecular gate". In the presence of target 8-oxo-dG, the capping aptamer displaces from the surface due to the high affinity of the analyte with the capping aptamer, thus inducing delivery of the preloaded fluorescent dye. In contrast, in the absence of 8-oxo-dG, a poor payload delivery is accomplished. This aptamer-based nanodevice has great sensitivity for 8-oxo-dG, resulting in a LOD of 1 nM and a detection time of ca. 60 min. Moreover, the aptasensor is able to accurately detect 8-oxo-dG in unmodified urine and serum without pre-concentration treatments. This diagnostic tool is validated in a set of 38 urine and serum samples from patients diagnosed of colorectal cancer and control patients. These samples are also analyzed using a standardized and specific ELISA kit. The aptasensor displays excellent sensitivity (95.83/100%) and specificity (80/100%) for 8-oxo-dG detection in serum and urine samples, respectively. Our results may serve as a basis for the development of generalized fluorogenic diagnostic platforms for the easy diagnosis of cancer in biofluids as well as for monitoring therapeutic treatments and detection of relapses without the use of expensive equipment or trained personnel., This study was supported by the Spanish Government (project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE)), the Generalitat Valenciana (project PROMETEO/2018/024) and the Universitat Politecnica de Valencia - Hospital Universitari Doctor Peset POLISABIO collaboration program (UPV-FISABIO) (NanOdGSens_2.0). FISABIO Grupos Emergentes (UGP-19-037). Red Tematica Biologia y Medicina Redox. S.S. thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support "Sara Borrell" (CD16/000237). C.B. thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support "Miguel Servet Tipo I" (CP19/00077). L.P. thanks Ministerio de Economia, Industria y Competitividad for his FPI grant. We acknowledge the support of the Electron Microscopy Service of Universitat Politecnica de Valencia (UPV).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Monofloral honey authentication by voltammetric electronic tongue: A comparison with 1H NMR spectroscopy

  • Lozano-Torres, Beatriz
  • Soto Camino, Juan
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Juan-Borras, María del Sol|||0000-0003-4774-9484
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
[EN] Proton-nuclear-magnetic-resonance-spectroscopy (H-1 NMR) is the widely accepted reference method for monitoring honey adulteration; however, the need to find cheaper, faster, and more environmentally friendly methodologies makes the voltammetric-electronic-tongue (VET) a good alternative. The present study aims to demonstrate the ability of VET (in comparison with H-1 NMR) to predict the adulteration of honey with syrups. Samples of monofloral honeys (citrus, sunflower and heather, assessed by pollen analysis) simulating different levels of adulteration by adding syrups (barley, rice and corn) from 2.5 to 40% (w/w) were analyzed using both techniques. According to the indicators (slope, intercept, regression coefficient-R-2, root mean square error of prediction-RMSEP) of the partial-least-squares (PLS) regression models, in general terms, the performance of these models obtained by both techniques was good, with an average error lower than 5% in both cases. These results support the use of VET as a screening technique to easily detect honey adulteration with syrups., The authors are grateful for financial support from the "Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigacon" of Spain under the project PID2019-106800RB-I00 (2019). Also, we wish to thank the Spanish Government (project RTI2018-100910-B-C41 (MCUI/FEDER, EU)), the Generalitat Valenciana (project PROMETEO 2018/024 B.L-T) and the Spanish "Ministerio de Educacion, Cultura y Deporte" (PhD grant FPU15/02707).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Vascular Senescence: A Potential Bridge Between Physiological Aging and Neurogenic Decline

  • Rojas-Vázquez, Sara
  • Blasco-Chamarro, Laura
  • López-Fabuel, Irene
  • Fariñas, Isabel
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The adult mammalian brain contains distinct neurogenic niches harboring populations of neural stem cells (NSCs) with the capacity to sustain the generation of specific subtypes of neurons during the lifetime. However, their ability to produce new progeny declines with age. The microenvironment of these specialized niches provides multiple cellular and molecular signals that condition NSC behavior and potential. Among the different niche components, vasculature has gained increasing interest over the years due to its undeniable role in NSC regulation and its therapeutic potential for neurogenesis enhancement. NSCs are uniquely positioned to receive both locally secreted factors and adhesion-mediated signals derived from vascular elements. Furthermore, studies of parabiosis indicate that NSCs are also exposed to blood-borne factors, sensing and responding to the systemic circulation. Both structural and functional alterations occur in vasculature with age at the cellular level that can affect the proper extrinsic regulation of NSCs. Additionally, blood exchange experiments in heterochronic parabionts have revealed that age-associated changes in blood composition also contribute to adult neurogenesis impairment in the elderly. Although the mechanisms of vascular- or blood-derived signaling in aging are still not fully understood, a general feature of organismal aging is the accumulation of senescent cells, which act as sources of inflammatory and other detrimental signals that can negatively impact on neighboring cells. This review focuses on the interactions between vascular senescence, circulating pro-senescence factors and the decrease in NSC potential during aging. Understanding the mechanisms of NSC dynamics in the aging brain could lead to new therapeutic approaches, potentially include senolysis, to target age-dependent brain decline., Work in the laboratory of IF is supported by Spanish grants from FEDER/Ministerio de Ciencia e Innovación (MICI)-Agencia Estatal de Investigación (SAF2017-86690-Rand Network of Excellence iDIFFER RED2018-102723-T), Instituto de Salud Carlos III (CIBERNED CB06/05/0086 and RETIC Tercel RD16/0011/0017) and Generalitat Valenciana (Prometeo 2017/030). Work in the laboratory of RM-M is supported by Spanish Government project RTI2018-100910-B-C41 (MCUI/FEDER, EU) and the Generalitat Valenciana project PROMETEO 2018/024. SR-V and LB-C are recipients of predoctoral contracts from the Spanish Ministerio de Educación. IL-F is a recipient of a Juan de la Cierva postdoctoral contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Impact of Brain Endothelial Senescence on Neurogenesis: Application of Novel Strategies for Age-Related Senescence Detection

  • Rojas Vázquez, Sara
[ES] El envejecimiento se concibe como un proceso progresivo de deterioro funcional que se produce a lo largo de la vida. En general, el avance de la edad va acompañado del deterioro de múltiples tejidos, la alteración de la homeostasis y el aumento de la fragilidad. La edad se considera el principal factor de riesgo de un gran número de enfermedades con elevadas tasas de mortalidad, como las patologías cardiovasculares, el cáncer, la fibrosis pulmonar, la esteatosis hepática y los trastornos neurodegenerativos, entre otros. A medida que aumenta la población de edad avanzada, estas patologías son cada vez más frecuentes en nuestra sociedad y constituyen actualmente una de las principales preocupaciones sanitarias en atención primaria. Por consiguiente, comprender los mecanismos que causan el envejecimiento y el consiguiente deterioro de la salud es un reto importante para la comunidad científica, respaldado por un significativo interés socioeconómico. Alcanzar este objetivo permitiría realizar intervenciones específicas contra las enfermedades relacionadas con la edad, promover un envejecimiento saludable y prolongar la vida humana. En este contexto, la senescencia celular se ha convertido en un importante objetivo de investigación, ya que este destino celular se considera un factor que contribuye al deterioro funcional y estructural de los tejidos con el aumento de la edad, dando lugar a enfermedades crónicas. Los trastornos neurodegenerativos son en su mayoría de etiología desconocida, y en la actualidad sólo se dispone de tratamientos paliativos. La neurodegeneración puede deberse a la disminución de la neurogénesis que se produce con el envejecimiento. A este respecto, la vasculatura cerebral representa un componente esencial de los nichos neurogénicos, donde residen las células con capacidad para generar nuevas neuronas. Los microvasos cerebrales contribuyen sustancialmente a preservar la homeostasis y el potencial neurogénico de estas regiones, pero también experimentan cambios estructurales y funcionales con la edad. Sin embargo, aún no está claro si estas alteraciones están relacionadas con la senescencia celular. De ahí que el propósito de esta tesis sea profundizar en los entresijos de la senescencia relacionada con la edad y su impacto en el proceso de envejecimiento cerebral. En este sentido, hemos desarrollado una sonda fluorogénica para la detección in vivo de la actividad ß-Gal, un marcador ampliamente utilizado de senescencia celular. Hemos estimado la carga de células senescentes de forma no invasiva en estudios longitudinales utilizando esta sonda durante el envejecimiento natural y acelerado o durante tratamientos senolíticos. Estos resultados nos han permitido establecer una correlación real entre envejecimiento y senescencia. Por otro lado, hemos centrado nuestros esfuerzos en crear estrategias para detectar la senescencia en las células endoteliales cerebrales y estudiar sus efectos sobre la neurogénesis durante el envejecimiento. Los resultados mostraron que las células endoteliales senescentes a nivel cerebral tienen un impacto perjudicial sobre la neurogénesis y las células madre neurales, lo que sitúa a estas células como diana para futuros estudios sobre el envejecimiento cerebral., [CA] L'envelliment es concep com un procés progressiu de deterioració funcional que es produeix al llarg de la vida. En general, l'avanç de l'edat va acompanyat de la deterioració de múltiples teixits, l'alteració de l'homeòstasi i l'augment de la fragilitat. L'edat es considera el principal factor de risc d'un gran nombre de malalties amb elevades taxes de mortalitat, com les patologies cardiovasculars, el càncer, la fibrosi pulmonar, la esteatosis hepàtica i els trastorns neurodegeneratius, entre altres. A mesura que augmenta la població d'edat avançada, aquestes patologies són cada vegada més freqüents en la nostra societat i constitueixen actualment les principals preocupacions sanitàries en atenció primària. Per consegüent, comprendre els mecanismes que causen l'envelliment i la consegüent deterioració de la salut és un repte important per a la comunitat científica, recolzat per un significatiu interés socioeconòmic. Aconseguir aquest objectiu permetria realitzar intervencions específiques contra les malalties relacionades amb l'edat, promoure un envelliment saludable i prolongar la vida humana. En aquest context, la senescència cel·lular s'ha convertit en un important objectiu d'investigació, ja que aquest destí cel·lular es considera un factor que contribueix a la deterioració funcional i estructural dels teixits amb l'augment de l'edat, donant lloc a malalties cròniques. Els trastorns neurodegeneratius són en la seua majoria d'etiologia desconeguda, i en l'actualitat només es disposa de tractaments pal·liatius. La neurodegeneración pot deure's a la disminució de la neurogènesi que es produeix amb l'envelliment. Referent a això, la vasculatura cerebral representa un component essencial dels nínxols neurogènics, on resideixen les cèl·lules amb capacitat per a generar noves neurones. Els microvasos cerebrals contribueixen substancialment a preservar l'homeòstasi i el potencial neurogènic d'aquestes regions, però també experimenten canvis estructurals i funcionals amb l'edat. No obstant això, encara no és clar si aquestes alteracions estan relacionades amb la senescència cel·lular. D'aquí ve que el propòsit d'aquesta tesi siga aprofundir en els secrets de la senescència relacionada amb l'edat i el seu impacte en el procés d'envelliment cerebral. En aquest sentit, hem desenvolupat una sonda fluorogénica per a la detecció in vivo de l'activitat ß-Gal, un marcador àmpliament utilitzat de senescència cel·lular. Hem estimat la càrrega de cèl·lules senescentes de forma no invasiva en estudis longitudinals utilitzant aquesta sonda durant l'envelliment natural i accelerat o durant tractaments senolíticos. Aquests resultats ens han permés establir una correlació real entre envelliment i senescència. D'altra banda, hem centrat els nostres esforços a crear estratègies per a detectar la senescència en les cèl·lules endotelials cerebrals i estudiar els seus efectes sobre la neurogènesi durant l'envelliment. Els resultats van mostrar que les cèl·lules endotelials *senescentes a nivell cerebral tenen un impacte perjudicial sobre la neurogènesi i les cèl·lules mare *neurales, la qual cosa situa a aquestes cèl·lules com a diana per a futurs estudis sobre l'envelliment cerebral., [EN] Ageing is conceived as a progressive process of functional decline that occurs over the course of life. In general, advancing age is accompanied by the deterioration of multiple tissues, altered homeostasis and increased frailty. Age is considered to be the main risk factor for a large number of diseases with high mortality rates, such as cardiovascular pathologies, cancer, pulmonary fibrosis, hepatic steatosis, and neurodegenerative disorders, among others. As the elderly population grows, these pathologies are becoming increasingly prevalent in our society and are now the leading health concerns in primary care. Consequently, comprehending the mechanisms that cause ageing and resulting health decline is a major challenge for the scientific community, backed by significant socio-economic interest. Achieving this goal would allow for targeted interventions against age-related diseases, promote healthy ageing, and extend human lifespan. In this context, cellular senescence has emerged as an important research target, as this cellular fate is considered a contributing factor to the functional and structural deterioration of tissues with increasing age, leading to chronic diseases. Neurodegenerative disorders are mostly of unknown etiology, and only palliative treatments are currently available. Neurodegeneration may be prompted by the decline in neurogenesis that occurs with ageing. In this regard, the brain vasculature represents an essential component of the neurogenic niches, where cells with the capacity to generate new neurons reside. Brain microvessels contribute substantially to preserving the homeostasis and neurogenic potential of these regions, but they also undergo structural and functional changes with age. However, whether these alterations are linked to cellular senescence it is not yet clear. Hence, the purpose of this thesis is to delve deeper into the intricacies of age-related senescence and its impact on the process of brain ageing. In this regard, we have developed a fluorogenic probe for the in vivo detection of ß-Gal activity, a widely used marker of cellular senescence. We have estimated the senescent cell burden non-invasively in longitudinal studies using this probe during natural and accelerated ageing or during senolytic treatments. These results have allowed us to establish a real correlation between ageing and global senescence. On the other hand, we have focused our efforts on creating strategies to detect senescence in brain endothelial cells and to study its effects on neurogenesis during ageing. The results showed that senescent endothelial cells at the brain level have a detrimental impact on neurogenesis and neural stem cells, positioning these cells as a target for future studies on brain ageing., This PhD thesis has been supported by a pre-doctoral scholarship from the Spanish Ministry of Universities, “Programa de Formación del Profesorado Universitario (FPU)”, and a technical expert contract funded by the European Commission. The research has been funded by the following research projects led by Ramón Mártinez Máñez: - Gobierno de España (RTI2018-100910-B-C41 and PID2021-126304OB-C41). - Generalitat Valenciana (PROMETEO 2018/024 and CIPROM/2021/007). - CIBER-BBN- Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (CB06/01/2012). And by the following research projects led by Isabel Fariñas: - 2014-2018. Estudio de células madre en el ámbito de las investigaciones básicas en terapia celular. Fundación Botín-Banco de Santander. - 2018-2021. Regulación del comportamiento de las células madre neurales por el medio sistémico: el nicho extendido. MINECO (SAF2017-86690-R). - 2016-ongoing. CIBER en Enfermedades Neurodegenerativas (CIBERNED). ISCIII (Programa de Investigación Cooperativa, CB06/05/0086). - 2017-2021. Efectos directos y remotos de la respuesta inflamatoria sobre las células madre neurales. Generalitat Valenciana (Proyectos de Excelencia, PROMETEO/2017/030). - 2017-2021. RETIC de terapia celular ISCIII (RD16/0011/0017). - 2021-2024 Regulación molecular de la heterogeneidad celular en los nichos neurogénicos adultos MICINN (PID2020- 117937GB-I00). - 2021-2025. Una aproximación multidisciplinar al estudio de la respuesta al daño genómico en células madre neurales: de levadura a mamíferos y vuelta. Generalitat Valenciana. Programa Prometeo de Proyectos de Excelencia (PROMETEO/2021/028).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Engineering nanoparticle communication in living systems by stigmergy: An application to enhance antitumor therapy in triple-negative breast cancer

  • Estepa-Fernández, Alejandra
  • Lérida-Viso, Araceli
  • Blandez, Juan F.
  • Alfonso-Navarro, María
  • Vivo-Llorca, Gema
  • Orzaez, Mar
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Esteve-Moreno, Juan José|||0000-0002-1259-7663
  • Candela-Noguera, Vicente
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The engineering of nanoparticle communication has gained growing attention in the last years, however, efforts to communicate nanoparticles with living systems is still a barely studied emerging topic. Here, we explore a nanoparticle cooperation strategy that involves nanoparticle-cell-nanoparticle communication in vivo through stigmergy (a strategy in which nanodevices communicate by modifying the environment). First, mesoporous silica nanoparticles loaded with the senescence inductor palbociclib and coated with a heterobifunctional poly(ethylene glycol) that binds covalently to a MUC1-binding aptamer (NP(palbo)PEG-MUC1), is designed to specifically deliver the pro-senescent drug palbociclib in MDA-MB-231 breast cancer cells. Once the first nanoparticle modifies the environment due to the induction of senescence, a second community of nanoparticles, loaded with the senolytic navitoclax and coated with a hexa-oligo-saccharide (NP(nav)-Gal), releases its cargo to eliminate tumor senescent cells selectively. The targeted therapy through stigmergy communication is tested in vitro, and in vivo, where delays tumor growth and reduces metastases in a mouse model of human triple-negative breast cancer while minimizing undesired drugs side effects., R.M. laboratory members thank the financial support from the Spanish Government projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 and (MCUI/FEDER, EU) and the Generalitat Valenciana (project PROMETEO 2018/024). This work was funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). M.O. thanks the financial support from the Spanish Government project (PID2020-115048RB-I0 0) and the Generalitat Valenciana (project PROMETEO/2019/065). A.E-F. is grateful to the Spanish Government for her Ph.D. grant (FPU17/05454), A.L-V. is grateful to the Instituto de Salud Carlos III for her Ph.D. i-PFIS grant (IFI17/00039). J.B. thanks to the Instituto de Salud Carlos III for his Sara Borrell contract (CD19/00038).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Targeted-lung delivery of dexamethasone using gated mesoporous silica nanoparticles. A new therapeutic approach for acute lung injury treatment

  • García-Fernández, Alba|||0000-0002-8416-1674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancho, Mónica
  • Bisbal, Viviana
  • Amorós, Pedro
  • Orzáez, Mar
[EN] Acute lung injury (ALI) is a critical inflammatory syndrome, characterized by increased diffuse inflammation and severe lung damage, which represents a clinical concern due to the high morbidity and mortality in critical patients. In last years, there has been a need to develop more effective treatments for ALI, and targeted drug delivery to inflamed lungs has become an attractive research field. Here, we present a nanodevice based on mesoporous silica nanoparticles loaded with dexamethasone (a glucocorticoid extensively used for ALI treatment) and capped with a peptide that targets the TNFR1 receptor expressed in pro-inflammatory macrophages (TNFR-Dex-MSNs) and avoids cargo leakage. TNFR-Dex-MSNs nanoparticles are preferentially internalized by pro-inflammatory macrophages, which overexpressed the TNFR1 receptor, with the subsequent cargo release upon the enzymatic hydrolysis of the capping peptide in lysosomes. Moreover, TNFR-Dex-MSNs are able to reduce the levels of TNF-alpha and IL-1I3 cytokines in activated pro-inflammatory M1 macrophages. The antiinflammatory effect of TNFR-Dex-MSNs is also tested in an in vivo ALI mice model. The administered nanodevice (intravenously by tail vein injection) accumulated in the injured lungs and the controlled dexamethasone release reduces markedly the inflammatory response (TNF-alpha IL-6 and IL-1I3 levels). The attenuation in lung damage, after treatment with TNFR-Dex-MSNs, is also confirmed by histopathological studies. Besides, the targeted-lung dexamethasone delivery results in a decrease of dexamethasone derived side-effects, suggesting that targeted nanoparticles can be used for therapy in ALI and could help to overcome the clinical limitations of current treatments., A. Garcia-Fernandez thanks the Spanish government for her FPU fellowship. The R. Martinez-Manez group is grateful to the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-BC22-AR (MCUI/AEI/FEDER, UE) and the Generalitat Valencia (Project PROMETEO/2018/024) for support. M.Orz ' aez group thanks to the financial support from the Spanish Government (SAF2017-84689-R project MINECO/AEI/FEDER, UE) and the Generalitat Valenciana (project PROMETEO/2019/065). The authors would thank the Server Medical Art platform for using their templates to design some schemes. Would like to thank I. Borreda and J. Forteza from Instituto Valenciano de Patologia for its technical support in the histopathology analysis and Animal Facilities from Centro de Investigación Principe Felipe for its support in the animal research and procedures.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A 1-to-2 demultiplexer hybrid nanocarrier for cargo delivery and activation

  • de Luis-Fernández, Beatriz
  • Villalonga, Reynaldo
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] A biocomputing strategy implemented in hybrid nanocarriers for controlled cargo delivery is described. The nanodevice consists of enzyme-functionalized Janus Au-mesoporous silica nanoparticles, which behave as an electronic demultiplexer (DEMUX). The nanocarrier is capable of reading molecular information from the environment (lactose) and selecting one of two possible outputs (galactose production or 4-methylumbellilferone release and activation) depending on the presence of an addressing input NAD(+)., The authors wish to thank the Spanish Government (projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE), CTQ2017-87954-P), the Generalitat Valenciana (PROMETEO 2018/024), the Comunidad de Madrid (IND2017/BMD-7642) and CIBER-BBN (NANOCOMMUNITY project) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Horseradish Peroxidase-Functionalized Gold Nanoconjugates for Breast Cancer Treatment Based on Enzyme Prodrug Therapy

  • Vivo-Llorca, Gema
  • Diez-Sánchez, Paula
  • Orzáez, Mar
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Introduction: Breast cancer has the highest mortality rate among cancers in women. Patients suffering from certain breast cancers, such as triple-negative breast cancer (TNBC), lack effective treatments. This represents a clinical concern due to the associated poor prognosis and high mortality. As an approach to succeed over conventional therapy limitations, we present herein the design and evaluation of a novel nanodevice based on enzyme-functionalized gold nanoparticles to efficiently perform enzyme prodrug therapy (EPT) in breast cancer cells. Results: In particular, the enzyme horseradish peroxidase (HRP) which oxidizes the prodrug indole-3-acetic acid (IAA) to release toxic oxidative species is incorporated on gold nanoconjugates (HRP-AuNCs), obtaining an efficient nanoplatform for EPT. The nanodevice is biocompatible and effectively internalized by breast cancer cell lines. Remarkably, co-treatment with HRP-AuNCs and IAA (HRP-AuNCs/IAA) reduces the viability of breast cancer cells below 5%. Interestingly, 3D tumor models (multicellular tumor spheroid-like cultures) co-treated with HRP-AuNCs/IAA exhibit a 74% reduction of cell viability, whereas the free formulated components (HRP, IAA) have no effect. Conclusion: Altogether, our results demonstrate that the designed HRP-AuNCs nanoformulation shows a remarkable therapeutic performance. These findings might help to bypass the clinical limitations of current tumor enzyme therapies and advance towards the use of nanoformulations for EPT in breast cancer., Gema Vivo-Llorca thanks the Generalitat Valenciana for her fellowship ACIF/2017/072. Paula Díez thanks the Generalitat Valenciana for her contract APOSTD/2020/153 and to the Instituto de Salud Carlos III and the European Social Fund for the financial support "Sara Borrell", CD20/00120. Antoni Llopis-Lorente thanks funding from the European Union¿s Horizon 2020 research and innovation programme under grant agreement No 847675. Images were prepared using Servier Medical Art (https://smart.servier.com/). We thank the Spanish Government (project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE); SAF2017-84689-R-B (MCUI/ AEI/FEDER, UE)) and the Generalitat Valenciana (project PROMETEO/2018/024 and PROMETEO/2019/065) for support. A pre-print version of this work was published as a chapter of the PhD thesis of the first author Gema VivoLlorca
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer

  • Loras, Alba
  • Quintás, Guillermo
  • Gil Grau, Salvador
  • Ruiz-Cerdá, José Luis
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Patients with non-muscle invasive bladder cancer (NMIBC) undergo lifelong monitoring based on repeated cystoscopy and urinary cytology due to the high recurrence rate of this tumor. Nevertheless, these techniques have some drawbacks, namely, low accuracy in detection of low-grade tumors, omission of pre-neoplastic lesions and carcinomas in situ (CIS), invasiveness, and high costs. This work aims to identify a urinary metabolomic signature of recurrence by proton Nuclear Magnetic Resonance (H-1 NMR) spectroscopy for the follow-up of NMIBC patients. To do this, changes in the urinary metabolome before and after transurethral resection (TUR) of tumors are analyzed and a Partial Least Square Discriminant Analysis (PLS-DA) model is developed. The usefulness of this discriminant model for the detection of tumor recurrences is assessed using a cohort of patients undergoing monitoring. The trajectories of the metabolomic profile in the follow-up period provide a negative predictive value of 92.7% in the sample classification. Pathway analyses show taurine, alanine, aspartate, glutamate, and phenylalanine perturbed metabolism associated with NMIBC. These results highlight the potential of H-1 NMR metabolomics to detect bladder cancer (BC) recurrences through a non-invasive approach., This work was partly supported by the financial support of FEDER cofounded MINECO grant NANOPROBE, MAT2015-64139-C4-1-R, MAT2015-64139-C4-2-R, RTI2018-100910-B-C41 and RTI2018-100910-B-C43 (MCUI/AEI/FEDER, UE), ISCIII-RETICRD12/0036/0009, CTQ2016-79561-P, PROMETEO II/2014/047 and PROMETEO 2018/024. A.L. acknowledges a predoctoral grant from the Generalitat Valenciana (VALI+D ACIF/2015/115).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Overview of the Evolution of Silica-Based Chromo-Fluorogenic Nanosensors

  • Pla, Luis
  • Lozano-Torres, Beatriz
  • Ros-Lis, José Vicente
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
[EN] This review includes examples of silica-based, chromo-fluorogenic nanosensors with the aim of illustrating the evolution of the discipline in recent decades through relevant research developed in our group. Examples have been grouped according to the sensing strategies. A clear evolution from simply functionalized materials to new protocols involving molecular gates and the use of highly selective biomolecules such as antibodies and oligonucleotides is reported. Some final examples related to the evolution of chromogenic arrays and the possible use of nanoparticles to communicate with other nanoparticles or cells are also included. A total of 64 articles have been summarized, highlighting different sensing mechanisms., This research was funded by the Spanish Government (projects RTI2018-100910-B-C41, RTI2018-100910-B-C44, and AGL2015-70235-C2-2-R) and the Generalitat Valenciana (project PROMETEO/2018/024) for support. B.L.-T. is grateful to the Spanish MEC for her FPU grant. Additionally, L.P. thanks the Spanish MEC for his FPI fellowship.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Electro-responsive films containing voltage responsive gated mesoporous silica nanoparticles grafted onto PEDOT-based conducting polymer

  • García-Fernández, Alba|||0000-0002-8416-1674
  • Monreal-Trigo, Javier|||0000-0002-4067-1867
  • Alcañiz Fillol, Miguel|||0000-0002-4579-9210
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Lozano-Torres, Beatriz
  • Blandez, Juan F.
  • Soto Camino, Juan
  • Collazos-Castro, Jorge E.
[EN] The characteristics and electromechanical properties of conductive polymers together to their biocompatibility have boosted their application as a suitable tool in regenerative medicine and tissue engineering. However, conducting polymers as drug release materials are far from being ideal. A possibility to overcome this drawback is to combine conducting polymers with on-command delivery particles with inherent high-loading capacity. In this scenario, we report here the preparation of conduction polymers containing gated mesoporous silica nanoparticles (MSN) loaded with a cargo that is delivered on command by electro-chemical stimuli increasing the potential use of conducting polymers as controlled delivery systems. MSNs are loaded with Rhodamine B (Rh B), anchored to the conductive polymer poly(3,4-ethylenedioxythiophene) (PEDOT) doped with poly[(4-styrenesulfonic acid)-co-(maleic acid)], functionalized with a bipyridinium derivative and pores are capped with heparin (P3) by electrostatic interactions. P3 releases the entrapped cargo after the application of ¿640 mV voltage versus the saturated calomel electrode (SCE). Pore opening in the nanoparticles and dye delivery is ascribed to both (i) the reduction of the grafted bipyridinium derivative and (ii) the polarization of the conducting polymer electrode to negative potentials that induce detachment of positively charged heparin from the surface of the nanoparticles. Biocompatibility and cargo release studies were carried out in HeLa cells cultures., Alba Garcia-Fernandez, Beatriz Lozano-Torres contributed equally to this work. A. Garcia-Fernandez and B. Lozano-Torres are grateful to the "Ministerio de Economia y Competitividad" of the Spanish Government for her PhD fellowships. J. F. Blandez thanks the "Universitat Politecnica de Valencia" for his postdoctoral fellowship (PAID-10-17). The authors thank to the Spanish Government (Projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/AEI/FEDER, EU)) and the Generalitat Valencia (Project PROMETEO2018-024) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gated Organonanoclays for Large Biomolecules: Controlled Release Triggered by Surfactant Stimulus

  • Poyatos-Racionero, Elisa
  • Pérez-Esteve, Édgar|||0000-0002-0452-1394
  • Medaglia, Serena|||0000-0003-3537-9842
  • Aznar, Elena|||0000-0003-0361-3876
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
[EN] The low toxicity and high adsorption capacities of clay minerals make them attractive for controlled delivery applications. However, the number of controlled-release studies in the literature using clay minerals is still scarce. In this work, three different clays from the smectite group (Kunipia F, montmorillonite; Sumecton SA, saponite; and Sumecton SWN, hectorite) were successfully loaded with rhodamine B dye and functionalized with oleic acid as a gatekeeper to produce organonanoclays for active and controlled payload-release. Moreover, hematin and cyanocobalamin have also been encapsulated in hectorite gated clay. These organonanoclays were able to confine the entrapped cargos in an aqueous environment, and effectively release them in the presence of surfactants (as bile salts). A controlled delivery of 49 +/- 6 mu g hematin/mg solid and 32.7 +/- 1.5 mu g cyanocobalamin/mg solid was reached. The cargo release profiles of all of the organonanoclays were adjusted to three different release-kinetic models, demonstrating the Korsmeyer-Peppas model with release dependence on (i) the organic-inorganic hybrid system, and (ii) the nature of loaded molecules and their interaction with the support. Furthermore, in vitro cell viability assays were carried out with Caco-2 cells, demonstrating that the organonanoclays are well tolerated by cells at particle concentrations of ca. 50 mu g/mL., This research was funded by the Spanish Government (projects RTI2018-100910-B-C41, RTI2018-101599-B-C22-AR and RTI2018-101599-B-C21-AR (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO 2018/024). E.P-R. is grateful to the Generalitat Valenciana for her ACIF/2016/023 PhD. grant. A.B. thanks the Ministerio de Universidades (Spanish Government) for her Beatriz Galindo contract BG20/00020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Secreted Enzyme-Responsive System for Controlled Antifungal Agent Release

  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Pérez-Esteve, Édgar|||0000-0002-0452-1394
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Bozik, Matej
  • Montero, Ana
  • García-Casado, Esther
  • Lhotka, Miroslav
  • Frankova, Adela
  • Kloucek, Pavel
[EN] Essential oil components (EOCs) such as eugenol play a significant role in plant antimicrobial defense. Due to the volatility and general reactivity of these molecules, plants have evolved smart systems for their storage and release, which are key prerequisites for their efficient use. In this study, biomimetic systems for the controlled release of eugenol, inspired by natural plant defense mechanisms, were prepared and their antifungal activity is described. Delivery and antifungal studies of mesoporous silica nanoparticles (MSN) loaded with eugenol and capped with different saccharide gates-starch, maltodextrin, maltose and glucose-against fungus Aspergillus niger-were performed. The maltodextrin- and maltose-capped systems show very low eugenol release in the absence of the fungus Aspergillus niger but high cargo delivery in its presence. The anchored saccharides are degraded by exogenous enzymes, resulting in eugenol release and efficient inhibition of fungal growth., This research was funded by the project NutRisk (Project No: CZ.02.1.01/0.0/0.0/16_019/0000845), the Spanish Government (projects RTI2018-100910-B-C41, RTI2018-101599-B-C22-AR and RTI2018-101599-B-C21-AR (MINECO/FEDER)) and the GeneralitatValenciana (project PROME-TEO 2018/024); by the National Agency for Agricultural Research of the Ministry of Agriculture of the Czech Republic under project Biostore QK21010064; and by the Research Infrastructure METROFOOD-CZ supported by the Ministry of Education, Youth, and Sports of the Czech Republic under project number LM201810. A.B. thanks the Spanish Government for financial support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Enzyme-controlled mesoporous nanosensor for the detection of living Saccharomyces cerevisiae

  • Jiménez-Falcao, Sandra
  • Villalonga, Anabel
  • Arévalo-Villena, María
  • Briones-Pérez, Ana
  • Martínez-Ruíz, Paloma
  • Villalonga, Reynaldo
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We report herein the construction of an integrated and sensitive enzyme-powered colorimetric nanosensor for the quantification of living Saccharomyces cerevisiae. The nanodevice is provided with a pH-sensitive supramolecular nanovalve in capped benzimidazole-functionalized mesoporous silica nanoparticles with beta-cyclodextrincoated gold nanoparticles containing adatamantane-modified glucose oxidase as bioactive element. The sensing approach relies on the ability of living S. cerevisiae cells to produce invertase, which hydrolyzes sucrose to fructose and glucose. Enzymatic transformation of glucose to gluconic acid on the nanosensor surface results in the opening of the pores and delivery of an encapsulated dye, as a consequence of the local decrease in the pH. The nanosensor allows the detection of the living yeast in the range of 8.10(2) - 4.10(8) CFU/mL, exhibiting high selectivity and reproducibility, and retaining full sensing capacity after 2 weeks of storage. The nanodevice has also been successfully validated in wine samples spiked with S. cerevisiae., Financial support from the Spanish Ministry of Economy and Competitiveness (MINECO Projects CTQ2017-87954-P and RTI2018-100910-B-C41), the Junta de Comunidades de Castilla La Mancha (JCCM Project POII-2014-011-A), the Comunidad de Madrid (Project IND2017/BMD-7642) and the Generalitat Valenciana (Project PROMETEO2018/024) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The Chemistry of Senescence

  • Lozano-Torres, Beatriz
  • Estepa-Fernández, Alejandra
  • Rovira, Miguel
  • Orzaez, Mar
  • Serrano, Manuel
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
[EN] Senescence is a state of permanent cell cycle arrest. Cellular senescence can promote tissue remodelling but can negatively affect regenerative capacities of tissues and contribute to inflammation and the progression of cancer and ageing-related diseases. This Review highlights the chemical characteristics of senescence and how we can target senescent cells with small molecules to induce senescence in hyperproliferative tissues. Alternatively, these small molecules can also be administered to inhibit senescence or eliminate senescent cells as the basis of a promising strategy to treat ageing-related diseases. We also describe advances in detecting senescence in in vitro and in vivo models, such that we can evaluate response to treatments intended to induce or eliminate senescent cells., R.M. laboratory members thank the financial support from the Spanish Government (projects MAT2015-64139-C4-1-R, RTI2018-100910-B-C41 and AGL2015-70235-C2-2-R) and the Generalitat Valenciana (project PROMETEO 2018/024). B.L-T. and A.E. are grateful to the Spanish Ministry of Economy for their PhD grants (FPU15/02707 and FPU17/05454). M.R. was holder of a "la Caixa"-Severo Ochoa PhD scholarship. Work in the laboratory of M. S. was funded by IRB and by grants from the Spanish Ministry of Economy (MINECO, SAF), the European Research Council (ERC Advanced Grant) and by "la Caixa" Foundation. M.O. thanks the financial support from SAF2017-84689-R project and MINECO/AEI/FEDER, UE. The IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from the MINECO. The funders had no role in the design, data collection, decision to publish or preparation of the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer

  • Acevedo-León, Delia
  • Monzó-Beltrán, Lidia
  • Gómez-Abril, Segundo Ángel
  • Estañ-Capel, Nuria
  • Camarasa-Lillo, Natalia
  • Pérez-Ebri, Marisa Luisa
  • Escandón-Álvarez, Jorge
  • Alonso-Iglesias, Eulalia
  • Santaolaria-Ayora, María Luisa
  • Carbonell-Moncho, Araceli
  • Ventura-Gayete, Josep
  • Pla, Luis
  • Bagán-Debón, Leticia
  • Viña-Almunia, Aurora
  • Martínez-Santamaría, M. Amparo
  • Ruiz-Luque, María
  • Alonso-Fernández, Jorge
  • Bañuls, Celia
  • Sáez. Guillermo
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The role of oxidative stress (OS) in cancer is a matter of great interest due to the implication of reactive oxygen species (ROS) and their oxidation products in the initiation of tumorigenesis, its progression, and metastatic dissemination. Great efforts have been made to identify the mechanisms of ROS-induced carcinogenesis; however, the validation of OS byproducts as potential tumor markers (TMs) remains to be established. This interventional study included a total of 80 colorectal cancer (CRC) patients and 60 controls. By measuring reduced glutathione (GSH), its oxidized form (GSSG), and the glutathione redox state in terms of the GSSG/GSH ratio in the serum of CRC patients, we identified significant changes as compared to healthy subjects. These findings are compatible with the effectiveness of glutathione as a TM. The thiol redox state showed a significant increase towards oxidation in the CRC group and correlated significantly with both the tumor state and the clinical evolution. The sensitivity and specificity of serum glutathione levels are far above those of the classical TMs CEA and CA19.9. We conclude that the GSSG/GSH ratio is a simple assay which could be validated as a novel clinical TM for the diagnosis and monitoring of CRC., This work was partially supported by grants GST, UGP-19-037 FISABIO, Universitat Politecnica de Valencia-the Hospital Universitario Doctor Peset POLISABIO collaboration program (UPV-FISABIO) NanOdGSens-2, the Spanish Government project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE), the Generalitat Valenciana project PROMETEO/2018/024 and PI18/00932 by Instituto de Salud Carlos III and co-funded by the European Regional Development Fund (ERDF "A way to build Europe"). C.B. is a recipient of a Miguel Servet contract (CP19/00077) from the Instituto de Salud Carlos III.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Towards the Enhancement of Essential Oil Components&apos, Antimicrobial Activity Using New Zein Protein-Gated Mesoporous Silica Microdevices

  • Poyatos-Racionero, Elisa
  • Guarí-Borràs, Gemma
  • Ruiz Rico, María
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Aznar, Elena|||0000-0003-0361-3876
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
[EN] The development of new food preservatives is essential to prevent foodborne outbreaks or food spoilage due to microbial growth, enzymatic activity or oxidation. Furthermore, new compounds that substitute the commonly used synthetic food preservatives are needed to stifle the rising problem of microbial resistance. In this scenario, we report herein, as far as we know, for the first time the use of the zein protein as a gating moiety and its application for the controlled release of essential oil components (EOCs). The design of microdevices consist of mesoporous silica particles loaded with essential oils components (thymol, carvacrol and cinnamaldehyde) and functionalized with the zein (prolamin) protein found in corn as a molecular gate. The zein protein grafted on the synthesized microdevices is degraded by the proteolytic action of bacterial enzymatic secretions with the consequent release of the loaded essential oil components efficiently inhibiting bacterial growth. The results allow us to conclude that the new microdevice presented here loaded with the essential oil component cinnamaldehyde improved the antimicrobial properties of the free compound by decreasing volatility and increasing local concentration., This research was funded by the Government of Spain (projects RTI2018-100910-B-C41, RTI2018-101599-B-C22-AR and RTI2018-101599-B-C21-AR (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO 2018/024, grant numbers ACIF/2016/023 and APOSTD/2019/118).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Peptide-Capped Mesoporous Nanoparticles: Toward a more Efficient Internalization of Alendronate

  • Añón, Elena
  • Costero, Ana M.
  • Amorós del Toro, Pedro
  • El Haskouri, Jamal
  • Parra Álvarez, Margarita
  • Gil Grau, Salvador
  • Gaviña, Pablo
  • Terencio Silvestre, María Carmen
  • Alfonso-Navarro, María
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Osteoporosis is an illness which appears when the osteoblast/osteoclast activities are unbalanced taking place bone resorption (caused by osteoclasts) in higher extension than bone formation (induced by osteoblasts). Alendronate is one of the most used drugs for osteoporosis treatment despite its scarce bioavailability. Here we present the synthesis and characterization of mesoporous gated nanoparticles (two sets) for the controlled release of alendronate. The first set of nanoparticles (S1) were loaded with sulforhodamine B and capped with a peptide that could be selectively hydrolyzed by cathepsin K enzyme (overexpressed in osteoclasts). The second set (S2) was functionalized with aminopropyl moieties, loaded with nitrobenzofurazan labelled alendronate and capped with the same peptide. Both nanoparticles were internalized by RAW 264.7 macrophages (which could differentiate in osteoclasts) and were able to release its entrapped cargo in the presence of cathepsin K added in the macrophage lysates. Using S2 nanoparticles 4.2% of the total alendronate amount in contact with the cells is liberated inside them and could produce its therapeutic effect., We thank the Spanish Government (RTI2018-100910-B-C41, RTI2018-100910-B-C42 (MCUI/AEI/FEDER, UE)) and the Generalitat Valenciana (PROMETEU/2018/024) for support. SCSIE (Universitat de Valencia) is gratefully acknowledged for all the equipment employed. NMR was registered at the U26 facility of ICTS "NANBIOSIS" at the Universitat of Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity

  • González-Gualda, Estela
  • Pàez-Rives, Marta
  • Lozano-Torres, Beatriz
  • Macias, David
  • Wilson III, Joseph R.
  • González-López, Cristina
  • Ou, Hui-Ling
  • MIrón-Barroso, Sofía
  • Zhang, Zhenguang
  • Lérida-Viso, Araceli
  • Blandez, Juan F.
  • Rovira, Miguel
  • Fruk, Ljiljana
  • Martins, Carla P.
  • Serrano, Manuel
  • Doherty, Gary J.
  • Muñoz-Espín, Daniel
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Pharmacologically active compounds with preferential cytotoxic activity for senescent cells, known as senolytics, can ameliorate or even revert pathological manifestations of senescence in numerous preclinical mouse disease models, including cancer models. However, translation of senolytic therapies to human disease is hampered by their suboptimal specificity for senescent cells and important toxicities that narrow their therapeutic windows. We have previously shown that the high levels of senescence-associated lysosomal beta-galactosidase (SA-beta-gal) found within senescent cells can be exploited to specifically release tracers and cytotoxic cargoes from galactose-encapsulated nanoparticles within these cells. Here, we show that galacto-conjugation of the BCL-2 family inhibitor Navitoclax results in a potent senolytic prodrug (Nav-Gal), that can be preferentially activated by SA-beta-gal activity in a wide range of cell types. Nav-Gal selectively induces senescent cell apoptosis and has a higher senolytic index than Navitoclax (through reduced activation in nonsenescent cells). Nav-Gal enhances the cytotoxicity of standard senescence-inducing chemotherapy (cisplatin) in human A549 lung cancer cells. Concomitant treatment with cisplatin and Nav-Gal in vivo results in the eradication of senescent lung cancer cells and significantly reduces tumour growth. Importantly, galacto-conjugation reduces Navitoclax-induced platelet apoptosis in human and murine blood samples treated ex vivo, and thrombocytopenia at therapeutically effective concentrations in murine lung cancer models. Taken together, we provide a potentially versatile strategy for generating effective senolytic prodrugs with reduced toxicities., Royal Society, Grant/Award Number: RG160806; Medical Research Council, Grant/Award Number: MR/R000530/1; Cancer Research UK, Grant/Award Number: C62187/A26989 and C62187/A29760; CRUK Cambridge Centre Early Detection Programme, Grant/Award Number: RG86786
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice

  • Lerida-Viso, Araceli
  • Estepa-Fernández, Alejandra
  • Lozano-Torres, Beatriz
  • Alfonso, María
  • Blandez, Juan F.
  • Bisbal, Viviana
  • Sepúlveda, Pilar
  • Orzáez, Mar
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Many anticancer agents used in clinics induce premature senescence in healthy tissues generating accelerated aging processes and adverse side-effects in patients. Cardiotoxicity is a well-known limiting factor of anticancer treatment with doxorubicin (DOX), a very effective anthracycline widely used as antitumoral therapy in clinical practice, that leads to long-term morbidity and mortality. DOX exposure severely affects the population of cardiac cells in both mice and human hearts by inducing premature senescence, which may represent the molecular basis of DOX-induced cardiomyopathy. Here, we demonstrate that senescence induction in the heart contributes to impaired cardiac function in mice upon DOX treatment. Concomitant elimination of senescent cells with the senolytic Navitoclax in different formulations produces a significant decrease in senescence and cardiotoxicity markers together with the restoration of the cardiac function in mice followed by echocardiography. These results evidence the potential clinical use of senolytic therapies to alleviate cardiotoxicities induced in chemotherapy-treated patients., R.M. laboratory members thank the financial support from the Spanish Government projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO 2018/024). M.O. thanks the financial support from the Spanish Government project (PID2020-115048RB-I00) and the Generalitat Valenciana (project PROMETEO/2019/065). A. L-V. is grateful to the Instituto de Salud Carlos III for her Ph.D. i-PFIS grant (IFI17/00039). A.E-F. and B.L.-T thanks to the Spanish Government for their Ph.D. grant (FPU17/05454) and (FPU15/02707). J.B. thanks to the Instituto de Salud Carlos III for his Sara Borrell contract (CD19/00038). M.A. thanks her postdoctoral fellowship (PAID-10-17). The funders had no role in the design, data collection, decision to publish, or preparation of the manuscript. The authors thank Alberto Hernandez for confocal microscopy, Alicia Martinez for flow cytometry, and Laura Ramirez for genomics guidance. The authors thank for the use of Biorender.com.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Immunochemical Design of Antibody-Gated Indicator Delivery (gAID) Systems Based on Mesoporous Silica Nanoparticles

  • Climent, Estela
  • Weller, Michael G.
  • Rurack, Knut
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] In this work, the optimization of the immunochemical response of antibody-gated indicator delivery (gAID) systems prepared with mesoporous silica nanoparticles has been studied along various lines of system tailoring, targeting the peroxide-type explosive TATP as an exemplary analyte. The mechanism of detection of these gAID systems relies on a displacement of an antibody "cap" bound to hapten derivatives anchored to the surface of a porous hybrid material, allowing the indicator cargo stored in the mesopores to escape and massively amplify the analyte-related signal. Since our aim was to obtain gAID systems with the best possible response in terms of sensitivity, selectivity, and assay time, sera obtained from different immunization boosts were screened, the influence of auxiliary reagents was assessed, structural hapten modification (hapten heterology) was investigated, and various indicator dyes and host materials were tested. Considering that highly selective and sensitive immunological responses are best obtained with highaffinity antibodies which, however, could possess rather slow dissociation constants, leading to slow responses, the main challenge was to optimize the immunochemical recognition system for a rapid response while maintaining a high sensitivity and selectivity. The best performance was observed by grafting a slightly mismatching (heterologous) hapten to the surface of the nanoparticles in combination with high-affinity antibodies as "caps", yielding for the first time gAID nanomaterials for which the response time could be improved from hours to <5 min. The materials showed favorable detection limits in the lower ppb range and discriminated TATP well against H2O2 and other explosives. Further optimization led to straightforward integration of the materials into a lateral flow assay without further treatment or conditioning of the test strips while still guaranteeing remarkably fast overall assay times., This research was funded by the German Research Foundation (DFG; CL 761/1-19), the Spanish Government (project RTI2018-100910-B-C41 (MCUI/FEDER, EU)), and the Generalitat Valenciana (project PROMETEO 2018/024).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Novel probes, carriers and prodrugs to target senescent cells in vivo

  • Lozano Torres, Beatriz
[ES] La presente tesis doctoral titulada "Nuevas sondas, portadores y pro-fármacos dirigidos a células senescentes in vivo" se centra en el diseño, preparación, caracterización y evaluación de sondas basadas en fluoróforos funcionalizados o en nanopartículas, así como en el desarrollo de profármacos, aplicadas al campo de la senescencia celular. En el primer capítulo se introducen, a nivel general, los diferentes conceptos relacionados con el reconocimiento molecular y la detección de biomarcadores. Seguidamente se introducen conceptos básicos de senescencia celular y envejecimiento, así como el papel que juegan las células senescentes a nivel fisiológico, en enfermedades asociadas al envejecimiento celular y en el cáncer. Por último, se aborda también la creciente necesidad de desarrollar nuevas herramientas de diagnóstico y terapias centradas en la detección y tratamiento de dichas enfermedades. En el segundo capítulo se exponen los objetivos generales de la presente tesis doctoral, así como los objetivos concretos que son abordados en los diferentes capítulos experimentales. En el tercer capítulo se describe una nueva sonda molecular para la detección de senescencia in vivo. En concreto, se describe el diseño de una sonda de dos fotones basada en un fluoróforo de naftalimida conectada, mediante un éster metílico de L-histidina, con una galactosa acetilada que esta unida a uno de los átomos de nitrógeno aromático de la L-histidina a través de un enlace N-glicosídico hidrolizable (AHGa). La sonda inicial presenta una baja emsión pero en células senescentes se transforma en un fluoróforo con alto rendimiento cuantico que permite visualizar estas células debido a la hidrólisis del enlace N-glicosidico por la enzima ¿-galactosidasa sobreexpresada en este tipo de células. La sonda es capaz de detectar in vitro células de melanoma humano SK-Mel-103 tratadas con quimioterapia inductora de senescencia frente a células control. Adicionalmente, se validó la detección in vivo de senescencia en ratones con xenoinjertos tumorales tratados con quimioterapia inductora de senescencia. Basándonos en los resultados obtenidos en el capítulo tres, en el capítulo cuatro se describe un sistema similar cuyas características confieren al fluoróforo una mayor longitud de onda de excitación (HeckGal). La nueva sonda es capaz de detectar células senescentes debido a la sobreexpresión de la enzima ¿-galactosidasa asociada a senescencia en gran variedad de líneas celulares con diversos métodos de inducción de senescencia. Esta sonda se validó también in vivo en un modelo ortotópico de cáncer de mama de ratón tratado con quimioterapia inductora de senescencia, y en un modelo de ratón de fibrosis renal. Seguidamente, el capítulo cinco, se centra en un nuevo concepto de sondas moleculares no invasivas, que proporcionan una señal fácilmente legible a través de simples medidas de fluorescencia de la orina. Esta idea se llevó a cabo mediante la funcionalización de una sonda con grupos que le confieren características diuréticas (rápida eliminación renal) y el concepto se aplicó al diseño de una sonda para a la detección en orina de la carga senescente en diversos modelos. La sonda (Cy7Gal) está basada en la cianina-7 que es hidrolizada por la enzima ¿-galactosidasa en un fluoróforo altamente emisivo Cy7. Cy7Gal y Cy7 contienen restos de ácido sulfónico que aumentan su solubilidad en agua y desencadenan su rápida excreción por el sistema urinario. El grado de senescencia se cuantificó por medición directa de fluorescencia en orina en tres modelos de senescencia en ratones: (i) un modelo ortotópico de cáncer de mama en ratones BALB/cByJ con senescencia inducida por quimioterapia; (ii) ratones BALB / cByJ envejecidos de forma natural; y (iii) ratones con senescencia acelerada (SAMP8, del inglés Senescence Accelerated Mouse-Prone 8). Además, las imágenes IVIS ex vivo permite, [CA] La tesi doctoral titulada "Noves sondes, portadors i profàrmacs dirigits a cèl·lules senescents in vivo" se centra en el desenvolupament i avaluació de sondes basades en fluoròfors funcionalitzats o en nanopartícules, així com en el desenvolupament de profàrmacs, aplicades a el camp de la senescència cel·lular. Primer s'introdueixen els diferents conceptes relacionats amb el sensing i amb la sescencia cel·lular, abordant la necessitat de noves eines diagnòstiques i terapèutiques d'aquestes malalties. En els capítols 3:04 es descriuen una nova sonda molecular dos fotons per a la detecció de senescència in vivo en ratolins amb xenoempelts tumorals tractats amb quimioteràpia inductora de senescència, una altra sonda per a la detecció in vivo en un model ortotòpic de càncer de mama de ratolí tractat amb quimioteràpia inductora de senescència, i en un model de ratolí de fibrosi renal. El capítol 5, se centra en un nou concepte de sondes moleculars no invasives, que proporcionen un senyal fàcilment llegible a través de simples mesures de fluorescència de l'orina. Finalment, pel que fa a detecció de senescència cel·lular es refereix, es presenta en el capítol sis la detecció in vivo de senescència cel·lular mitjançant l'alliberament controlat de Nile Blue en nanopartícules de sílice mesoporoses funcionalitzades amb un galactohexasacárido. Un cop assolits els objectius planificats pel que fa a la diagnosi, en el capítol set es va abordar la millora d'un dels senolíticos més potents i àmpliament conegut en el camp de la senescència cel·lular que existeix a dia d'avui al mercat: el Navitoclax., [EN] The doctoral thesis entitled "New probes, carriers and pro-drugs directed to senescent cells in vivo" focuses on the development and evaluation of probes based on functionalized fluorophores or nanoparticles, as well as on the development of prodrugs, applied to the field of cellular senescence. First, the different concepts related to sensing and cell sescence are introduced, addressing the need for new diagnostic and therapeutic tools for these diseases. Chapters three and four describe a new two-photon molecular probe for in vivo senescence detection in mice with tumor xenografts treated with senescence-inducing chemotherapy, another probe for in vivo detection in an orthotopic mouse breast cancer model. treated with senescence-inducing chemotherapy, and in a mouse model of renal fibrosis. Chapter five focuses on a new concept of non-invasive molecular probes, which provide an easily readable signal through simple measurements of urine fluorescence. Finally, regarding the detection of cellular senescence, chapter six presents the in vivo detection of cellular senescence through the controlled release of Nile Blue in mesoporous silica nanoparticles functionalized with a galactohexasaccharide. Once the planned objectives with regard to diagnosis had been achieved, chapter seven addressed the improvement of one of the most powerful and widely known senolytics in the field of cellular senescence that exists on the market today: Navitoclax., The authors thank the financial support from the Spanish Government (projects MAT2015-64139-C4-1-R and AGL2015-70235-C2-2-R) and the Generalitat Valenciana (project PROMETEOII/2014/047). R.M laboratory members thank the financial support from the Spanish Government (project RTI2018-100910-B-C41) and the Generalitat Valenciana (project PROMETEO 2018/024). B.L-T. is grateful to the Spanish Ministry of Economy for their PhD grants (FPU15/02707). Work in the laboratory of MS was funded by the IRB and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (ERDF) (SAF2013-48256-R), the European Research Council (ERC-2014-AdG/669622), and the “laCaixa” Foundation. D.M.-E. laboratory is supported by the Cancer Research UK (CRUK) Cambridge Centre Early Detection Programme, by a CRUK Early Detection OHSU Project Award (C62187/A26989), by a Medical Research Council (MRC) New Investigators Research Grant (NIRG, MR/R000530/1). Work in the laboratory of I.F. is supported by grants from the Spanish Government (SAF2017-86690-R), Instituto de Salud Carlos III (CIBERNED and RETIC Tercel), and Generalitat Valenciana (Prometeo 2017/030).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

New nanostructured supports with signal amplification features for the detection of molecules and biomolecules of interest

  • Pla Blasco, Luis
[ES] La presente tesis doctoral titulada "New nanostructured suports with signal amplification features for the detection of molecules and biomolecules of interest" se centra en el diseño y preparación de nuevos materiales híbridos orgánicos-inorgánicos constituidos por puertas moleculares soportadas sobre alúmina mesoporosa con el objetivo de desarrollar nuevos sistemas sensores con aplicaciones potenciales en el campo de la diagnosis y del control alimentario. En el primer capítulo de la tesis se introducen los conceptos en los que están basados los estudios realizados y los materiales preparados. A continuación, en el segundo capítulo se describen los objetivos generales de la tesis que serán abordados en los siguientes apartados. En el tercer capítulo se presenta el diseño y optimización de un nanodispositivo para la detección de la bacteria Mycoplasma fermentans. En primer lugar, los poros de una placa de alúmina mesoporosa se cargan con un indicador fluorescente (rodamina B). Seguidamente, la superficie es funcionalizada con una secuencia de ADN complementaria a una región altamente conservada de la subunidad ribosomal 16S de la bacteria Mycoplasma fermentans. El impedimento estérico generado por las secuencias de ADN ancladas al exterior de los poros impide la salida del indicador encapsulado. Únicamente en presencia de DNA de la bacteria Mycoplasma fermentans, se produce la apertura de los poros permitiéndose la difusión de la carga (rodamina B) que es posteriormente medida mediante espectroscopía de fluorescencia. En el capítulo cuatro se diseña de un nanodispositivo capaz de detectar de forma rápida, sensible y selectiva la bacteria Staphylococcus aureus. Para la preparación del material sensor, un soporte de alúmina mesoporosa es, en primer lugar, cargado con el indicador fluorescente rodamina B. A continuación, los poros del soporte son tapados mediante el anclaje de un aptámero que reconoce de forma específica la bacteria. Solamente en presencia de Staphylococcus aureus se produce la liberación del indicador encapsulado, que es posteriormente medido mediante espectroscopía de fluorescencia. Además, la respuesta obtenida es específica para Staphylococcus aureus. Este sistema ha sido ensayado en muestras reales. En el sexto capítulo, diseña un nanodispositivo híbrido orgánico-inorgánico consistente en un material de alúmina mesoporosa cubierto con una secuencia de ADN específica para la detección de ADN del hongo Pneumocystis jirovecii. En este caso, el soporte de alúmina cargado con rodamina B se recubre con una secuencia de ADN específica para el reconocimiento de este hongo. En presencia del organismo, la horquilla hibrida con el ADN del hongo, lo que resulta en una conformación triplex con elevada afinidad y estabilidad que induce, al mismo tiempo, el desplazamiento de este complejo de la superficie. Como consecuencia de este reconocimiento la carga se libera y es cuantificada mediante espectroscopía de fluorescencia. El sistema ha sido satisfactoriamente validado. En el séptimo capítulo, se diseña un sistema sensor con la capacidad de detectar gluten de forma rápida y sencilla en extractos de alimentos procesados y no procesados. Para ello, un soporte de alúmina mesoporosa se carga con rodamina B y los poros se recubren con un aptámero específicamente diseñado para la detección de la proteína gliadina, que constituye el 50 % del total del clúster de elementos que forman el gluten. La elevada afinidad y especificidad entre el aptámero y la proteína en cuestión hacen que en presencia de ésta se produzca un desplazamiento de la puerta molecular que permite la difusión del colorante encapsulado que es finalmente monitorizado mediante espectroscopía de fluorescencia. Finalmente, en el capítulo octavo se discuten de forma conjunta los resultados obtenidos en los capítulos anteriores y la potencial aplicación de los sistemas desarrollados en el actual sistem, [CA] La present tesi doctoral, titulada "New nanostructured supports with signal amplification features for the detection of molecules and biomolecules of interest", es centra en el disseny i preparació de nous materials híbrids orgànics-inorgànics constituïts per portes moleculars suportades sobre alúmina mesoporosa amb l'objectiu de desenvolupar nous sistemes sensors amb potencials aplicacions en el camp de la diagnosi i del control alimentari. En el primer capítol de la tesi s'introdueixen els conceptes en què estan basats els estudis realitzats i els materials preparats. A continuació, en el segon capítol es descriuen els objectius generals de la tesi que seran abordats en els següents apartats. En el tercer capítol es presenta el disseny i optimització d'un nanodispositiu per a la detecció de la bactèria Mycoplasma fermentans. Primerament, els porus d'una placa d'alúmina mesoporosa són carregats amb un indicador fluorescent (rodamina B). Seguidament, la superfície és funcionalitzada amb una seqüència d'ADN complementaria a una regió altament conservada de la subunitat ribosomal 16S de la bactèria Mycoplasma fermentans. L'impediment estèric generat per les seqüències d'ADN ancorades a l'exterior dels porus impedeix l'alliberament de l'indicador encapsulat. Únicament en presencia d'ADN de la bactèria Mycoplasma fermentans, es produeix l'obertura dels porus permetent la difusió de la càrrega (rodamina B) que és posteriorment mesurada mitjançant fluorescència. En el capítol quatre es dissenya un nanodispositiu capaç de detectar de forma ràpida, sensible i selectiva la bactèria Staphylococcus aureus. Per a la preparació del material sensor, el suport d'alúmina mesoporosa és, primerament, carregat amb l'indicador fluorescent rodamina B. A continuació, els porus del suport són tapats mitjançant l'ancoratge d'un aptàmer que reconeix de forma específica a la bactèria. Solament en presència de Staphylococcus aureus es produeix l'alliberament de l'indicador encapsulat, que és posteriorment mesurat mitjançant espectroscòpia de fluorescència. A més a més, la resposta obtinguda és específica per Staphylococcus aureus. Aquest sistema ha sigut validat amb mostres reals de pacients. En el sisè capítol, es dissenya un nanodispositiu híbrid orgànic-inorgànic consistent en un material d'alúmina mesoporosa cobert amb una seqüència d'ADN específica per a la detecció de l'ADN del fong Pneumocystis jirovecii. En aquest cas, el suport d'alúmina carregat amb l'indicador fluorescent rodamina B és recobert amb una seqüència d'ADN específica per al reconeixement d'aquest fong. En presència de l'organisme, la forquilla hibrida amb l'ADN del fong, resultant en una conformació triplex amb elevada afinitat i estabilitat, que indueix, al mateix temps, el desplaçament d'aquest complex de la superfície. Com a conseqüència d'aquest reconeixement la càrrega és alliberada i quantificada mitjançant espectroscòpia de fluorescència. El sistema ha sigut validat com a mètode diagnòstic mitjançant l'anàlisi de mostres reals de pacients. En el seté capítol, es dissenya un sistema sensor amb la capacitat de detectar gluten de forma ràpida i senzilla en extractes d'aliments processats i no processats. Per a això, un suport d'alúmina mesoporosa es carrega amb indicador fluorescent rodamina B i posteriorment és recobert amb un aptàmer específicament dissenyat per a la detecció de la proteïna gliadina, que constitueix el 50 % del total del clúster d'elements que formen el gluten. L'elevada afinitat i especificitat entre l'aptàmer i la proteïna en qüestió fa que en presència d'aquesta es produesca un desplaçament de la porta molecular que permet la difusió de la càrrega encapsulada i que serà finalment monitoritzada mitjançant espectroscòpia de fluorescència. Finalment, en el capítol vuité es discuteixen de manera conjunta els result, [EN] The PhD thesis hereby presented and entitled "New nanostructured supports with signal amplification features for the detection of molecules and biomolecules of interest", focuses in the design and preparation of new hybrid organic-inorganic materials constituted by molecular gates supported over mesoporous alumina with the aim of developing new sensor probes of potential applications in the fields of diagnosis and food control. In the first chapter, the concepts in which studies and prepared materials are based, are introduced. Next, the second chapter describes the general objectives of this thesis, which will be approached in the following sections. In the third chapter, it is presented in detail the design and optimization process of a nanodevice applied for the detection of Mycoplasma fermentans bacterium. First of all, mesoporous alumina porous films are charged with a fluorescent indicator (rhodamine B). Then, the surface is functionalized with a DNA sequence complementary to a highly conserved region of the 16S ribosomal subunit of the bacterium Mycoplasma fermentans. Steric hindrance generated by DNA sequences on the surface inhibits the release of the encapsulated indicator. Only in the presence of bacterium Mycoplasma fermentans DNA, molecular gates open, allowing payload diffusion to the solution, which is measured by fluorescence spectroscopy. In chapter four, it is carried out the design and optimization of a nanodevice able to detect Staphylococcus aureus bacterium in a fast, sensitive and selective way. For the sensor preparation, alumina mesoporous support is, first, loaded with the rhodamine B fluorescent dye. Then, the mesoporous are blocked through the attachment of an aptamer that recognises specifically this bacterium. Exclusively in the presence of Staphylococcus aureus it is accomplished the release of the encapsulated dye, which is later monitored by fluorescence spectroscopy. The response obtained is specific for Staphylococcus aureus. This system has been validated in real samples. In the sixth chapter, it is detailed the design and optimization process of a hybrid organic-inorganic nanodevice based on a capped mesoporous alumina material for the detection of Pneumocystis jirovecii fungus DNA. In this case, the mesoporous alumina support is loaded with a fluorescent dye and decorated with a specific oligonucleotide sequence designed for the recognition of Pneumocystis fungus. In the presence of the target organism, the fork-like oligonucleotide hybridises with the DNA of the fungus, which results in the adoption of a triplex conformation with high affinity and stability that induces, at the same time, the displacement of this complex from the surface. Consequently, the payload diffused to the solution is quantified through fluorescence spectroscopy. The system has been successfully validated. In the seventh chapter, it was developed a sensor system for gluten detection, in a quick and easy way, in processed and non-processed food extracts. For this, a mesoporous alumina support is loaded with the fluorescent dye rhodamine B, and later was functionalized with an aptamer specifically designed for the detection of gliadin, a protein that constitutes 50 % of average cluster elements that forms gluten. The protein-aptamer high affinity and specificity induce the displacement of the capping aptamer and cargo delivery, which is monitored through fluorescence spectroscopy. Finally, in the eighth chapter, the results obtained in the previous chapters and the potential application of the systems developed as health and food control system are discussed., We thank the Spanish Government projects MAT2015-64139-C4-1-R, AGL2015-70235-C2-2-R, and TEC2015-71324-R (MINECO/FEDER, UE), the Generalitat Valenciana (project PROMETEOII/2014/047), the Catalan authority (project AGAUR 2014SGR1344), and ICREA under the 2014 ICREA Academia Award for support. This study was supported by the Spanish Government projects RTI2018-100910-B-C41 and SAF2017-82251-R (MCUI/AEI/FEDER, UE), the Generalitat Valenciana (project PROMETEO/2018/024), the Universitat Politècnica de València−Instituto de Investigación Sanitaria La Fe (B02-MIRSA project), CIBER-BBN (NANOPATH and valorization project CANDI-EYE) and co-financed by the EU through the Valencian Community ERDF PO 2014-2020. This research was funded by the Spanish Government, projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and CTQ2017-84415-R
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies

  • Garrido-Cano, Iris
  • Adam-Artigues, Anna
  • Lameirinhas, Ana
  • Blandez, Juan F.
  • Rojo, Federico
  • Zazo, Sandra
  • Madoz-Gúrpide, Juan
  • Lluch, Ana
  • Bermejo, Begoña
  • Cejalvo, Juan Miguel
  • Eroles, Pilar
  • Candela-Noguera, Vicente
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
This work was supported by Spanish Government and cofinanced by FEDER Funds (PI18/01219, PI21/01351, PI18/00382, and RTI2018-100910-B-C41), CIBERBBN (CB07/01/2012), CIBERONC (CB16/12/00481) and the Generalitat Valenciana (project PROMETEO 2018/024). I.G.-C. was funded by Generalitat Valenciana (ACIF/2016/030), A.A. and A.L. were funded by Asociación Española Contra el Cancer. J.F.B., was funded by Instituto de Salud Carlos III and the European Social Fund for the financial support Sara Borrell (CD19/00038), V.C.-N., was funded by Ministerio de Ciencia e Innovación (FPU grant), and J.M.C. was funded by Sociedad Española de Oncología Médica (Río Hortega-SEOM). We are especially grateful to the associations Amunt Contra el Cáncer, Asociación de la Lucha Contra el Cáncer de Montesa, and Corazón Solidario Contra el Cáncer. Funding for open access charge: Universitat Politècnica de València.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Dualplex lateral flow assay for simultaneous scopolamine and &quot, cannibal drug&quot, detection based on receptor-gated mesoporous nanoparticles

  • Garrido-García, Eva María
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Climent, Estela
  • Rurack, Knut
[EN] We report herein the design of a strip-based rapid test utilizing bio-inspired hybrid nanomaterials for the in situ and at site detection of the drug scopolamine (SCP) using a smartphone for readout, allowing SCP identification in diluted saliva down to 40 nM in less than 15 min. For this purpose, we prepared a nanosensor based on mesoporous silica nanoparticles loaded with a fluorescent reporter (rhodamine B) and functionalized with bethanechol, a potent agonist of recombinant human muscarinic acetylcholine receptor M-2 (M-2-AChR). M-2-AChR interaction with the anchored bethanechol derivative leads to capping of the pores. The sensing mechanism relies on binding of SCP to M-2-AChR resulting in pore opening and delivery of the entrapped rhodamine B reporter. Moreover, the material was incorporated into strips for lateral-flow assays coupled to smartphone readout, giving fast response time, good selectivity, and exceptional sensitivity. In an attempt to a mobile analytical test system for law enforcement services, we have also developed a dualplex lateral flow assay for SCP and 3,4-methylenedioxypyrovalerone (MDPV) also known as the so-called "cannibal drug"., This research was funded by the Ministerio de Ciencia, Innovacion y Universidades (Spanish Government), the Agencia Estatal de Investigacion (AEI), the European Union (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22-AR (MCIU/AEI/FEDER, EU), the Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (Project PROMETEO 2018/024) and the German Research Foundation (DFG; CL 761/1-19). E. G. is grateful to the Spanish MEC for her FPU grant (FPU16/02464).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A chemical circular communication network at the nanoscale

  • de Luis-Fernández, Beatriz
  • Villalonga, Reynaldo
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Godoy-Reyes, Tania Mariel
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] In nature, coordinated communication between different entities enables a group to accomplish sophisticated functionalities that go beyond those carried out by individual agents. The possibility of programming and developing coordinated communication networks at the nanoscale-based on the exchange of chemical messengers-may open new approaches in biomedical and communication areas. Here, a stimulus-responsive circular model of communication between three nanodevices based on enzyme-functionalized Janus Au-mesoporous silica capped nanoparticles is presented. The output in the community of nanoparticles is only observed after a hierarchically programmed flow of chemical information between the members., The authors wish to thank the Spanish Government (projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE), CTQ2017-87954-P), the Generalitat Valenciana (PROMETEO 2018/024), the Comunidad de Madrid (IND2017/BMD-7642) and CIBER-BBN (NANOCOMMUNITY project) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mechanistic Insight into the Turn-Off Sensing of Nitroaromatic Compounds Employing Functionalized Polyaniline

  • Venkatappa, Lakshmidevi
  • Ture, Satish Ashok
  • Yelamaggad, Channabasaveshwar V.
  • Sundaram, Venkata Narayanan Naranammalpu
  • Abbaraju, Venkataraman
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Conducting Polymers (CPs), in recent times have contributed significantly in the detection of High Energy Materials possessing nitro functional groups through fluorescence quenching studies. Camphor sulphuric acid doped polyaniline (C-PANI) is studied with a view to obtain easily processable PANI without pi-stacking for the detection of Picric acid(PA) and p-nitro toluene(pNT) in trace levels. The quenching constant and limit of detection were found to be 2.236x10(-6) M and 6.14x10(-7) M for PA and 1.9447x10(-7) M and 3.57x10(-7) M for pNT, respectively showing a very good sensitivity in detection. Resonance Raman spectroscopy (RRS) showed the involvement of the bipolaronic and benzenoid group in the charge transfer complex formed between the conducting polymer and the analyte. The photoluminescence studies indicated a predominant PET mechanism. The electrochemical studies employing cyclic voltammetry gave higher band gap on comparison with absorption studies. The positive and negative shift in oxidation and reduction potential of polymer-analyte was observed and collaborated with the fluorescence studies to understand the possible fluorescence quenching mechanism from electrochemical approach., The authors greatly acknowledge and thank Prof. G. U. Kulkarni, the Director of Centre for Nano and Soft Matter (CeNS) for providing the facility to work in the centre. Specifically, one of our author, Satish Ashok Ture, expresses his thanks to M/s Premier Explosive Limited for their Financial support (H/A: 4254). We also thank the Spanish Government (RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE)) and Generalitat Valenciana (PROMETEO2018/024) for their support. Part of this work is carried out under the Gulbarga University-Central University of Karnataka MoU program.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Chromo-fluorogenic probes for beta-galactosidase detection

  • Lozano-Torres, Beatriz
  • Blandez, Juan F.
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] beta-Galactosidase (beta-Gal) is a widely used enzyme as a reporter gene in the field of molecular biology which hydrolyzes the beta-galactosides into monosaccharides. beta-Gal is an essential enzyme in humans and its deficiency or its overexpression results in several rare diseases. Cellular senescence is probably one of the most relevant physiological disorders that involve beta-Gal enzyme. In this review, we assess the progress made to date in the design of molecular-based probes for the detection of beta-Gal both in vitro and in vivo. Most of the reported molecular probes for the detection of beta-Gal consist of a galactopyranoside residue attached to a signalling unit through glycosidic bonds. The beta-Gal-induced hydrolysis of the glycosidic bonds released the signalling unit with remarkable changes in color and/or emission. Additional examples based on other approaches are also described. The wide applicability of these probes for the rapid and in situ detection of de-regulation beta-Gal-related diseases has boosted the research in this fertile field, R.M laboratory members received the financial support from the Spanish Government (project RTI2018-100910-B-C41) and the Generalitat Valenciana (project PROMETEO 2018/024). B.L-T. received support from the Spanish Ministry of Economy for their PhD grants (FPU15/02707). J. F.-B received fellowship (CD19/00038)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

New bladder cancer non-invasive surveillance method based on voltammetric electronic tongue measurement of urine

  • Monreal-Trigo, Javier|||0000-0002-4067-1867
  • Alcañiz Fillol, Miguel|||0000-0002-4579-9210
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Ferrer, Alberto|||0000-0001-7244-5947
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Loras, Alba
  • Pascual, Lluís
  • Ruiz-Cerdá, José Luis
[EN] Bladder cancer (BC) is the sixth leading cause of death by cancer. Depending on the invasiveness of tumors, patients with BC will undergo surgery and surveillance lifelong, owing the high rate of recurrence and progression. In this context, the development of strategies to support non-invasive BC diagnosis is focusing attention. Voltammetric electronic tongue (VET) has been demonstrated to be of use in the analysis of biofluids. Here, we present the implementation of a VET to study 207 urines to discriminate BC and non-BC for diagnosis and surveillance to detect recurrences. Special attention has been paid to the experimental setup to improve reproducibility in the measurements. PLSDA analysis together with variable selection provided a model with high sensitivity, specificity, and area under the ROC curve AUC (0.844, 0.882, and 0.917, respectively). These results pave the way for the development of non-invasive low- cost and easy-touse strategies to support BC diagnosis and follow-up., This research was supported by the Spanish Ministry of Science, Innovation and Universities via a doctoral grant to the first author (FPU17/03239). Authors gratefully acknowledge the financial support of RTI2018-100910-B-C41 and RTI2018-100910-B-C43 (funded by MCIN/AEI/10.13039/501100011033/and FEDER A way to make Europe) and PROMETEO/2018/024 (the Generalitat Valenciana) projects. Authors also gratefully acknowledge CIBER-BBN.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Antibacterial Activity of Linezolid against Gram-Negative Bacteria: Utilization of E-Poly-l-Lysine Capped Silica Xerogel as an Activating Carrier

  • Guzel Kaya, Gulcihan
  • Tormo-Mas, María Ángeles
  • Deveci, Huseyin
  • Medaglia, Serena|||0000-0003-3537-9842
  • Candela-Noguera, Vicente
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] In recent times, many approaches have been developed against drug resistant Gram-negative bacteria. However, low-cost high effective materials which could broaden the spectrum of antibiotics are still needed. In this study, enhancement of linezolid spectrum, normally active against Gram-positive bacteria, was aimed for Gram-negative bacteria growth inhibition. For this purpose, a silica xerogel prepared from a low-cost precursor is used as a drug carrier owing to the advantages of its mesoporous structure, suitable pore and particle size and ultralow density. The silica xerogel is loaded with linezolid and capped with epsilon-poly-l-lysine. The developed nano-formulation shows a marked antibacterial activity against to Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. In comparison to free linezolid and epsilon-poly-l-lysine, the material demonstrates a synergistic effect on killing for the three tested bacteria. The results show that silica xerogels can be used as a potential drug carrier and activity enhancer. This strategy could provide the improvement of antibacterial activity spectrum of antibacterial agents like linezolid and could represent a powerful alternative to overcome antibiotic resistance in a near future., We thank the Spanish Government (projects RTI2018-100910-B-C41, RTI2018-101599-B-C22-AR and SAF2017-82251-R (MCUI/AEI/FEDER, UE)) and the Generalitat Valenciana (project PROMETEO/2018/024) for support. G.G.K. would like to thank Academic Staff Training Program (2016-OYP-071) and TUBITAK for 2214-A International Research Fellowship Program for PhD Students. S.M. thanks Generalitat Valenciana for her Santiago Grisolia fellowship. V.C.-N. thanks Spanish Ministerio de Educacion for his FPU grant (FPU15/02753).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Nanoprobe Based on Gated Mesoporous Silica Nanoparticles for The Selective and Sensitive Detection of Benzene Metabolite t,t-Muconic Acid in Urine

  • Domínguez-Rodríguez, Marcia|||0000-0002-0635-0699
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Blandez, Juan F.
  • Lozano-Torres, Beatriz
  • De La Torre-Paredes, Cristina
  • Licchelli, Maurizio
  • Mangano, Carlo
  • Amendola, Valeria
[EN] Benzene is a highly toxic aromatic hydrocarbon. Inhaling benzene can cause dizziness, vertigo, headaches, aplasia, mutations and, in the most extreme cases, cancer. Trans,trans-muconic acid (t,t-MA) is one of the metabolization products of benzene. Although different analytical methods have been reported for the determination of t,t-MA, these are often expensive, require trained personnel, are not suitable for on-site measurements, and use hazardous organic solvents. For these reasons, the development of reliable, selective and sensitive methods for rapid and in situ detection of t,t-MA are of importance. Addressing this challenge, a nanodevice for the selective and sensitive quantification of t,t-MA in urine is reported. The nanodevice used is achieved using mesoporous silica nanoparticles loaded with a dye reporter and capped with a dicopper(II) azacryptand. Pore opening and payload release is induced rapidly (10 min) and selectively with t,t-MA in urine, using a simple fluorimeter without sample pretreatment., The authors thank the Spanish Government (RTI2018-100910-B-C41) and the Generalitat Valenciana (PROMETEO 2018/024) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Glucose-Fueled Gated Nanomotors: Enhancing In Vivo Anticancer Efficacy via Deep Drug Penetration into Tumors

  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Esteve-Moreno, Juan José|||0000-0002-1259-7663
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Lucena-Sánchez, Elena
  • Pradana-López, Sandra
  • Sanz-Álvarez, Víctor
  • Garrido-Cano, Iris
  • Torres-Ruiz, Sandra
  • Cejalvo, Juan Miguel
  • Diez-Sánchez, Paula
[EN] Bioinspired nano/micromotors with drug delivery capabilities are emerging tools with the promising potential to treat numerous diseases. However, some major challenges must be overcome before reaching real biomedical applications. Above all, it is necessary to design engines that employ biocompatible and bioavailable fuels to induce efficient propulsion in biological environments. In addition, ideal nanomotors should also be capable of delivering the cargo on-command using selected stimuli. To tackle these challenges, we herein present the design and evaluation (both in vitro and in vivo) of a glucose-driven gated Janus nanomotor that performs on-demand anticancer drug delivery to treat solid tumors. The motor's nanoarchitectonics is based on the anisotropic conjunction of catalytic platinum nanodendrites (PtNds) and a mesoporous silica nanoparticle (acting as a nanocontainer for anticancer drug doxorubicin) capped with enzyme glucose oxidase (GOx). Autonomous nanomotor movement is achieved thanks to two catalytic components, GOx and PtNds, in a hybrid cascade reaction: GOx transforms glucose to give H2O2 that is subsequently catalyzed by PtNds into H2O and O2. Besides, gatekeeper moieties (GOx) respond to the presence of intracellular proteases, which induces doxorubicin delivery. Biological experiments with the nanomotor are carried out in cancer cell cultures, three-dimensional (3D) tumor models (spheroids), in vivo and in patient-derived organoids (PDOs). A strong anticancer effect is found and attributed to the synergistic combination glucose-induced propulsion, controlled drug delivery, elimination of glucose (by GOx), ROS production (H2O2 generation by GOx) and hypoxia reduction (O2 generated by PtNds). Taken together, this study advances the engineering of endogenously fueled nanomotors for in vivo operation and provides insights into the application of active particles in cancer therapy toward clinical application., The authors acknowledge the financial support from Project PROMETEO 2018/024 from the Generalitat Valenciana, Project RTI2018-100910-B-C41 and PID2021-126304OB-C41 funded by MCIN/AEI and FEDER, Project MFA/2022/049 from Advanced Materials program funding by European Union NextGenerationEU (PRTR-C17.I1) and the Generalitat Valenciana and the European Research Council (ERC) via Advanced Grant (101052997, EDISON). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. A.E. thanks the Generalitat Valenciana for her PhD grant (ACIF/2018/110). F.J.H. thanks MIU for his FPU grant (FPU20/06021). E.L.-S. is also grateful for her FPU fellowship funded by MINECO (FPU18/06539). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120) and Scientific Foundation of the Spanish Association Against Cancer (AECC) for her postdoctoral grant (INVES246470DIEZ). S.P.-L. thanks Investigo program of the Spanish Government funded by NextGenerationEU from the European Union. V.S.-A. thanks MIU for his FPI grant (PRE2022-103714), J.J.E.-M. thanks the AECC Scientific Foundation for his PhD grant (PRDVA21651ESTE). I.G.-C. was funded by Margarita Salas postdoctoral grant (European Union-Next generation EU). J.M.C. was funded by Sociedad Espanola de Oncologia Medica (Juan Rodes-SEOM). The authors are especially thankful to the associations Amunt Contra el Cancer, La Venuseta, Corazon Solidario Contra el Cancer, Mou-te Per Elles, and Asociacion Las Triples. Scheme A and Figures A-i,B-i, A-i, A, A, and A were created with BioRender.com https://BioRender.com/xs7c89a
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Nanoparticle-cell-nanoparticle communication by stigmergy to enhance poly(I:C) induced apoptosis in cancer cells

  • Ultimo, Amelia
  • De La Torre-Paredes, Cristina
  • Giménez, Cristina
  • Coll, Carmen
  • Aznar, Elena|||0000-0003-0361-3876
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Murguía, Jose R.|||0000-0001-9364-4603
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
[EN] Nanoparticle-cell-nanoparticle communication by stigmergy was demonstrated using two capped nanodevices. The first community of nanoparticles (i.e.S(RA)(IFN)) is loaded with 9-cis-retinoic acid and capped with interferon-gamma, whereas the second community of nanoparticles (i.e.S(sulf)(PIC)) is loaded with sulforhodamine B and capped with poly(I:C). The uptake ofS(RA)(IFN)by SK-BR-3 breast cancer cells enhanced the expression of TLR3 receptor facilitating the subsequent uptake ofS(sulf)(PIC)and cell killing., We thank the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/FEDER, EU)), Generalitat Valenciana (project PROMETEO2018/024) and CIBER-BBN (project NANOCOMMUNITY) for support. A. U. and C. G are grateful to the Ministry of Education, Culture and Sport for her doctoral FPU grant.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mesoporous silica nanoparticles for pulmonary drug delivery

  • García-Fernández, Alba|||0000-0002-8416-1674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Over the last years, respiratory diseases represent a clinical concern, being included among the leading causes of death in the world due to the lack of effective lung therapies, mainly ascribed to the pulmonary barriers affecting the delivery of drugs to the lungs. In this way, nanomedicine has arisen as a promising approach to overcome the limitations of current therapies for pulmonary diseases. The use of nanoparticles allows enhancing drug bioavailability at the target site while minimizing undesired side effects. Despite different approaches have been developed for pulmonary delivery of drugs, including the use of polymers, lipid-based nanoparticles, and inorganic nanoparticles, more efforts are required to achieve effective pulmonary drug delivery. This review provides an overview of the clinical challenges in main lung diseases, as well as highlighted the role of nanomedicine in achieving efficient pulmonary drug delivery. Drug delivery into the lungs is a complex process limited by the anatomical, physiological and immunological barriers of the respiratory system. We discuss how nanomedicine can be useful to overcome these pulmonary barriers and give insights for the rational design of future nanoparticles for enhancing lung treatments. We also attempt herein to display more in detail the potential of mesoporous silica nanoparticles (MSNs) as promising nanocarrier for pulmonary drug delivery by providing a comprehensive overview of their application in lung delivery to date while discussing the use of these particles for the treatment of respiratory diseases., We thank the Spanish Government (project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) ) and the Generalitat Valenciana (project PROMETEO/2018/024) for support
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer

  • Marcelo, Gonçalo A.
  • Galhano, Joana
  • Robalo, Tiago T.
  • Cruz, Maria Margarida
  • Duarte, Maria Paula
  • Capelo-Martínez, José Luis
  • Lodeiro, Carlos
  • Oliveira, Elisabete
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cancer-related opportunistic bacterial infections are one major barrier for successful clinical therapies, often correlated to the production of genotoxic factors and higher cancer incidence. Although dual anticancer and antimicrobial therapies are a growing therapeutic fashion, they still fall short when it comes to specific delivery and local action in in vivo systems. Nanoparticles are seen as potential therapeutic vectors, be it by means of their intrinsic antibacterial properties and effective delivery capacity, or by means of their repeatedly reported modulation and maneuverability. Herein we report on the production of a biocompatible, antimicrobial magneto-fluorescent nanosystem (NANO3) for the delivery of a dual doxorubicin-ofloxacin formulation against cancer-related bacterial infections. The drug delivery capacity, rendered by its mesoporous silica matrix, is confirmed by the high loading capacity and stimuli-driven release of both drugs, with preference for tumor-like acidic media. The pH-dependent emission of its surface fluorescent SiQDs, provides an insight into NANO3 surface behavior and pore availability, with the SiQDs working as pore gates. Hyperthermia induces heat generation to febrile temperatures, doubling drug release. NANO3-loaded systems demonstrate significant antimicrobial activity, specifically after the application of hyperthermia conditions. NANO3 structure and antimicrobial properties confirm their potential use in a future dual anticancer and antimicrobial therapeutical vector, due to their drug loading capacity and their surface availability for further modification with bioactive, targeting species., This work was funded by the Associate Laboratory for Green Chemistry-LAQV which is financed by national funds from FCT/MCTES (UIDB/50006/2020 and UIDP/50006/2020) as well as the Scientific Society PROTEOMASS (Portugal) for funding support (General Funding Grant 2021). G.M thanks to FCT/MEC (Portugal) for his doctoral grant PD/BD/142865/2018. E.O thanks FCT/MEC (Portugal) for the individual contract, CEECIND/00648/2017. This work was also funded by FCT-Foundation for Science and Technology, I.P., through projects UIDB/04077/2020, UIDP/04077/2020, OrMagNa-PTDC/NAN-MAT/28785/2017, BioISI-UID/Multi/04046/2019, UIDB/04046/2020 and UIDP/04046/2020 Centre grants (BioISI) and NECL infrastructure. The authors also acknowledge the financial support from Project PROMETEO 2018/024 from the Generalitat Valenciana and Project RTI2018-100910-B-C41 funded by MCIN/AEI /10.13039/501100011033/ and FEDER A way to make Europe.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

An enzyme-controlled Janus nanomachine for on-command dual and sequential release

  • Pérez-Calabuig, Ana M.
  • Diez-Sánchez, Paula
  • Martínez-Ruiz, Paloma
  • Sánchez, Alfredo
  • Villalonga, Reynaldo
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] A novel nanomachine for dual and sequential delivery of two different compounds was developed by grafting a thiol group and a pH sensitive beta-cyclodextrin-based gate-like ensemble on acetylcholinesterase-modified Au-mesoporous silica Janus nanoparticles., This work was supported by CTQ2017-87954-P and RTI2018100910-B-C41 grants from the Spanish Ministry of Economy and Competitiveness and PROMETEO2018/024 from the Generalitat Valenciana.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Development of enzyme-functionalized hybrid mesoporous nanodevices for advanced chemical communication

  • de Luis Fernández, Beatriz
[ES] La presente tesis doctoral se centra en el diseño, síntesis y caracterización de varios nanodispositivos híbridos orgánico-inorgánicos, utilizando como soporte nanopartículas de sílice mesoporosa equipadas con enzimas y puertas moleculares, los cuales muestran capacidades comunicativas además de la evaluación de diferentes estrategias de comunicación. El primer capítulo incluye un resumen de diferentes conceptos sobre los que se fundamentan los estudios realizados tales como nanotecnología, materiales de sílice mesoporosa, materiales con puertas moleculares que reaccionan a estímulos específicos, partículas Janus y biocomputación. Finalmente, se incluyen conceptos básicos acerca de la comunicación química, materiales y estrategias empleados hasta ahora y ejemplos representativos. A continuación, en el segundo capítulo, se presentan los objetivos generales de esta tesis doctoral que son abordados en los siguientes capítulos experimentales. El tercer capítulo muestra un sistema de biocomputación para liberación basado en nanopartículas Janus de oro-sílice mesoporosa capaces de comunicarse con el entorno procesando la información e imitando la función lógica booleana propia de un demultiplexer y que resulta en la liberación controlada de la carga. Se muestra que dicho nanodispositivo puede llevar a cabo sus funciones en medios complejos como en células cancerígenas. En el cuarto capítulo, se presenta un modelo circular de comunicación dentro de una red de tres nanopartículas diferentes basado en el intercambio jerárquicamente programado de mensajes químicos. La parte mesoporosa del nanodispositivo 1 (S1βgal) es cargada con la especie fluorescente [Ru(bpy)3]Cl2 y tapada con cadenas de oligo(etilenglicol) que contienen puentes disulfuro y que funcionan como puertas moleculares, mientras que la enzima β-galactosidasa es unida a la parte del oro. En la nanopartícula 2 (S2galox), la enzima galactosa oxidasa es inmovilizada en la cara del oro mientras que la sílice mesoporosa es cargada con 4-(bromometil)benzoato de metilo y los poros tapados con un derivado de arilboronato autoinmolante sensible a H2O2 que forma un complejo huéspedanfitrión con β-ciclodextrina. Finalmente, el nanodispositivo 3 (S3est) es funcionalizado con la enzima esterasa en la parte del oro, cargada con la especie reductora hidroclururo de tris(2-carboxietil)fosfina (TCEP) en la parte mesoporosa y tapada con una nanoválvula supramolecular que responde a pH (βciclodextrina:benzimidazol). En el quinto capítulo, se muestra un modelo interactivo de comunicación química entre una nanopartícula Janus abiótica y un organismo vivo (Saccharomyces cerevisiae). En particular, el nanodispositivo está basado en nanopartículas funcionalizadas con glucosa oxidasa en la parte del oro, cargadas con el genotóxico fleomicina y tapadas con la puerta molecular sensible a pH (βciclodextrina:benzimidazol). El microorganismo usado en el estudio es una levadura modificada que expresa GFP bajo el control del promotor del gen RNR3; la transcripción de dicho gen es inducida con la exposición a agentes que dañan el ADN. La ruta de comunicación interactiva empieza con la adición de sacarosa (estímulo de entrada) la cual es hidrolizada en glucosa por la invertasa localizada en el espacio periplásmico de las levaduras y que difunde al nanodispositivo donde es trasformada en el correspondiente ácido por la glucosa oxidasa de la parte del oro. La bajada local de pH da lugar a la apertura de la nanoválvula sensible a pH del nanovehículo y con ello a la liberación de fleomicina (mensaje de vuelta) que induce la expresión de GFP (señal de salida) en las levaduras. En el sexto capítulo, proponemos una estrategia para establecer una comunicación lineal entre dos microorganismos diferentes que no interactúan entre ellos mediada por un nanodispositivo que actúa como traductor químico. Finalmente, las conclusiones generales de la presente tesis doctoral son expuestas en el capítulo siete. El estudio de las capacidades comunicativas de los nanodispositivos mesoporosos funcionalizados con enzimas permite la construcción de estrategias de cooperación entre diferentes entidades que permiten funcionalidades que van más allá que aquellas llevadas a cabo por agentes individuales., [CA] La present tesi doctoral es centra en el disseny, síntesi i caracterització de diversos nanodispositius híbrids orgànic-inorgànics, utilitzant com a suport nanopartícules de sílice mesoporosa equipades amb enzims i portes moleculars, i que mostren capacitats comunicatives a més de l’avaluació de diferents estratègies de comunicació. El primer capítol inclou un resum de diferents conceptes sobre els quals es fonamenten els estudis realitzats com ara nanotecnologia, materials de sílice mesoporosa, materials amb portes moleculars que reaccionen a estímuls específics, partícules Janus i biocomputació. Finalment, s’inclouen conceptes bàsics sobre la comunicació química, materials i estratègies utilitzades fins ara i exemples representatius. A continuació, en el segon capítol, es presenten els objectius generals d’aquesta tesi doctoral que són abordats en els següents capítols experimentals. El tercer capítol mostra un sistema de biocomputació per alliberament basat en nanopartícules Janus d’or-sílice mesoporosa capaços de comunicar-se amb l’entorn processant la informació i imitant la funció lògica booleana pròpia d’un demultiplexer i que resulta en l’alliberament controlat de la càrrega. Es mostra que aquest nanodispositiu pot dur a terme les seves funcions en mitjans complexos com en cèl·lules canceroses. En el quart capítol, es presenta un model circular de comunicació dins d’una xarxa de tres nanopartícules diferents basat en l’intercanvi jeràrquicament programat de missatges químics. La part mesoporosa del nanodispositiu 1 (S1βgal) es carrega amb l’espècie fluorescent [Ru(bpy)3]Cl2 i es tapa amb cadenes d’oligo(etilenglicol) que contenen ponts disulfur i que funcionen com portes moleculars, mentre que l’enzim β-galactosidasa s’immobilitza a la part de l’or. A la nanopartícula 2 (S2galox), l’enzim galactosa oxidasa s’immobilitza a la cara de l’or mentre que la sílice mesoporosa es carrega amb 4-(bromometil)benzoat de metil i els porus són tapats amb un derivat d’arilboronat autoimmolant sensible a H2O2 que forma un complex hoste-amfitrió amb β-ciclodextrina. Finalment, el nanodispositu 3 (S3est) es funcionalitza amb l’enzim esterasa en la part de l’or, es carrega amb l’espècie reductora hidroclurur de tris (2-carboxietil) fosfina (TCEP) a la part mesoporosa i es tapa amb una nanoválvula supramolecular que respon a pH (β-ciclodextrina:benzimidazol). En el cinqué capítol, es mostra un model interactiu de comunicació química entre una nanopartícula Janus abiòtica i un organisme viu (Saccharomyces cerevisiae). En particular, el nanodispositiu està basat en nanopartícules funcionalitzades amb glucosa oxidasa en la part de l’or, carregades amb el genotòxic fleomicina i tapades amb la porta molecular sensible a pH (βciclodextrina:benzimidazol). El microorganisme utilitzat en l’estudi és un rent modificat que expressa GFP sota el control del promotor del gen RNR3; la transcripció d’aquest gen és induïda amb l’exposició a agents que danyen l’ADN. La ruta de comunicació interactiva comença amb l’addició de sacarosa (estímul d’entrada) la qual és hidrolitzada en glucosa per la invertasa localitzada en l’espai periplasmàtic dels rents i que difon al nanodispositiu on és transformada en el corresponent àcid per la glucosa oxidasa de la part de l’or. La baixada local de pH dona lloc a l’obertura de la nanoválvula sensible a pH del nanovehicle i amb això l’alliberament de fleomicina (missatge de tornada) que indueix l’expressió de GFP (senyal de sortida) en el rent. En el sisé capítol, proposem una estratègia per establir una comunicació lineal entre dos microorganismes diferents que no interactuen entre ells facilitada per un nanodispositiu que actua com a traductor químic. Finalment, les conclusions generals de la present tesi doctoral són exposades en el capítol set. L’estudi de les capacitats comunicatives dels nanodispositius mesoporosos funcionalitzats amb enzims permet la construcció d’estratègies de cooperació entre diferents entitats que permeten funcionalitats que van més enllà que aquelles dutes a terme per agents individuals. Esperem que els resultats obtinguts inspiren aplicacions futures en diferents àrees com ara biomedicina, nanorobots, materials que imiten la naturalesa i tecnologies de la informació., [EN] This PhD Thesis is focused on the design, synthesis and characterization of several hybrid organic-inorganic nanodevices using mesoporous silica nanoparticles equipped with enzymes and molecular gates which display communication capabilities as well as the design and evaluation of different communication strategies. The first chapter includes an overview of the different concepts which lay the foundations of the presented studies such as nanotechnology, mesoporous silica materials, stimuli-responsive gated materials, Janus particles and biocomputing. Basic concepts of chemical communication, materials and enabling technologies employed so far and representative examples in this field are also included. Next, in the second chapter, the general objectives of this PhD Thesis that are addressed in the following experimental chapters are presented. The third chapter shows a biocomputing delivery system based on Janus gold-mesoporous silica nanoparticles capable of chemically communicating with the environment and processing the information mimicking a demultiplexer Boolean logic function which results in a programmed cargo release. Finally, it is shown that such nanodevice is operative in complex media such as cancer cells. In the fourth chapter, it is presented a circular model of communication within a network of three different nanoparticles based on the hierarchically programmed exchange of chemical messages. The mesoporous face of nanodevice 1 (S1βgal) is loaded with the fluorescent dye [Ru(bpy)3]Cl2 and capped with disulfidecontaining oligo(ethylene glycol) chains acting as gatekeepers, whereas the enzyme β-galactosidase is attached to the gold face. In nanoparticle 2 (S2galox), the enzyme galactose oxidase is immobilized on the Au face, while the mesoporous silica is loaded with methyl 4-(bromomethyl)benzoate and the mesopores capped with a H2O2-sensitive self-immolative arylboronate derivative which forms a host-guest complex with β-cyclodextrin. Finally, the nanodevice 3 (S3est) is functionalized with the enzyme esterase on the Au face, loaded with the reductive species tris(2- carboxyethyl)phosphine hydrochloride (TCEP) in the mesoporous face and capped with a pH-responsive supramolecular nanovalve (β-cyclodextrin:benzimidazole). In the fifth chapter, it is showed an interactive model of chemical communication between an abiotic Janus nanoparticle and a living organism (Saccharomyces cerevisiae). In particular, the nanodevice is based on Janus goldmesoporous silica nanoparticles functionalized with glucose oxidase on the Au face, loaded with the genotoxin phleomycin and capped with a pH-responsive (βcyclodextrin:benzimidazole) gatekeeper. The microorganism used in the studies is an engineered budding yeast that expresses GFP under the control of the RNR3 promoter; RNR3 gene transcription is induced upon exposure to DNA-damaging agents. The interactive communication pathway starts with the addition of sucrose (input) which is hydrolyzed into glucose by invertase located in periplasmic space of yeasts and diffuses to the nanodevice where it is transformed into the corresponding acid by glucose oxidase on the Au face. The local drop in pH leads to uncapping of the pH-sensitive nanovalve in the nanocarrier and the release of phleomycin (feedback messenger) that induces GFP expression (output) in yeasts. In the sixth chapter, we propose a strategy to establish linear communication between two different non-interacting microorganisms mediated by a nanodevice which acts as a chemical “nanotranslator”. Finally, the general conclusions from this PhD Thesis are presented in chapter seven. The study of communication capabilities of enzyme-functionalized mesoporous nanodevices enables the construction of strategies of cooperation between different entities allowing sophisticated functionalities that go beyond those carried out by individual agents. We hope that the obtained results inspire future applications in different areas such as biomedicine, nanorobots, life-like materials and information technologies., The authors wish to thank the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/AEI/FEDER, UE), CTQ2017-87954-P), the Generalitat Valenciana (PROMETEO 2018/024), the Comunidad de Madrid (IND2017/BMD7642) and CIBER-BBN (NANOCOMMUNITY project) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Avidin-gated mesoporous silica nanoparticles for signal amplification in electrochemical biosensor

  • Jimenez-Falcao, Sandra
  • Parra-Nieto, Jorge
  • Pérez-Cuadrado, Hugo
  • Martínez-Ruiz, Paloma
  • Villalonga, Reynaldo
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We report herein a novel sensing strategy for electrochemical biosensors, by using mesoporous silica nanoparticles loaded with the redox probe methylene blue and capped with an avidin/imminobiotin stimulus-responsive gate-like ensemble as signal amplification element. As a proof of concept, an aptasensor for carcinoembryonic antigen (CEA) was constructed by attaching a biotin and thiol-functionalized anti-CEA DNA hairpin aptamer on gold nanoparticles modified carbon screen-printed electrodes. The biosensing approach relied on the unfolding of the aptamer molecule after specific recognition of CEA, unmasking the biotin residue and allowing further association with the avidin-capped mesoporous nanocarrier. Incubation with H2SO4 trigger the release of the encapsulated redox probe allowing the detection of the cancer biomarker from 1.0 pg/mL to 160 ng/mL., Financial support from the Spanish Ministry of Economy and Competitiveness (projects CTQ2014-58989-P, CTQ2015-71936-REDT, CTQ2017-87954-P and RTI2018-100910-B-C41, fellowship BES-2015-073565 to SJF) and the Generalitat Valencia (Project PROMETEO/2018/024) are gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

An Interactive Model of Communication between Abiotic Nanodevices and Microorganisms

  • de Luis-Fernández, Beatriz
  • Rincón, Paola
  • Villalonga, Reynaldo
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Gadea Vacas, José|||0000-0002-3612-7914
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Aznar, Elena|||0000-0003-0361-3876
  • Murguía, Jose R.|||0000-0001-9364-4603
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The construction of communication models at the micro¿/nanoscale involving abiotic nanodevices and living organisms has the potential to open a wide range of applications in biomedical and communication technologies. However, this area remains almost unexplored. Herein, we report, as a proof of concept, a stimuli¿responsive interactive paradigm of communication between yeasts (as a model microorganism) and enzyme¿controlled Janus Au¿mesoporous silica nanoparticles. In the presence of the stimulus, the information flows from the microorganism to the nanodevice, and then returns from the nanodevice to the microorganism as a feedback., B.dL. is grateful to the Spanish Government for her FPU PhD fellowship. The authors wish to thank the Spanish Government (projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and CTQ2017-87954-P), the Generalitat Valenciana (project PROMETEO2018/024), the Comunidad de Madrid (Project IND2017/BMD-7642) and CIBER-BBN (NANOCOM project) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Role of miR-99a-5p in breast cancer: Translating molecular findings into clinical tools

  • Garrido Cano, Iris
[ES] La presente tesis doctoral, titulada "papel del miR-99a-5p en cáncer de mama: transformando hallazgos moleculares en herramientas clínicas" está centrada en el estudio del microRNA miR-99a-5p en cáncer de mama y en la determinación de su potencial como diana terapéutica y biomarcador para el diagnóstico de dicha enfermedad. En el primer capítulo, se lleva a cabo una revisión general del cáncer de mama y los microRNAs. A continuación, en el segundo capítulo se presentan los objetivos. En el tercer capítulo se compararon los perfiles de expresión de microRNAs de una línea celular de cáncer de mama resistente a doxorrubicina frente a la línea celular parental, dando lugar a la identificación del microRNA miR-99a-5p como el más desregulado entre ambas. A continuación, se confirmó que el miR-99a-5p aumenta la sensibilidad a doxorrubicina mediante la inhibición directa de la expresión de COX-2, que conlleva la inhibición de la expresión de la proteína ABCG2, ampliamente descrita por su papel en resistencia a fármacos. En base a los resultados obtenidos, se diseñaron nanodispositivos basados en nanopartículas mesoporosas de sílice para la liberación de miR-99a-5p y doxorrubicina en los tumores. Se confirmó la eficacia de las nanopartículas para reducir el crecimiento tumoral así como los efectos adversos asociados a la doxorrubicina libre en un modelo ortotópico murino de cáncer de mama. En el cuarto capítulo, se evaluó el potencial del miR-99a-5p como biomarcador para el diagnóstico del cáncer de mama. Se determinó la expresión del microRNA en tumores primarios de cáncer de mama y en tejidos sanos. Los resultados mostraron que el miR-99a-5p se encuentra infraexpresado en los tejidos cancerosos. A continuación, con el objeto de determinar el potencial del miR-99a-5p como biomarcador mínimamente invasivo, se determinaron los niveles de expresión en plasma de pacientes de cáncer de mama y de donantes sanos. Se encontró que el miR-99a-5p se encuentra a mayor concentración en el plasma de pacientes con cáncer de mama. Estos resultados se validaron en una cohorte independiente. Mediante el análisis en base a curvas ROC se confirmó que el miR-99a-5p es útil como biomarcador no invasivo para el diagnóstico del cáncer de mama incluso en estadíos tempranos de la enfermedad. El quinto capítulo se centra el diseño y validación de un biosensor basado en soportes de alúmina mesoporosa para la detección del miR-99a-5p en plasma. Los poros de una placa de alúmina mesoporosa se cargaron con el fluoróforo rodamina B, y se utilizaron oligonucleótidos complementarios a la secuencia del miR-99a-5p como puertas moleculares capaces de retener los fluoróforos en el interior de los poros. En presencia del miR-99a-5p, se produce liberación de rodamina B, que es posteriormente detectada ópticamente. Se confirmó la especificidad del biosensor, así como su alta sensibilidad. Además, utilizando muestras de plasma de pacientes de cáncer de mama y controles sanos, se confirmó la eficiencia del dispositivo para detectar cáncer de mama incluso en estadíos tempranos. Por último, en los capítulos cinco y seis se presentan la discusión general y las conclusiones principales extraídas. En conclusión, esta tesis doctoral demuestra que el miR-99a-5p tiene potencial como diana terapéutica y biomarcador para el cáncer de mama, y podría ser útil para mejorar el pronóstico de los pacientes con dicha enfermedad. Se ha elucidado que uno de los mecanismos por los que el miR-99a-5p está involucrado en sensibilidad a doxorrubicina es mediante la regulación del eje COX-2/ABCG2. Además, las nanopartículas diseñadas para la administración combinada de miR-99a-5p y doxorrubicina se presentan como una herramienta con gran potencial para el tratamiento oncológico. Por último, aprovechando el potencial del miR-99a-5p como biomarcador diagnóstico, se ha desarrollado un sistema de detección que podría ser una herramienta útil para mejorar la detección temprana del cáncer de mama., [CA] La present tesis doctoral, titulada "paper del miR-99a-5p en càncer de mama: transformant descobriments moleculars en eines clíniques" està centrada en l'estudi del microRNA miR-99a-5p en càncer de mama i en la determinació del seu potencial com a diana terapèutica i biomarcador per al diagnòstic d'aquesta malaltia. En el primer capítol, es du a terme una revisió general del càncer de mama i els microRNAs. A continuació, en el segon capítol es presenten els objectius. En el tercer capítol es van comparar els perfils d'expressió de microRNAs d'una línia cel·lular de càncer de mama resistent a doxorrubicina amb la seua línia parental, donant lloc a la identificació del microRNA miR-99a-5p com el més desregulat entre ambdues. A continuació, es va confirmar que el miR-99a-5p augmenta la sensibilitat al fàrmac mijançant la inhibició directa de l'expressió de COX-2 de forma directa, que comporta la inhibició de l'expressió de la proteïna ABCG2 que està àmpliament descrita pel seu paper en resistència a fàrmacs. Basant-se en els resultats obtinguts, es van dissenyar nanodispositius basats en nanopartícules mesoporoses de sílice per a l'alliberament d'una combinació de miR-99a-5p i doxorrubicina en els tumors. L'eficacia dels sistemes per a reduir el creixement tumoral així com els efectes adversos associats a la doxorrubicina lliure es va confirmar en un model ortotòpic murí de càncer de mama. En el quart capítol, es va avaluar el potencial del miR-99a-5p com a biomarcador per al diagnòstic del càncer de mama. Es va determinar l'expressió del microRNA en tumors primaris de càncer de mama i en teixits sans. Els resultats van mostrar que el miR-99a-5p es troba infraexpressat en els teixits cancerosos. A continuació, amb l'objectiu de determinar el potencial del miR-99a-5p com a biomarcador mínimament invasiu, es van determinar els nivells d'expressió en plasma de pacients de càncer de mama i de donants sans. Es va trobar que el miR-99a-5p es troba a major concentració en el plasma de pacients amb càncer de mama. Aquestos resultats es van validar en una cohort independent. Per mitjà de l'anàlisi basant-se en corbes ROC es va confirmar que el miR-99a-5p és útil com a biomarcador no invasiu per al diagnòstic del càncer de mama inclús en estadis primerencs de la malaltia. El quint capítol es centra en el disseny i validació d'un biosensor basat en suports d'alúmina nanoporosa per la detecció del miR-99a-5p en plasma. Els porus d'una placa d'alúmina es van carregar amb l'indicador fluorescent rodamina B, i es van utilitzar oligonucleòtids complementaris a la seqüència del miR-99a-5p com a portes moleculars amb la capacitat de retindre els fluoròfors a l'interior dels porus. En presència del miR-99a-5p, es produeix l'alliberament de rodamina B, que serà posteriorment detectada òpticament. Es va confirmar l'especificitat del biosensor, així com la seua alta sensibilitat. A més, utilitzant mostres de plasma de pacients de càncer de mama i controls sans, es va confirmar l'eficiència del dispositiu per a detectar càncer de mama inclús en estadis primerencs. Finalment, en els capítols sis i set es presenten la discussió general i les conclusions principals. En conclusió, aquesta tesi doctoral demostra que el miR-99a-5p té potencial com a diana terapèutica i biomarcador per al càncer de mama, i podria ser útil per a millorar el pronòstic dels pacients amb dita malaltia. S'ha elucidat que un dels mecanismes pels quals el miR-99a-5p està involucrat en sensibilitat a doxorrubicina és per mitjà de la regulació de l'eix COX-2/ABCG2. A més, les nanopartícules dissenyades per a l'administració combinada de miR-99a-5p i doxorrubicina es presenta com una ferramenta amb gran potencial per al tractament oncològic. Finalment, aprofitant el potencial del miR-99a-5p com a biomarcador diagnòstic, s'ha desenvolupat un sistema de detecció que podria ser una ferramenta útil per a millorar la detecció primerenca del càncer de mama., [EN] This PhD thesis, entitled "Role of miR-99a-5p in breast cancer: translating molecular findings into clinical tools" is focused on the study of the microRNA miR-99a-5p in breast cancer and in determining its potential as a therapeutic target and biomarker for the diagnosis of this disease. In the first chapter, a general review of breast cancer is carried out and microRNAs are also introduced. Next, in the second chapter, the objectives are detailed. In the third chapter, the microRNA expression profile of a doxorubicin-resistant breast cancer cell line was compared with its parental cell line, leading to the identification of the microRNA miR-99a-5p as the most deregulated between the two of them. Subsequently, it was confirmed that miR-99a-5p increases drug sensitivity through directly targeting COX-2, which leads to the inhibition of the expression of the ABCG2 protein, widely described to be involved in drug resistance. Based on the obtained results, nanodevices based on mesoporous silica nanoparticles were designed for the combined release of miR-99a-5p and doxorubicin in tumors. The ability of the systems to specifically target the CD44 receptor, which is overexpressed in breast cancer tumors, as well as to release the cargo specifically after internalization, were tested in vitro. Furthermore, the efficacy of the nanoparticles to reduce tumor growth and the adverse effects associated with free doxorubicin was confirmed in a murine orthotopic model of breast cancer. In the fourth chapter, the potential of miR-99a-5p as a biomarker for the diagnosis of breast cancer was evaluated. First, microRNA expression was determined in primary breast cancer tumors and compared with healthy tissues. The results showed that miR-99a-5p is downregulated in breast cancer tissues. Next, to determine the potential of the microRNA as a minimally invasive biomarker, the expression levels of miR-99a-5p in plasma of breast cancer patients and healthy donors were determined. In this case, it was found that miR-99a-5p is at higher concentrations in the plasma of breast cancer patients. These results were validated in an independent cohort. Through the ROC curve analysis, it was confirmed that miR-99a-5p is useful as a non-invasive biomarker for the diagnosis of breast cancer even at early stages. The fifth chapter focus on the design and validation of a biosensor based on nanoporous alumina supports for the detection of miR-99a-5p in plasma. The pores of the alumina plate were loaded with the fluorescent indicator rhodamine B, and oligonucleotides with a sequence complementary to the miR-99a-5p were used as molecular gates able to maintain fluorophores inside the pores. In the presence of miR-99a-5p, the capping oligonucleotide is displaced, leading to the opening of the pores and the release of rhodamine B, which is subsequently optically detected. The specificity and high sensitivity of the biosensor were confirmed. Furthermore, the efficiency of the device to detect breast cancer even at early stages was confirmed using plasma samples from breast cancer patients and healthy controls. Finally, chapters five and six present the general discussion and conclusions. In conclusion, this PhD thesis demonstrates that miR-99a-5p is a molecule with potential as a therapeutic target and biomarker for breast cancer, and it could be useful to improve the prognosis of patients. It has been elucidated that one of the mechanisms by which miR-99a-5p is involved in doxorubicin sensitivity is through the regulation of the COX-2/ABCG2 axis. Furthermore, nanoparticles designed for the combined administration of miR-99a-5p and doxorubicin are presented as a tool with great potential for cancer treatment and could be useful for the administration of microRNAs as therapy. Finally, taking advantage of the potential of miR-99a-5p as a diagnostic biomarker, a detection system has been developed and could be a useful tool to improve early detection of breast cancer., This work was supported by, CIBERONC (CB16/12/00481), CIBER-BBN (CB07/01/2012), Spanish Government PI18/01219 (ISCIII), project RTI2018- 100910-B-C41 (MCUI/AEI/FEDER, UE) and the Generalitat Valenciana (PROMETEO/2018/024) for support. IG-C was funded by Generalitat Valenciana (ACIF/2016/030). LP was funded by Ministerio de Economia, Industria y Competitividad (FPI grant). SS was funded by Instituto de Salud Carlos III and the European Social Fund for the financial support “Sara Borrell” (CD16/000237). JMC was funded by Sociedad Española de Oncología Médica (Río Hortega-SEOM. The authors would like to thank the INCLIVA Biobank (PT17/0015/0049; B.000768 ISCIII) and the Valencian Biobanking Network integrated into the Spanish National Biobanks Network for providing the human biological samples. We would also like to thank the plasma donors and the nursing staff that accepted to participate in this study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of Giardia intestinalis

  • Gonzalez-Alvarez, Isabel
  • Vivancos, Verónica
  • Coll Merino, Mª Carmen
  • Sánchez-Dengra, B.
  • Ruiz Picazo, Alejandro
  • Bermejo, Marival
  • Dea-Ayuela, M. Auxiliadora
  • Gonzalez -Alvarez, Marta
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Giardiasis is a parasitism produced by the protozoa Giardia intestinalis that lives as trophozoite in the small intestine (mainly in the duodenum) attached to the intestinal villus by means of billed discs. The first line treatment is metronidazole, a drug with high bioavailability, which is why to obtain therapeutic concentrations in duodenum, it is necessary to administer high doses of drug to patients with the consequent occurrence of side effects. It is necessary to developed new therapeutical approaches to achieve a local delivery of the drug. In this sense, we have developed gated mesoporous silica microparticles loaded with metronidazole and with a molecular gate pH dependent. In vitro assays demonstrated that the metronidazole release is practically insignificant at acidic pHs, but in duodenum conditions, the metronidazole delivery from the microparticles is effective enough to produce an important parasite destruction. In vivo assays indicate that this microparticulate system allows to increase the concentration of the drug in duodenum and reduce the concentration in plasma avoiding systemic effects. This system could be useful for other intestinal local treatments in order to reduce doses and increase drug availability in target tissues., M.G.-A., I.G.-A. and M.B. thank the financial support from the project "MODELOS IN VITRO DE EVALUACION BIOFARMACEUTICA" SAF2016-78756(AEI/FEDER, EU) funded by Agencia Estatal Investigacion and European Union, through FEDER (Fondo Europeo de Desarrollo Regional). The authors thank the financial support from the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22-AR (MCUI/FEDER, EU)), Generalitat Valenciana (project PROMETEO 2018/024) and Universitat Politecnica de Valencia-FISABIO (project A41METRO-RELEASE). The authors also thank the Electron Microscopy Service at the UPV for support. B.S.-D. received a grant from the Ministry of Science, Innovation and Universities of Spain, grant number FPU17/00530.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

New advanced anti-tumor therapies based on hybrid mesoporous nanodevices

  • Lucena Sánchez, Elena
[ES] La presente tesis doctoral titulada "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" se centra en el diseño, síntesis, caracterización y evaluación de nuevos nanodispositivos híbridos orgánico-inorgánicos. En concreto, se han desarrollado nanopartículas de sílice mesoporosas (MSNs) y nanopartículas Janus combinando MSNs con platino y con oro con el objetivo de mejorar los tratamientos anti-tumorales. El primer capítulo es una introducción general que incluye una visión global del contexto en el que se enmarca la investigación realizada. En particular, se incluye información básica sobre los diferentes tipos de nanopartículas empleados en esta tesis doctoral, así como la descripción de la enfermedad del cáncer y la aplicación de los nanomateriales como terapia. A continuación, en el segundo capítulo, se presentan los objetivos generales y específicos de esta tesis doctoral. Los capítulos tercero y cuarto describen dos estrategias terapéuticas basadas en el desarrollo de nanopartículas con movimiento para mejorar la terapia antitumoral. Concretamente, en el primer capítulo experimental se presenta un nanodispositivo autopropulsado para la liberación controlada de fármacos en respuesta al glutatión (GSH) intracelular. Éste se basa en nanopartículas tipo Janus compuestas por sílice mesoporosa y oro, funcionalizadas en la parte del oro con la enzima catalasa, cargadas con doxorrubicina y con cadenas de oligo(etilenglicol) (S-S-PEG) unidas por puentes disulfuro en la cara de la sílice. Una vez sintetizado y caracterizado el dispositivo, se confirmó su movimiento y se demostró el funcionamiento de la puerta molecular. Finalmente, la internalización celular y la liberación de doxorrubicina se estudiaron en cultivos celulares. Motivados por los resultados anteriores, en el cuarto capítulo se describe un nuevo nanomotor diseñado como tratamiento antitumoral y similar al anterior. En este caso, la nanopartícula Janus desarrollada está compuesta por una nanopartícula de sílice mesoporosa junto con una de platino, cargada con doxorrubicina y cubierta con S-S-PEG. Al igual que en el trabajo anterior, se consigue la autopropulsión del dispositivo. Además, se obtuvo el perfil cinético de liberación del cargo en respuesta a estímulos y se confirmó su aplicación en cultivos celulares. Los capítulos cinco y seis se centran en una estrategia terapéutica nueva que consiste en potenciar la acción del sistema inmune sobre el tumor para conseguir su eliminación. En el primero de estos capítulos experimentales, se utilizaron nanopartículas MSNs cargadas con el fármaco JQ-1 y un siRNA frente al factor de crecimiento transformante ßeta (TGF-ß) como inmunoterapia. Una vez sintetizadas y caracterizadas, se confirmó la capacidad de estas nanopartículas para llevar a cabo la liberación de los cargos, junto con la disminución en la expresión de PD-L1 y en la producción de TGF-ß. Por último, se confirmó su aplicabilidad al ser capaces de inducir la eliminación de células de melanoma por el sistema inmune. De acuerdo con el último capítulo experimental, se describe un nuevo enfoque inmunoterapéutico basado en la comunicación química. En este caso, empleamos una nanopartícula Janus de oro y sílice funcionalizada con un péptido llamado pHLIP en la cara de sílice y el anticuerpo contra el receptor PD-1 unido a la cara de oro (J-pHLIP-PD1). La membrana de la célula tumoral es decorada por este nanodispositivo y gracias a la exposición del anticuerpo PD-1, se consiguió atrapar a los linfocitos T circulantes, desencadenando la eliminación de células tumorales por el sistema inmunitario. Además, estos resultados se confirmaron en un modelo metastásico B16-F10-Luc con una reducción de nódulos metastáticos. Finalmente, en el capítulo séptimo y octavo, se aborda la discusión general y las conclusiones derivadas de los estudios experimentales presentados en esta tesis doctoral., [CA] Aquesta tesi doctoral titulada "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" se centra en el disseny, síntesi, caracterització i avaluació de nous nanodispositius híbrids orgànic-inorgànics. En concret, s'han desenvolupat nanopartícules de sílice mesoporoses (MSNs) i nanopartícules Janus combinant MSNs amb platí i amb or per al tractament antitumoral. El primer capítol és una introducció general que inclou una visió global del context on s'emmarca la recerca realitzada. En particular, es presenta informació bàsica sobre les nanopartícules emprades en aquesta tesi doctoral, així com la descripció de la malaltia del càncer i l'aplicació dels nanomaterials com a teràpia. A continuació, al segon capítol, es presenten els objectius generals i específics d'aquesta tesi doctoral. Els capítols tercer i quart descriuen dues estratègies terapèutiques basades en el desenvolupmanet de nanopartícules amb moviment per aconseguir una millora de la terapia antitumoral. Concretament, al primer capítol experimental es presenta un nanodispositiu autopropulsat per a l'alliberament controlat de fàrmacs en resposta al glutatió (GSH) intracel·lular. Aquest es basa en nanopartícules tipus Janus compostes per sílice mesoporosa i or, funcionalitzades a la part de l'or amb l'enzim catalasa, carregades amb doxorrubicina i amb cadenes d'oligo(etilenglicol) (SS-PEG) unides per ponts disulfur a la cara de la sílice. Una vegada sintetitzat i caracteritzat el dispositiu, es va confirmar la seua capacitat de moviment i es va demostrar el funcionament correcte de la porta molecular. Finalment, la internalització cel·lular i l'alliberament de doxorrubicina es van estudiar en cultius cel·lulars. Motivats pels resultats anteriors, al quart capítol es descriu un nanomotor nou dissenyat com a tractament antitumoral i similar a l'anterior. En aquest cas, la nanopartícula Janus desenvolupada està composta per una nanopartícula de sílice mesoporosa juntament amb una de platí, carregada amb doxorrubicina i coberta amb S-S-PEG. Igual que en el treball anterior, s'aconsegueix autopropulsió del dispositiu. A més, es va obtenir el perfil cinètic d'alliberament del càrrec en resposta a estímuls i se'n va confirmar l'aplicació en cultius cel·lulars. Els capítols cinc i sis se centren en una estratègia terapèutica nova que consisteix a potenciar l'acció del sistema immune sobre el tumor per aconseguir-ne l'eliminació. Al primer d'aquests capítols experimentals, es van utilitzar nanopartícules MSNs carregades amb el fàrmac JQ-1 i un siRNA davant del factor de creixement transformant ßeta (TGF-ß) com a immunoteràpia. Un cop sintetitzades i caracteritzades, es va confirmar la capacitat d'aquestes nanopartícules per dur a terme l'alliberament dels càrrecs, juntament amb la disminució de l'expressió de PD-L1 i de la producció de TGF-ß. Finalment, se'n va confirmar l'aplicabilitat en ser capaços d'induir l'eliminació de cèl·lules de melanoma pel sistema immune. D'acord amb el darrer capítol experimental, es descriu un nou enfocament immunoterapèutic basat en la comunicació química. En aquest cas, fem servir una nanopartícula Janus d'or i sílice funcionalitzada amb un pèptid anomenat pHLIP a la cara de sílice i l'anticòs contra el receptor PD-1 unit a la cara d'or (J-pHLIP-PD1). La membrana de la cèl·lula tumoral és decorada per aquest nanodispositiu i gràcies a l'exposició de l'anticòs PD-1, es va aconseguir atrapar els limfòcits T circulants, desencadenant l'eliminació de cèl·lules tumorals pel sistema immunitari. A més, aquests resultats es van confirmar en un model metastàtic B16-F10-Luc amb una reducció de nòduls metastàtics. Finalment, al capítol setè i vuitè, s'aborda la discussió general i les conclusions derivades dels estudis experimentals presentats en aquesta tesi doctoral., [EN] The present PhD thesis entitled "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" focuses on the design, synthesis, characterization, and evaluation of new hybrid organic-inorganic nanodevices. We have developed mesoporous silica nanoparticles (MSNs) and Janus platinum-MSN and gold-MSN nanoparticles for tumor treatment. The first chapter is a general introduction that includes an overview of the context related to the research developed in this thesis. In particular, it includes basic information about different nanoparticles used in this doctoral thesis along with the description of cancer disease characteristics and the application of nanomaterials as therapy. Next, in the second chapter, the general and specific objectives of this Ph.D. thesis are presented. The third and fourth chapters describe two nanotechnology-based therapeutic strategies based on the development of nanomotors to improve cancer therapy. Specifically, the first experimental chapter presents a self-moving nanodevice for controlled drug release in response to intracellular glutathione (GSH). It is based on Janus gold-mesoporous silica nanoparticles functionalized with the enzyme catalase in the gold face, loaded with doxorubicin and capped with disulfide-linked oligo(ethylene glycol) (S-S-PEG) chains on the silica face. Once synthesized and characterized, the nanosystem motion was confirmed and the proper gating mechanism of the nanodevice was proven. Finally, the cellular uptake and doxorubicin release capacity have been demonstrated in cell cultures. Encouraged by the above results, chapter four describes a similar nanomotor design for antitumor therapy. In this case, the nanoparticle developed is composed of a Janus platinum-mesoporous silica nanoparticle, loaded with doxorubicin, and capped with S-S-PEG. As well as in the previous work, self-propulsion of the nanoparticles was achieved. Moreover, the stimuli-responsive cargo release kinetic profile was obtained and its application was confirmed in cell cultures. Chapters five and six focus on a new therapeutic strategy, empowering the immune system action on tumors to reach tumor cell death. In the first of these experimental chapters, JQ-1 and transforming growth factor-beta (TGF-ß) siRNA-loaded nanoparticles were used as efficient tumor immunotherapy. Once synthesized and characterized, the efficient cargo delivery was accomplished along with the programmed death-ligand 1 (PD-L1) downregulation and TGF-ß silencing. Lastly, its application was confirmed by triggering a specific immunogenic removal of tumor cells in melanoma cells. In chapter six, the development of a new communication-based immunotherapeutic approach is reported. In this case, we employ Janus gold-MSN functionalized with a peptide called pHLIP onto silica face and anti-PD-1 antibody bound to gold face (J-pHLIP-PD1). Tumor cell membrane is decorated by this nanodevice, leaving exposed on the surface PD-1 antibody which catches circulating T lymphocytes. It triggers immune system-induced-tumor leveling. Moreover, J-pHLIP-PD1 treatment-associated reduction of metastatic burden was also proven. Finally, in the seventh and eighth chapter, the general discussion and conclusions derived from the presented experimental studies of this Ph.D. thesis are exposed., The authors thank the Spanish Government (Projects MAT2015-64139-C4-1, AGL2015-70235-C2-2-R, CTQ2014-58989-P, CTQ2015-71936-REDT and CTQ2017-87954-P) and the Generalitat Valencia (PROMETEO/2018/024) for support. The Comunidad de Madrid (IND2017/BMD-7642) is also gratefully acknowledged. The authors thank the Spanish Government (project PID2021-126304OB-C41, (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO CIPROM/2021/007). E.L-S is grateful for her FPU fellowship funded by MINECO (FPU18/06539). This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). This study forms part of the Advanced Materials program (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON) and by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Understanding of mechanistic perspective in sensing of energetic nitro compounds through spectroscopic and electrochemical studies

  • Ture, Satish A.
  • Patil, Veerabhadragouda B.
  • Yelamaggad, Channabasaveshwar V.
  • Abbaraju, Venkataraman
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Understanding the probable mechanism of detection plays a significant role in selecting a particular fluorophore for the detection of the complicated and low volatile analyte namely, nitroaromatic and non-aromatic high energy materials (HEMs) in the development of detection devices when compared with the existing techniques. The fluorescence quenching employing conducting polymers-based response of HEMs have attained great significance in recent times. Amongst all conducting polymers, functionalized polyaniline can act as a fluorophore in quenching studies. This report also reveals the importance of studying electrochemical methods associated with the changes observed in the oxidation potential and its resemblance with fluorescence quenching study in establishing the probable mechanism associated with the sensing study of HEMs (viz., RDX, PETN, CL-20 and RDX: CL-20 Cocrystal). FTIR and resonance Raman characterization helped us to understand the interaction between nitro groups present in HEMs with benzenoid unit or polaronic or bipolaronic nitrogen of camphor sulfonic acid doped polyaniline (CSA[PANi]). Employing Stern Volmer plot, the efficiency of quenching and quenching mechanisms of complex structure formed between the fluorophore and HEMs is understood., Generalitat Valenciana, Grant/Award Number: PROMETEO2018/024; Spanish Government RTI2018-100910-B-C41 [MCUI/AEI/FEDER, UE]; M/s Premier Explosives Limited, Grant/Award Number: H/A: 4254
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A glutathione disulfide-sensitive Janus nanomachine controlled by an enzymatic AND logic gate for smart delivery

  • Mayol, Beatriz
  • Diez-Sánchez, Paula
  • Sánchez, Alfredo
  • De La Torre, Cristina
  • Villalonga, Anabel
  • Lucena-Sánchez, Elena
  • Martinez-Ruiz, Paloma
  • Vilela, Diana
  • Villalonga, Reynaldo
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] This work describes the assembly of a novel enzyme-controlled nanomachine operated through an AND Boolean logic gate for on-command delivery. The nanodevice was constructed on Au-mesoporous silica Janus nanoparticles capped with a thiol-sensitive gate-like molecular ensemble on the mesoporous face and functionalized with glutathione reductase on the gold face. This autonomous nanomachine employed NADPH and glutathione disulfide as input chemical signals, leading to the enzymatic production of reduced glutathione that causes the disruption of the gating mechanism on the mesoporous face and the consequent payload release as an output signal. The nanodevice was successfully used for the autonomous release of doxorubicin in HeLa cancer cells and RAW 264.7 macrophage cells., Financial support from the Spanish Ministry of Economy and Competitiveness (projects CTQ2017-87954-P, MAT2015-64139-C4-1 and RTI2018-100910-B-C41) is gratefully acknowledged. The authors also thank the Generalitat Valencia (Project PROMETEO/2018/024) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Innovative use of essential oil cold diffusion system for improving air quality on indoor cultural heritage spaces

  • Díaz Alonso, Julia
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Regidor Ros, Jose Luis|||0000-0002-1361-5050
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Bosch-Roig, Pilar|||0000-0003-2019-399X
[EN] Bioaerosols play an important role in Cultural Heritage (CH) spaces air quality and biodeterioration risk and there is a growing interest to reduce them in actual conservation strategies. Essential oils (EOs) have been wellknown in several fields for their antimicrobial properties and they have found use in a number of applications. In this work Melaleuca alternifolia (Tea tree) and Thymus vulgaris (Thyme) EOs are cold diffused in unventilated lab spaces for reducing air bacterial and fungi contamination. Moreover, Tea tree EO was also tested in an unventilated real CH space. The effectiveness of EOs in reducing air bacterial and fungi contamination in unventilated indoor spaces during 24 h was evaluated. Air quality was also analyzed by means of temperature, humidity and particulate matter variation. EOs' diffusion system CH artworks risks was studied by means of thermography, diffusion range and EOs compounds deposition on the artistic materials by GC-MS. Tea tree EOs vaporization showed the best results with 77,3% and 95,0% fungi and bacteria air contamination reduction, with no thermohydrometric alteration and absence of EOs components deposition on the artistic vault., The authors wish to thank to the priest of the Santos Juanes Church of Valencia; the 'Direccion General de Patrimonio' and Professor Pilar Roig Picazo; for giving us the permits needed in order to develop this research. We would like to thank to Fundacion Hortensia Herrero, the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22-AR (MCUI, FEDER, EU) and A.B. her Beatriz Galindo contract BG20/00020) and the Generalitat Valenciana (project PROM-ETEO 2018/024) for its financial support. Authors wish to thank the collaboration of the Dr. Ignacio Bosch Roig on the thermographic analysis and Dr. Enrique Vivo Soria for the review of the thermohydrometric data.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Fluorogenic Detection of Human Serum Albumin Using Curcumin-Capped Mesoporous Silica Nanoparticles

  • Otri, Ismael
  • Medaglia, Serena|||0000-0003-3537-9842
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Mesoporous silica nanoparticles loaded with rhodamine B and capped with curcumin are used for the selective and sensitive fluorogenic detection of human serum albumin (HSA). The sensing mesoporous silica nanoparticles are loaded with rhodamine B, decorated with aminopropyl moieties and capped with curcumin. The nanoparticles selectively release the rhodamine B cargo in the presence of HSA. A limit of detection for HSA of 0.1 mg/mL in PBS (pH 7.4)-acetonitrile 95:5 v/v was found, and the sensing nanoparticles were used to detect HSA in spiked synthetic urine samples., This research was funded by the Spanish Government (RTI2018-100910-B-C41 (MCUI/FEDER, EU)) and the Generalitat Valenciana (PROMETEO 2018/024). I.O. was funded by Erasmus Mundus Programme, Action 2, Lot 1, Syria (predoctoral fellowship). S.M. was funded by Generalitat Valenciana (Santiago Grisolia fellowship).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Nanodevices for the Efficient Codelivery of CRISPR-Cas9 Editing Machinery and an Entrapped Cargo: A Proposal for Dual Anti-Inflammatory Therapy

  • García-Fernández, Alba|||0000-0002-8416-1674
  • Murguía, Jose R.|||0000-0001-9364-4603
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Vivo-Llorca, Gema
  • Sancho, Mónica
  • García-Jareño, Alicia Belén
  • Ramírez-Jiménez, Laura
  • Barber-Cano, Eloísa
  • Orzaez, Mar
[EN] In this article, we report one of the few examples of nanoparticles capable of simultaneously delivering CRISPR-Cas9 gene-editing machinery and releasing drugs for one-shot treatments. Considering the complexity of inflammation in diseases, the synergistic effect of nanoparticles for gene-editing/drug therapy is evaluated in an in vitro inflammatory model as proof of concept. Mesoporous silica nanoparticles (MSNs), able to deliver the CRISPR/Cas9 machinery to edit gasdermin D (GSDMD), a key protein involved in inflammatory cell death, and the anti-inflammatory drug VX-765 ((CRISPR)-C-GSDMD45-VX-MSNs), were prepared. Nanoparticles allow high cargo loading and CRISPR-Cas9 plasmid protection and, thus, achieve the controlled codelivery of CRISPR-Cas9 and the drug in cells. Nanoparticles exhibit GSDMD gene editing by downregulating inflammatory cell death and achieving a combined effect on decreasing the inflammatory response by the codelivery of VX-765. Taken together, our results show the potential of MSNs as a versatile platform by allowing multiple combinations for gene editing and drug therapy to prepare advanced nanodevices to meet possible biomedical needs., The authors thank the financial support from Project RTI2018-100910-B-C41 funded by MCIN/AEI/10.13039/501100011033/and FEDER A way to make Europe, and the Generalitat Valenciana (Project PROMETEO 2018/024) for support. A.G.F. is grateful to the Spanish Government for an FPU grant and G.V. is grateful to the Generalitat Valenciana for a VALI+D grant.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer

  • Estepa-Fernández, Alejandra
  • Lerida-Viso, Araceli
  • Blandez, Juan F.
  • Galiana, Irene
  • Orzaez, Mar
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Triple-negative breast cancer (TNBC) is a very aggressive subtype of breast cancer with a poor prognosis and limited effective therapeutic options. Induction of senescence, arrest of cell proliferation, has been explored as an effective method to limit tumor progression in metastatic breast cancer. However, relapses occur in some patients, possibly as a result of the accumulation of senescent tumor cells in the body after treatment, which promote metastasis. In this study, we explored the combination of senescence induction and the subsequent removal of senescent cells (senolysis) as an alternative approach to improve outcomes in TNBC patients. We demonstrate that a combination treatment, using the senescence-inducer palbociclib and the senolytic agent navitoclax, delays tumor growth and reduces metastases in a mouse xenograft model of aggressive human TNBC (hTNBC). Furthermore, considering the off-target effects and toxicity derived from the use of navitoclax, we propose a strategy aimed at minimizing the associated side effects. We use a galacto-conjugated navitoclax (nav-Gal) as a senolytic prodrug that can preferentially be activated by ß-galactosidase overexpressed in senescent cells. Concomitant treatment with palbociclib and nav-Gal in vivo results in the eradication of senescent hTNBC cells with consequent reduction of tumor growth, while reducing the cytotoxicity of navitoclax. Taken together, our results support the efficacy of combination therapy of senescence-induction with senolysis for hTNBC, as well as the development of a targeted approach as an effective and safer therapeutic opportunity, This work was supported by the Spanish Government projects (RTI2018-100910-B-C41, RTI2018-101599-B-C22 and PID2020 -115048RB-I00 (MCUI/FEDER, EU) ) and the Generalitat Valenciana (PROMETEO 2018/024 and PROMETEO/2019/065) . A.E-F. is grateful to the Spanish Government for her Ph.D. grant (FPU17/05454) , A.L-V. is grateful to the Instituto de Salud Carlos III for her Ph.D. i-PFIS grant (IFI17/00039) . J.B. thanks to the Instituto de Salud Carlos III for his Sara Borrell contract (CD19/00038) . Thank the financial support from the FEDER found of European Union (IDIFEDER/2021/044) . The authors thank Alberto Herna?ndez for the confocal microscope, Alicia Martinez for flow cytometry, and Viviana Bisbal for veterinary assistance. The authors thank for the use of Biorender.com in the graphical abstract Fig. 2 and Fig. 3.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Triplex hybridization-based nanosystem for the rapid screening of pneumocystis pneumonia in clinical samples

  • Pla, Luis
  • Aviñó, Anna
  • Eritja, Ramón
  • Ruiz-Gaitán, Alba
  • Pemán, Javier
  • Friaza, Vicente
  • Calderón, Enrique J.
  • Santiago Felipe, Sara
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Pneumocystis pneumonia (PcP) is a disease produced by the opportunistic infection of the fungus Pneumocystis jirovecii. As delayed or unsuitable treatments increase the risk of mortality, the development of rapid and accurate diagnostic tools for PcP are of great importance. Unfortunately, current standard methods present severe limitations and are far from adequate. In this work, a time-competitive, sensitive and selective biosensor based on DNA-gated nanomaterials for the identification of P. jirovecii is presented. The biosensor consists of a nanoporous anodic alumina (NAA) scaffold which pores are filled with a dye reporter and capped with specific DNA oligonucleotides. In the presence of P. jirovecii genomic DNA, the gated biosensor is open, and the cargo is delivered to the solution where it is monitored through fluorescence spectroscopy. The use of capping oligonucleotides able to form duplex or triplex with P. jirovecii DNA is studied. The final diagnostic tool shows a limit of detection (LOD) of 1 nM of target complementary DNA and does not require previous amplification steps. The method was applied to identify DNA from P. jirovecii in unmodified bronchoalveolar lavage, nasopharyngeal aspirates, and sputum samples in 60 min. This is a promising alternative method for the routinely diagnosis of Pneumocystis pneumonia., This research was funded by the Spanish Government, (projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and CTQ2017-84415-R), the Generalitat Valenciana (project PROMETEO/2018/024) and CIBER-BBN (projects NANOPATH and CANDI-EYE).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Validation of an automated system for the experimentation of photothermal therapies on cell cultures

  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Monreal-Trigo, Javier|||0000-0002-4067-1867
  • Ibáñez Civera, Francisco Javier|||0000-0002-1035-2662
  • Masot Peris, Rafael|||0000-0002-1114-649X
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Garcia-Breijo, Eduardo|||0000-0002-9745-8485
  • Pardo-Huguet, María
  • De La Torre, Cristina
[EN] Hyperthermia is a technique used in treatments against cancer, consisting in heating the cancerous tissue to 40-44 ºC to produce apoptosis. The addition of noble metal nanoparticles would suppose a great progress in this technique development, due to their ability to produce heat or release drugs in or near the cancer cells when irradiated at a certain wavelength. This paper presents the validation of a prototype automated system for the basic experimentation of hyperthermia mediated by nanoparticles on cell cultures. It consists of a laser beam irradiating the samples placed in a 2D moving mechanism, an ambient temperature control to keep the samples in an incubation temperature range, and a thermographic camera to measure the temperature achieved. The system is controlled from a computer by a graphical user interface. The validation is done first in a suspension of gold nanostars and water to validate the temperature ranges, and then in SK-Mel and HeLa cell cultures, with varying concentrations and exposure times and measuring the cell viability 24 h after. These experiments showed that the treatment is possible and will cause cell death within a certain range of the variables to be applied. Also, an in-silico model of gold nanoparticle and its suspension in water was developed to try to predict the temperatures achieved during the treatment. The results of this model simulations are compared with the experiment results., We thank the financial support from the Spanish Government (projects RTI2018-100910-B-C41, RTI2018-100910-B-C43 and FPU17/03800) and the Generalitat Valenciana (project PROMETEO 2018/024). Funding for open access charge: CRUE-Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery

  • Ultimo, Amelia
  • Orzáez, Mar
  • Santos-Martinez, Maria J.
  • Ruiz-Hernández, Eduardo
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
[EN] The main cause of subretinal neovascularisation in wet age-related macular degeneration (AMD) is an abnormal expression in the retinal pigment epithelium (RPE) of the vascular endothelial growth factor (VEGF). Current approaches for the treatment of AMD present considerable issues that could be overcome by encapsulating anti-VEGF drugs in suitable nanocarriers, thus providing better penetration, higher retention times, and sustained release. In this work, the ability of large pore mesoporous silica nanoparticles (LP-MSNs) to transport and protect nucleic acid molecules is exploited to develop an innovative LP-MSN-based nanosystem for the topical administration of anti-VEGF siRNA molecules to RPE cells. siRNA is loaded into LP-MSN mesopores, while the external surface of the nanodevices is functionalised with polyethylenimine (PEI) chains that allow the controlled release of siRNA and promote endosomal escape to facilitate cytosolic delivery of the cargo. The successful results obtained for VEGF silencing in ARPE-19 RPE cells demonstrate that the designed nanodevice is suitable as an siRNA transporter., This research was funded by the Wellcome Trust Institutional Strategic Support Fund, the European Research Council under Grant agreement No. 758887, and the European Union's Horizon 2020 research and Innovation programme under Grant Agreement No 952259 (NANOFACTS). We also thank the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO2018/024) for their support. A.U. is grateful to the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 713567.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Aptamer-Capped nanoporous anodic alumina for Staphylococcus aureus detection

  • Pla, Luis
  • Santiago Felipe, Sara
  • Tormo-Mas, María Ángeles
  • Pemán, Javier
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The development of new detection systems for an accurate and rapid identification of pathogens has become an essential challenge in the biomedical field. Herein a highly selective platform based on aptamer-gated nano materials for specific Staphylococcus aureus detection is presented. In the proposed design, a nanoporous anodic alumina (NAA) scaffold is loaded with the fluorescent indicator rhodamine B, while pores entrances are capped by a DNA aptamer which selectively recognizes S. aureus cells in less than 1 h. When S. aureus cells are present, the solid is selectively uncapped, and the dye is released to the medium. This nanodevice allows the detection of bacterial concentrations between 2 and 5 CFU mL-1 (in buffer and blood, respectively) and it has demonstrated excellent behavior in terms of specificity and robustness. A set of 25 different clinical samples are analyzed using this simple procedure obtaining excellent results, which agree with conventional hospital reference techniques for the identification of S. aureus. This new method is sensitive, rapid and low cost, and avoids steps such as polymerase chain amplification reaction, which makes it suitable for use in point-of-care detection systems., This study was supported by the Spanish Government (projects RTI2018-100910-B-C41 and SAF2017-82251-R (MCUI/AEI/FEDER, UE)), the Generalitat Valenciana (project PROMETEO/2018/024), the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (B02-MIRSA project) and CIBER-BBN (NANOPATH and valorization project CANDI-EYE). It has been also co-financed by the EU through the Valencian Community ERDF PO 2014-2020. S.S. thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support "Sara Borrell" (CD16/000237). L.P. thanks to Ministerio de Economia, Industria y Competitividad for his FPI grant. The authors are grateful for the professional English language editing to Mr. Arash Javadinejad, English Instructor and pubication Editor at the Instituto de Investigacion Sanitaria La Fe, Valencia, Spain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Mesoporous silica and gold-based nanodevices: new controlled delivery platforms for biomedical applications

  • Vivo Llorca, Gema
[ES] La presente tesis doctoral titulada "Mesoporous silica and gold-based nanodevices: new controlled delivery platforms for biomedical applications" se centra en el diseño, síntesis, caracterización y evaluación de distintos nanodispositivos híbridos orgánico-inorgánicos. En concreto, se utilizan como soporte nanopartículas mesoporosas de sílice y nanopartículas de oro para su aplicación biomédica, en concreto en el campo del cáncer de mama. En el primer capítulo se introduce el marco general en el que se engloban los estudios realizados. Se presentan los conceptos relacionados con nanotecnología y nanomedicina, así como la interacción de las nanopartículas a nivel biológico con el organismo y las células. Finalmente, se introducen conceptos básicos del cáncer de mama y la aplicación de nanomateriales como terapia. A continuación, en el segundo capítulo, se exponen los objetivos de la presente tesis doctoral que son abordados en los siguientes capítulos experimentales. En el tercer capítulo se describe el primer nanomaterial para la liberación controlada de dos inhibidores (navitoclax y S63845) de las proteínas anti- apoptóticas de la familia Bcl-2. Este sistema se ha diseñado con el objetivo de superar la resistencia a navitoclax en un modelo celular de cáncer de mama triple negativo. En concreto, se han preparado nanopartículas mesoporosas de sílice cargadas con navitoclax y S63845, y funcionalizadas con un aptámero dirigido a la proteína de superficie MUC1, que actúa como puerta molecular. En este trabajo hemos demostrado que las nanopartículas diseñadas son internalizadas preferentemente por células tumorales de cáncer de mama. También hemos demostrado la capacidad de las nanopartículas de revertir la resistencia a navitoclax en un modelo celular de cáncer de mama triple negativo. Además, ponemos de manifiesto la disminución del principal efecto adverso (trombocitopenia) asociado a la administración del navitoclax en su formulación libre, gracias a la encapsulación en las nanopartículas. En el capítulo cuatro se presenta un sistema sensible a pH para la liberación controlada de un cargo fluorescente y la maquinaria de edición génica basada en el sistema CRISPR/Cas9, dirigido a la edición del gen codificante de la proteína fluorescente verde (GFP, del inglés gren fluorescent protein). El nanodispositivo está constituido por nanopartículas mesoporosas de sílice cargadas con rodamina B, funcionalizadas con polietilenimina y revestidas con el plásmido codificante del sistema CRISPR/Cas9. En este trabajo se ha demostrado el escape lisosomal de las nanopartículas, mediado por el efecto esponja de protones de la PEI. Asimismo, mostramos un nanodispositivo pionero en su campo, basado en nanopartículas mesoporosas de sílice, capaz de realizar la doble función de llevar a cabo la edición del gen codificante de GFP y la liberación exitosa del cargo fluorescente. En el quinto, y último, capítulo experimental se propone una nueva aproximación para realizar una terapia enzimática prodroga empleando nanopartículas de oro como transportadores enzimáticos. En este caso, se aborda la funcionalización de nanopartículas de oro con la enzima peroxidasa de rábano (HRP, del inglés horseradish peroxidase), capaz de transformar la prodroga inocua ácido indol-3-acético en especies radicales que resultan tóxicas para las células tumorales. En este capítulo se ha demostrado el efecto terapéutico del nanodispositivo en combinación con la prodroga en modelos celulares de cáncer de mama de los subtipos luminal A y triple negativo. Además, se ha confirmado la eficacia terapéutica del sistema en esferoides tumorales formados por células de cáncer de mama triple negativo. Por último, se presentan en el capítulo seis las conclusiones extraídas del desarrollo de esta tesis doctoral. Los resultados obtenidos en este trabajo contribuirán al desarrollo de nuevos nanomateriales inteligentes con aplicación en diversas áreas de la nanomedicina., [CA] La present tesi doctoral titulada "Mesoporous silica and gold-based nanodevices: new controlled delivery platforms for biomedical applications" se centra en el disseny, síntesi, caracterització i avaluació de diferents nanodispositius híbrids orgànic-inorgànics. En concret, s'utilitzen com a suport nanopartícules mesoporoses de sílice i nanopartícules d'or per a la seua aplicació biomèdica, en concret en el camp del càncer de mama. En el primer capítol s'introdueix el marc general en el qual s'engloben els estudis realitzats. Es presenten els conceptes relacionats amb la nanotecnologia i nanomedicina, així com la interacció de les nanopartícules a nivell biològic amb l'organisme i les cèl·lules. Finalment, s'introdueixen conceptes bàsics del càncer de mama i l'aplicació de nanomaterials com a teràpia. A continuació, en el segon capítol, s'exposen els objectius de la present tesi doctoral que són abordats en els següents capítols experimentals. En el tercer capítol es descriu el primer nanomaterial utilitzat per a l'alliberament controlat de dos inhibidors (navitoclax i S63845) de les proteïnes anti-apoptòtiques de la família Bcl-2. Aquest sistema s'ha dissenyat amb l'objectiu de superar la resistència a navitoclax en un model cel·lular de càncer de mama triple negatiu. En concret, s'han preparat nanopartícules mesoporoses de sílice carregades amb navitoclax i S63845, i funcionalitzades amb un aptàmer dirigit a la proteïna de superfície MUC1, que actua com a porta molecular. En aquest treball hem demostrat que les nanopartícules dissenyades són internalitzades preferentment per cèl·lules tumorals de càncer de mama. També hem demostrat la capacitat de les nanopartícules de revertir la resistència a navitoclax en un model cel·lular de càncer de mama triple negatiu. A més, posem de manifest la disminució del principal efecte advers (trombocitopènia) associat a l'administració del navitoclax en la seua formulació lliure, gràcies a l'encapsulació en les nanopartícules. En el capítol quatre es presenta un sistema sensible a pH per a l'alliberament controlat d'una càrrega fluorescent i la maquinària d'edició gènica basada en el sistema CRISPR/Cas9, dirigit a l'edició gènica del gen codificant de la proteïna fluorescent verda (GFP, del anglés gren fluorescent protein). El nanodispositiu està constituït per nanopartícules mesoporoses de sílice carregades amb rodamina B, funcionalitzades amb polietilenimina i revestides amb el plàsmid codificant del sistema CRISPR/Cas9. En aquest treball s'ha demostrat la fuga lisosomal de les nanopartícules, mediat per l'efecte esponja de protons de la PEI. Així mateix, vam mostrar un nanodispositiu pioner en el seu camp, basat en nanopartícules mesoporoses de sílice, capaç de realitzar la doble funció de dur a terme l'edició del gen codificant de la GFP i l'alliberament exitós de la càrrega fluorescent. En el cinqué i últim capítol experimental es proposa una nova aproximació per a realitzar una teràpia enzimàtica prodroga emprant nanopartícules d'or com a transportadors enzimàtics. En aquest cas, s'aborda la funcionalització de nanopartícules d'or amb l'enzim peroxidasa de rave (HRP, del anglés horseradish peroxidase), capaç de transformar la prodroga innòcua àcid indol-3-acètic en espècies radicals que resulten tòxiques per a les cèl·lules tumorals. En aquest capítol s'ha demostrat l'efecte terapèutic del nanodispositiu en combinació amb la prodroga en models cel·lulars de càncer de mama dels subtipus luminal A i triple negatiu. A més, s'ha confirmat l'eficàcia terapèutica del sistema en esferoides tumorals formats per cèl·lules de càncer de mama triple negatiu. Finalment, en el capítol sis es presenten les conclusions extretes del desenvolupament d'aquesta tesi doctoral. Els resultats obtinguts en aquesta tesi contriburan al desenvolupament de nous nanomaterials intel·ligents amb aplicació en diverses àrees de la nanomedicina., [EN] This Ph.D. thesis entitled "Mesoporous silica and gold-based nanodevices: new controlled delivery platforms for biomedical applications" is focused on the design, synthesis, characterisation, and evaluation of several hybrid organic-inorganic nanomaterials. We have developed mesoporous silica nanoparticles and gold nanoparticles for biomedical applications, specifically in the breast cancer area. The first chapter includes an overview of the concepts related to the research performed. Introductory notions about nanotechnology and biomedicine are presented, as well as the basis of the interactions of nanoparticles with biological systems. Finally, breast cancer disease and the application of nanomaterials as therapy are described. Next, in the second chapter, the objectives addressed in the following experimental chapters are displayed. In the third chapter, we present the first nanomaterial for the controlled delivery of two inhibitors (navitoclax and S63845) of the Bcl-2 anti-apoptotic proteins. This nanosystem has been designed to overcome navitoclax resistance in a triple-negative breast cancer cellular model. We have prepared mesoporous silica nanoparticles loaded with navitoclax and S63845 and functionalised with an aptamer targeting MUC1 surface protein as a molecular gate. In this work, the specific targeting of the nanodevice to breast cancer cells has been demonstrated. The ability to overcome navitoclax resistance has been shown in navitoclax-resistant triple-negative breast cancer cells. Furthermore, navitoclax encapsulation in the nanoparticles has proved to reduce the main adverse effect (thrombocytopenia) associated with free formulated drug administration. In the fourth chapter, we describe a pH-responsive nanosystem for the controlled co-delivery of a fluorescent cargo and the genome-editing machinery based on CRISPR/Cas9, which targets the green fluorescent protein (GFP) coding gene. The nanodevice consists of mesoporous silica nanoparticles loaded with rhodamine B, functionalised with polyethyleneimine, and capped with the CRISPR/Cas9 plasmid. In the present work, we have shown the lysosomal scape capacity of the nanodevice enhanced by the proton sponge effect of PEI. We have also demonstrated a pioneering mesoporous silica-based nanodevice efficient in the simultaneous genome editing of the GFP gene (as a model gene) and the successful release of a fluorescent cargo (as a model drug). In the fifth and last experimental chapter, we propose a new approximation to develop enzyme prodrug therapy using gold nanoparticles as enzyme carriers. In this case, we use gold nanoparticles functionalised with the enzyme horseradish peroxidase (HRP), which transforms the non-toxic prodrug indol-3-acetic acid into radical species toxic to tumour cells. In this chapter, the therapeutic effect of the nanodevice in combination with the prodrug has been demonstrated in two breast cancer cell subtypes (luminal A and triple-negative breast cancers). Also, the therapeutic effect of the material has been corroborated in multicellular tumour spheroid-like cultures formed by triple-negative breast cancer cells. Finally, in the sixth chapter, the conclusions derived from the presented studies and the general conclusions of this Ph.D. thesis are released. The obtained results will promote the development of new smart nanomaterials with diverse biomedical applications., Gema Vivo-Llorca thanks the Generalitat Valenciana for her fellowship ACIF/2017/072. Vicente Candela-Noguera thanks the Spanish Government for his fellowship FPU15/02753. We would like to thank Servier for the workart used in the figures of this manuscript (Servier Medical Art https://smart.servier.com/). We thank the Spanish Government (project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE); SAF2017-84689-R-B (MCUI/AEI/FEDER, UE)) and the Generalitat Valenciana (project PROMETEO/2018/024 and PROMETEO/2019/065) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Phosphorogenic dipyrrinato-iridium(III) complexes as photosensitizers for photodynamic therapy

  • Prieto-Castañeda, A.
  • Lérida-Viso, A.
  • Avellanal-Zaballa, E.
  • Sola-Llano, R.
  • Bañuelos, J.
  • Agarrabeitia, A.R.
  • Ortiz, M.J.
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We have designed and synthesized a family of Ir(III) metal complexes coordinated with two cyclometalated bisfluorophenylpyridine ligands and an ancillary dipyrromethene which is functionalized with a mesityl group (Ir (dipy)-1), an ¿-chloroacetyl ester (Ir(dipy)-2) or a chain containing an ammonium cation (Ir(dipy)-3). The Ir (III) complexes feature a high triplet state population enabling red phosphorescence and efficient singlet oxygen generation. Ir(dipy)-2 and Ir(dipy)-3 are demonstrated to stain cells in both one-photon and two-photon confocal imaging. Moreover, Ir(dipy)-2 and Ir(dipy)-3 produce ROS in cells upon irradiation, inducing cell death by apoptosis. Colocalization studies in SK-Mel-103 cells show that Ir(dipy)-3 is partially accumulated in mitochondria and induces upon irradiation a disruption in their morphology. Overall our studies demonstrate that the prepared Ir(III) act as photosensitizers able to kill cells under irradiation, being suitable candidates for photodynamic therapy applications., Financial support from MINECO (MAT2017-83856-C3-2-P and 3-P), and PID2020-114755 GB-C32 and C33) and Gobierno Vasco (IT912-16) is gratefully acknowledged. A. L-V. was supported by an i-PFIS grant from Instituto de Salud Carlos III (IFI17/00039). E. A.-Z. thanks MINECO for a postdoctoral contract. The authors also wish to thank the Spanish Government (project RTI2018-100910-B-C41 (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO 2018/024) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Engineering chemical communication between micro/nanosystems

  • de Luis-Fernández, Beatriz
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Chemical communication, based on the exchange of molecules as messengers, allows different entities to share information, cooperate and orchestrate collective behaviors. In recent years, the development of strategies of chemical communication between micro/nanosystems is becoming a key emergent topic in micro/nanotechnology, biomimicry and related areas. In this tutorial review, we provide a general perspective of the concepts used on the topic of chemical communication, and the advances made using different approaches that include nanomaterials, synthetic biology and information-processing tools. Although studies in this direction are very recent, they can be divided in two main categories: (i) communication between abiotic systems and (ii) communication between living and abiotic systems. Using illustrative examples, we give an overview of the ongoing progress, potential applications in different areas and current challenges. The engineering of chemical communication between micro/nanosystems represents a paradigm shift and may open a myriad of new concepts, applications and new technological possibilities in the near future in a number of research fields., We thank the financial support from the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO 2018/024) for support. A. L.-L. gratefully acknowledges the COFUND project oLife, which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 847675. Fig. 4, 7, 8, 17, 18, 23-27, 29 and 30 were created with BioRender.com.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Ultrafast Directional Janus Pt-Mesoporous Silica Nanomotors for Smart Drug Delivery

  • Diez-Sánchez, Paula
  • Lucena-Sánchez, Elena
  • Villalonga, Reynaldo
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Development of bioinspired nanomachines with an efficient propulsion and cargo-towing has attracted much attention in the last years due to their potential biosensing, diagnostics, and therapeutics applications. In this context, self-propelled synthetic nanomotors are promising carriers for intelligent and controlled release of therapeutic payloads. However, the implementation of this technology in real biomedical applications is still facing several challenges. Herein, we report the design, synthesis, and characterization of innovative multifunctional gated platinum¿mesoporous silica nanomotors constituted of a propelling element (platinum nanodendrite face), a drug-loaded nanocontainer (mesoporous silica nanoparticle face), and a disulfide-containing oligo(ethylene glycol) chain (S¿S¿PEG) as a gating system. These Janus-type nanomotors present an ultrafast self-propelled motion due to the catalytic decomposition of low concentrations of hydrogen peroxide. Likewise, nanomotors exhibit a directional movement, which drives the engines toward biological targets, THP-1 cancer cells, as demonstrated using a microchip device that mimics penetration from capillary to postcapillary vessels. This fast and directional displacement facilitates the rapid cellular internalization and the on-demand specific release of a cytotoxic drug into the cytosol, due to the reduction of the disulfide bonds of the capping ensemble by intracellular glutathione levels. In the microchip device and in the absence of fuel, nanomotors are neither able to move directionally nor reach cancer cells and deliver their cargo, revealing that the fuel is required to get into inaccessible areas and to enhance nanoparticle internalization and drug release. Our proposed nanosystem shows many of the suitable characteristics for ideal biomedical destined nanomotors, such as rapid autonomous motion, versatility, and stimuli-responsive controlled drug release., The authors want to thank the Spanish Government for RTI2018-100910-B-C41 (MCIU/AEI/FEDER, UE) and CTQ2017-87954-P projects and the Generalitat Valenciana for support by project PROMETEO/2018/024. P.D. thanks the Spanish government for her Juan de la Cierva postdoctoral fellowship. E.L.-S. thanks MINECO for her FPU fellowship. A.E. is also grateful for her Ph.D. grant by the Generalitat Valenciana.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Real-Time In Vivo Detection of Cellular Senescence through the Controlled Release of the NIR Fluorescent Dye Nile Blue

  • Lozano-Torres, Beatriz
  • Blandez, Juan F.
  • Galiana, Irene
  • Alfonso-Navarro, María
  • Orzáez, Mar
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] In vivo detection of cellular senescence is accomplished by using mesoporous silica nanoparticles loaded with the NIR-FDA approved Nile blue (NB) dye and capped with a galactohexasaccharide (S3). NB emission at 672 nm is highly quenched inside S3, yet a remarkable emission enhancement is observed upon cap hydrolysis in the presence of beta-galactosidase and dye release. The efficacy of the probe to detect cellular senescence is tested in vitro in melanoma SK-Mel-103 and breast cancer 4T1 cells and in vivo in palbociclib-treated BALB/cByJ mice bearing breast cancer tumor., R.M. thanks financial support from the Spanish Government (RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/AEI/FEDER, UE)) and the Generalitat Valenciana (PROMETEO 2018/024). M.O. thanks the financial support from SAF2017-84689-R project and MINECO/AEI/FEDER, UE and the Generalitat Valenciana (PROMETEO/2019/065). B.L.-T. is grateful to the Spanish Ministry of Economy for her PhD grant. I.G. thanks her contract from IDM. J.F.-B. and M.A. thank the UPV for their postdoctoral fellowship.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A NIR light-triggered drug delivery system using core-shell gold nanostars-mesoporous silica nanoparticles based on multiphoton absorption photo-dissociation of 2-nitrobenzyl PEG

  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Gorbe, Mónica
  • Montes-Robles, Roberto
  • Cao Milán, Roberto
  • Díaz de Greñu-Puertas, Borja
  • Alfonso-Navarro, María
  • Orzaez, Mar
[EN] Gold nanostars coated with a mesoporous silica shell and functionalized with poly(ethylene glycol) containing photolabile 2-nitrobenzyl moieties are able to release doxorubicin after NIR light irradiation at low power irradiance via a multiphoton absorption photo-dissociation process., The authors gratefully acknowledge financial support from the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/AEI/FEDER,UE)), the Generalitat Valenciana (Project PROMETEO2018/024) and the European Union (Programme European Union Action 2-Erasmus Mundus Partnerships, Grant Agreement Number-2014-0870/001-001). A.H.-M. thanks the Erasmus Mundus Programme for his PhD scholarship for the EuroInkaNet project.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Sistemas optoelectrónicos para terapias fototérmicas dirigidas al cáncer de piel y optogenética en la regeneración de tejido nervioso

  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
[ES] Esta tesis doctoral se enfoca en la creación y validación de sistemas optoelectrónicos para aplicaciones biomédicas, en concreto para la terapia fototérmica contra el cáncer de piel y la optogenética para la regeneración de tejido nervioso. En su transcurso, se ha desarrollado un conjunto de herramientas y dispositivos que abarcan desde la experimentación sobre cultivos celulares hasta modelos computacionales que simulan el tratamiento. Para la terapia fototérmica, se ha diseñado y construido un equipo de experimentación in vitro validado sobre cultivos celulares. Este dispositivo, equipado con funcionalidades para controlar la potencia del láser, gestionar los tiempos de irradiación, realizar un posicionamiento automático de varias muestras bajo el haz, y monitorizar la evolución de la temperatura, se presenta como una herramienta altamente beneficiosa para la investigación en esta área. Después, se exploró la simulación mediante el Método de Elementos Finitos para analizar el comportamiento de las nanopartículas y sus suspensiones en agua, arrojando luz sobre sus potenciales aplicaciones en terapias fototérmicas y campos relacionados. Gracias al aprendizaje obtenido en los primeros pasos de este estudio, se logró el desarrollo de dos nuevos equipos que habilitan la realización de experimentos in vivo. Además, se ha implementado un modelo computacional diseñado para investigar el impacto de la terapia fototérmica en tejido biológico. Por último, se desarrolló un dispositivo optoelectrónico de reducidas dimensiones y alta potencia para la estimulación optogenética de neuronas modificadas genéticamente, con el objetivo de observar el transitorio de la estimulación y así entender en mayor medida las posibilidades que ofrece la optogenética en el campo de la regeneración de tejidos., [CA] Aquesta tesi doctoral es centra en la creació i validació de sistemes optoelectrònics per a aplicacions biomèdiques, específicament per a la teràpia fototèrmica contra el càncer de pell i l'optogenètica per a la regeneració del teixit nerviós. Durant el seu desenvolupament, s'han dut a terme un conjunt d'eines i dispositius, des de l'experimentació en cultius cel·lulars fins a models computacionals que simulen el tractament. Per a la teràpia fototèrmica, s'ha dissenyat i construït un dispositiu de experimentació in vitro validat en cultius cel·lulars. Aquest dispositiu, equipat amb funcionalitats per controlar la potència del làser, gestionar els temps d'irradiació, realitzar un posicionament automàtic de diverses mostres sota el feix i monitoritzar l'evolució de la temperatura, es presenta com una eina altament beneficiosa per a la recerca en aquest àmbit. A continuació, s'ha explorat la simulació mitjançant el Mètode d'Elements Finits per analitzar el comportament de les nanopartícules i les seves suspensions en aigua, aportant llum a les seves possibles aplicacions en teràpies fototèrmiques i camps relacionats. Gràcies al coneixement adquirit en les primeres etapes d'aquest estudi, s'ha aconseguit el desenvolupament de dos nous dispositius que possibiliten realitzar experiments in vivo. A més, s'ha implementat un model computacional dissenyat per investigar l'impacte de la teràpia fototèrmica en teixit biològic. Finalment, s'ha desenvolupat un dispositiu optoelectrònic de reduïdes dimensions i alta potència per a l'estimulació optogenètica de neurones modificades genèticament, amb l'objectiu d'observar la estimulació transitoria i comprendre millor les possibilitats que ofereix l'optogenètica en el camp de la regeneració de teixits., [EN] This doctoral thesis focuses on the creation and validation of optoelectronic systems for biomedical applications, specifically for photothermal therapy against skin cancer and optogenetics for nerve tissue regeneration. During its course, a set of tools and devices has been developed, ranging from experimentation on cell cultures to computational models simulating the treatment. For photothermal therapy, an in vitro device has been designed and constructed for experimentation in cell cultures. This device, equipped with functionalities to control laser power, manage irradiation times, perform automatic positioning of multiple samples under the beam, and monitor temperature evolution, emerges as a highly beneficial tool for research in this area. Next, simulation using the Finite Element Method was explored to analyze the behavior of nanoparticles and their suspensions in water, shedding light on their potential applications in photothermal therapies and related fields. Thanks to the knowledge gained in the early stages of this study, the development of two new devices enabling in vivo experiments was achieved. Furthermore, a computational model designed to investigate the impact of photothermal therapy on biological tissue has been implemented. Finally, a compact, high-power optoelectronic device was developed for the optogenetic stimulation of genetically modified neurons, with the aim of observing the stimulation transient and gaining a better understanding of the possibilities that optogenetics offers in the field of tissue regeneration., El material y las instalaciones utilizados en el desarrollo de este trabajo fueron financiados por las ayudas PID2021-126304OB-C44 y PID2021-124359OB-I00 de MCIN/AEI/10.13039/5011000110-33, el programa H2020 FetOpen con el proyecto número 964562, la ayuda de la Conselleria de Educación, Investigación, Cultura y Deporte de la Generalitat Valenciana CIPROM/2021/007 y el proyecto PROMETEO 2018/024, la Fundación Social Europea ACIF/2019/120, y el Ministerio de Ciencia, Innovación y Universidades con las becas doctorales FPU17/03239 y FPU17/03800. El trabajo ha recibido también financiación de la Agencia Estatal de Investigación con los proyectos números RTI2018-100910-B-C41, RTI2018-100910-B-C43-AR y PID2021-126304OB-C41, el Instituto de Salud Carlos III - CIBER-BBN: Safe N Medtech and Smart-4-Fabry Projects (asociado a los programas europeos del marco H2020 (H2020/2014-2020) con la ayuda número 814607) y el Ministerio de Ciencia e Innovación con las beca predoctorales FPU17/03800 y FPU17/03239
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Nanoprogrammed Cross-Kingdom Communication Between Living Microorganisms

  • de Luis-Fernández, Beatriz
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Martínez-Latorre, Javier|||0000-0001-5421-5371
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • López Del Rincón, Carmelo|||0000-0001-7459-1315
  • Murguía, Jose R.|||0000-0001-9364-4603
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The engineering of chemical communication at the micro/nanoscale is a key emergent topic in micro/nanotechnology, synthetic biology, and related areas. However, the field is still in its infancy; previous advances, although scarce, have mainly focused on communication between abiotic micro/nanosystems or between microvesicles and living cells. Here, we have implemented a nanoprogrammed cross-kingdom communication involving two different microorganisms and tailor-made nanodevices acting as "nanotranslators". Information flows from the sender cells (bacteria) to the nanodevice and from the nanodevice to receiver cells (yeasts) in a hierarchical way, allowing communication between two microorganisms that otherwise would not interact., B.d.L. is grateful to the Spanish Government for her FPU Ph.D. fellowship. The authors wish to thank the Spanish Government (projects RTI2018-100910-B-C41 and RTI2018101599-B-C22 (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO 2018/024) for support. Part of this work was included in the Ph.D. thesis of B.d.L.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

New Advances in In Vivo Applications of Gated Mesoporous Silica as Drug Delivery Nanocarriers

  • García-Fernández, Alba|||0000-0002-8416-1674
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
[EN] One appealing concept in the field of hybrid materials is related to the design of gated materials. These materials are prepared in such a way that the release of chemical or biochemical species from voids of porous supports to a solution is triggered upon the application of external stimuli. Such gated materials are mainly composed of two subunits: i) a porous inorganic scaffold in which a cargo is stored, and ii) certain molecular or supramolecular entities, grafted onto the external surface, that can control mass transport from the interior of the pores. On the basis of this concept, a large number of examples are developed in the past ten years. A comprehensive overview of gated materials used in drug delivery applications in in vivo models from 2016 to date is thus given here., The authors thank Spanish Government (Project No. RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE)) and Generalitat Valenciana (PROMETEO2018/024) for their support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Synthesis and fluorescence sensing of energetic materials using benzenesulfonic acid-doped polyaniline

  • Ture, Satish A.
  • Pattathil, Shruthy D.
  • Patil, Veerabhadragouda B.
  • Yelamaggad, Channabasaveshwar V.
  • Abbaraju, Venkataraman
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The Fluorescence sensing technique for trace detection of High Energy Materials (HEMs) has gained more attention in recent times. In the present paper, the interaction between the fluorophore and HEMs is studied using spectroscopic and electrochemical techniques. The fluorophore polyaniline (PANI) was functionalised by doping it with benzenesulfonic acid (BSA) to increase the processability, and mobility of ¿-electrons along with decreased ¿-stacking. It is observed that upon doping the solubility of BSA-PANI is increased, facilitating a higher quenching by commercial explosives, i.e., RDX, CL-20, CL-20:RDX cocrystal. The interaction studies undertaken though fluorescence quenching, FTIR and Resonance Raman studies shows that the benzenoid unit, polaron and bipolaron nitrogen in BSA-PANI interact with nitro groups of HEMs and form a charge-transfer complex between HEMs and BSA-PANI undergoing predominantly a PET mechanism. LOD value is found to be least for Cocrystal (1.876¿×¿10¿5 M) when compared to other HEMs 3.191¿×¿10¿5 M (CL-20), 5.904¿×¿10¿5 M (RDX), 3.734¿×¿10¿5 M (PETN) indicating that cocrystal can be detected in trace level. The collaborative study between cyclic voltammetry and the observed results of fluorescence quenching, revealed that the emeraldine salt form of (BSA-PANI) is sensitive to HEMs., The authors acknowledge and thank Prof. G. U. Kulkarni, the former Director of Centre for Nano and Soft Matter (CeNS) for providing the facility to work in the centre. The authors, S A Ture and V B Patil, expresses their thanks to M/s Premier Explosive Limited for their Financial support (H/A: 4254), the corresponding author expresses his thanks to UGC, New Delhi for the BSR faculty fellowship [F.4-5(11)/2019(BSR)]. We also thank the Spanish Government [RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE)] and Generalitat Valenciana (PROMETEO2018/024) for their support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Development of Geometry-Controlled All-Orthogonal BODIPY Trimers for Photodynamic Therapy and Phototheragnosis

  • Prieto-Castañeda, Alejandro
  • García-Garrido, Fernando
  • Díaz-Norambuena, Carolina
  • Escriche-Navarro, Blanca
  • Bañuelos, Jorge
  • Rebollar, Esther
  • García-Moreno, Inmaculada
  • de la Moya, Santiago
  • Agarrabeitia, Antonia R.
  • Ortiz, María J.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We have established an easy synthetic protocol for selectively developing all-orthogonal BODIPY trimers with unprece-dented geometries on the basis of selecting methyl oxidation versus electrophilic formylation of key dimeric precursors. Photophysical characterization together with biological assays unraveled the most suitable BODIPY-BODIPY geometrical arrangements within the trimer, forcing them to serve as molecular platforms for the development of new, advanced heavy-atom-free photosensitizers for photodynamic therapy and phototheragnosis., The authors acknowledge Spanish MICINN (PID2020-11455GB-C31, -C32, and -C33 and RTI2018-100910-BC41), Spanish Instituto de Salud Carlos III (IFI19/00026), Gobierno Vasco (IT1639-22), and Generalitat Valenciana (PROMETEO 2018/024) for financial support. A.P.-C. thanks Comunidad de Madrid for a research contract. C.D.-N. thanks MICINN for a FPI contract. B.E.-N. thanks the IFI19/00026 project, which is co-funded by the European Union, for a research contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gene-Directed Enzyme Prodrug Therapy by Dendrimer-Like Mesoporous Silica Nanoparticles against Tumor Cells

  • Candela-Noguera, Vicente
  • Aznar, Elena|||0000-0003-0361-3876
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Vivo-Llorca, Gema
  • Díaz de Greñu, Borja
  • Alfonso, María
  • Orzáez, Mar
[EN] We report herein a gene-directed enzyme prodrug therapy (GDEPT) system using gated mesoporous silica nanoparticles (MSNs) in an attempt to combine the reduction of side effects characteristic of GDEPT with improved pharmacokinetics promoted by gated MSNs. The system consists of the transfection of cancer cells with a plasmid controlled by the cytomegalovirus promoter, which promotes ß-galactosidase (ß-gal) expression from the bacterial gene lacZ (CMV-lacZ). Moreover, dendrimer-like mesoporous silica nanoparticles (DMSNs) are loaded with the prodrug doxorubicin modified with a galactose unit through a self-immolative group (DOXO-Gal) and modified with a disulfide-containing polyethyleneglycol gatekeeper. Once in tumor cells, the reducing environment induces disulfide bond rupture in the gatekeeper with the subsequent DOXO-Gal delivery, which is enzymatically converted by ß-gal into the cytotoxic doxorubicin drug, causing cell death. The combined treatment of the pair enzyme/DMSNs-prodrug are more effective in killing cells than the free prodrug DOXO-Gal alone in cells transfected with ß-gal., This research was funded by the Spanish Government (projects RTI2018-100910-B-C41, RTI2018-101599-B-C22 and SAF2017-84689-R (MCUI/FEDER, EU)) and the Generalitat Valenciana (projects PROMETEO 2018/024 and PROMETEO/2019/065). Vicente Candela-Noguera thanks the Spanish Government for his fellowship (FPU15/02753). Gema Vivo-Llorca thanks the Generalitat Valenciana for her fellowship (ACIF/2017/072).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy

  • Escriche-Navarro, Blanca
  • Lucena-Sánchez, Elena
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cancer immunotherapy has emerged in the past decade as a promising strategy for treating many forms of cancer by stimulating the patient's immune system. Although immunotherapy has achieved some promising results in clinics, more efforts are required to improve the limitations of current treatments related to lack of effective and targeted cancer antigens delivery to immune cells, dose-limiting toxicity, and immune-mediated adverse effects, among others. In recent years, the use of nanomaterials has proven promising to enhance cancer immunotherapy efficacy and reduce side effects. Among nanomaterials, attention has been recently paid to mesoporous silica nanoparticles (MSNs) as a potential multiplatform for enhancing cancer immunotherapy by considering their unique properties, such as high porosity, and good biocompatibility, facile surface modification, and self-adjuvanticity. This review explores the role of MSN and other nano/micro-materials as an emerging tool to enhance cancer immunotherapy, and it comprehensively summarizes the different immunotherapeutic strategies addressed to date by using MSN., B.E.-N., A.E., and E.L.-S. contributed equally to this work. The authors would like to thank the Spanish Government for RTI2018-100910-B-C41 and RTI2018-101599-B-C22 (MCUI/FEDER, EU) and the Generalitat Valenciana (Project PROMETEO 2018/024) for support by Project PROMETEO/2018/024. A.G.-F. acknowledges her current Margarita Salas postdoctoral fellowship from UPV-MIU and "Next Generation EU" program. B.E.-N. is grateful to the Spanish Instituto de Salud Carlos III (ISCIII) for the grant through Project "IFI19/00026", co-funded by European Union. A.E. is grateful for her Ph.D. grant by the Generalitat Valenciana. E.L.-S. thanks MINECO for her FPU fellowship.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

New Oleic Acid-Capped Mesoporous Silica Particles as Surfactant-Responsive Delivery Systems

  • Poyatos-Racionero, Elisa
  • Pérez-Esteve, Édgar|||0000-0002-0452-1394
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
[EN] A new delivery microdevice, based on hydrophobic oleic acid¿capped mesoporous silica particles and able to payload release in the presence of surfactants, has been developed. The oleic acid functionalization confers to the system a high hydrophobic character, which avoids cargo release unless surfactant molecules are present. The performance of this oleic¿acid capped microdevice in the presence of different surfactants is presented and its zero¿release operation in the absence of surfactants is demonstrated., The authors want to thank the Spanish Government (projects MAT2015-64139-C4-1-R, AGL2015-70235-C2-1-R and AGL2015-70235-C2-2-R (MINECO/FEDER)) and RTI2018-100910-B-C41, RTI2018-101599-B-C22 and RTI2018-101599-B-C21 (MCUI/AEI/FEDER, UE)) and Generalitat Valenciana (project PROMETEO/2018/024) for support. E.P.-R. thanks the Generalitat Valenciana for her predoctoral fellowship. A.B. wants to acknowledge the Spanish Government for the financial support Juan de la Cierva Incorporación IJCI-2014-21534. The authors also thank the Electron Microscopy Service at the UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Multiplexed Detection of Analytes on Single Test Strips with Antibody-Gated Indicator-Releasing Mesoporous Nanoparticles

  • Climent Terol, Estela
  • Biyikal, Mustafa
  • Gröninger, Delia
  • Weller, Michael G.
  • Rurack, Knut
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Rapid testing methods for the use directly at a point of need are expected to unfold their true potential especially when offering adequate capabilities for the simultaneous measurement of multiple analytes of interest. Considering the unique modularity, high sensitivity, and selectivity of antibody-gated indicator delivery (gAID) systems, a multiplexed assay for three small-molecule explosives (TATP, TNT, PETN) was thus developed, allowing to detect the analytes simultaneously with a single test strip at lower ppb concentrations in the liquid phase in <5 min using a fluorescence reader or a smartphone for readout. While the TNT and PETN systems were newly developed here, all the three systems also tolerated harsher matrices than buffered aqueous model solutions. Besides a single-track strip, the outstanding modularity of the hybrid biosensor materials in combination with strip-patterning technologies allowed us to obtain a multichannel strip in a straightforward manner, offering comparable analytical performance while allowing to be tailored even more to the user's need., Financial support from the Alexander von Humboldt Foundation (fellowship to E.C.), Germany's Federal Ministry for Economic Affairs and Energy (project DEmONS 06/12), the Spanish Government (project RTI2018-100910-B-C41 (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO 2018/024) is gratefully acknowledged. We thank S. Selve (Technical University Berlin) for TEM images, A. Zehl (Humboldt University Berlin) for elemental analysis, D. Pfeifer and C. Jager (BAM, Structural Analysis Division) for NMR support, A. Zimathies (BAM, Structural Analysis Division) for N<INF>2</INF> adsorption/desorption measurements, Y. Salinas and L. E. Santos for support on the materials screening, A. Walter, S. Ramin and A. Hesse for obtaining the sera and R. Gotor and J. Bell for their help in the fabrication of the home-made smartphone periphery. Open access funding enabled and organized by Projekt DEAL.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

MUC1 Aptamer-Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple-Negative Breast Cancer

  • Vivo-Llorca, Gema
  • Alfonso-Navarro, María
  • Orzáez, Mar
  • Candela-Noguera, Vicente
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. In the last years, navitoclax has emerged as a possible treatment for TNBC. Nevertheless, rapid navitoclax resistance onset has been observed thorough Mcl-1 overexpression. As a strategy to overcome Mcl-1-mediated resistance, herein we present a controlled drug co-delivery system based on mesoporous silica nanoparticles (MSNs) targeted to TNBC cells. The nanocarrier is loaded with navitoclax and the Mcl-1 inhibitor S63845 and capped with a MUC1-targeting aptamer (apMUC1-MSNs(Nav/S63845)). The apMUC1-capped nanoparticles effectively target TNBC cell lines and successfully induce apoptosis, overcoming navitoclax resistance. Moreover, navitoclax encapsulation protects platelets against apoptosis. These results point apMUC1-gated MSNs as suitable BH3 mimetics nanocarriers in the targeted treatment of MUC1-expressing TNBC., Gema Vivo-Llorca thanks the Generalitat Valenciana for her fellowship ACIF/2017/072. Vicente Candela-Noguera thanks the Spanish Government for his fellowship FPU15/02753. We would like to thank Servier for the workart used in the figures of this manuscript (Servier Medical Art ). We thank the Spanish Government (project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE); SAF2017-84689-R-B (MCUI/AEI/FEDER, UE)) and the Generalitat Valenciana (project PROMETEO/2018/024 and PROMETEO/2019/065) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A sensitive nanosensor for the in situ detection of the cannibal drug

  • Garrido-García, Eva María
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Alfonso-Navarro, María
  • Díaz de Greñu-Puertas, Borja
  • Costero, Ana M.
  • Gil Grau, Salvador
[EN] A bio-inspired nanodevice for the selective and sensitive fluorogenic detection of 3,4- methylenedioxypyrovalerone (MDPV), usually known as Cannibal drug, is reported. The sensing nanodevice is based on mesoporous silica nanoparticles (MSNs), loaded with a fluorescent reporter (rhodamine B) and functionalized on their external surface with a dopamine derivative (3), which specifically interacts with the recombinant human dopamine transporter (DAT), capping the pores. In the presence of MDPV, DAT detaches from the MSNs consequently causing rhodamine B release and allowing drug detection. The nanosensor shows a detection limit of 5.2 µM and it is able to detect the MDPV drug both in saliva and blood plasma samples., The authors thank the Spanish Government (projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and CTQ2017-87954-P) and the Generalitat Valencia (PROMETEO/2018/024) for support. E.G. is grateful to the Spanish MEC for her FPU grant. M.A. thanks her postdoctoral fellowship (PAID -10-17). The authors also thank the Electron Microscopy Service at the UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lactose-Gated Mesoporous Silica Particles for Intestinal Controlled Delivery of Essential Oil Components: An In Vitro and In Vivo Study

  • Poyatos-Racionero, Elisa
  • González-Álvarez, Isabel
  • Sánchez-Moreno, Paola
  • Sitia, Leopoldo
  • Gatto, Francesca
  • Pompa, Pier Paolo
  • González-Álvarez, Marta
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
[EN] Mesoporous silica microparticles functionalized with lactose for the specific release of essential oil components (EOCs) in the small intestine are presented. In vitro and in vivo intestinal models were applied to validate the microparticles (M41-EOC-L), in which the presence of lactase acts as the triggering stimulus for the controlled release of EOCs. Among the different microdevices prepared (containing thymol, eugenol and cinnamaldehyde), the one loaded with cinnamaldehyde showed the most significant Caco-2 cell viability reduction. On the other hand, interaction of the particles with enterocyte-like monolayers showed a reduction of EOCs permeability when protected into the designed microdevices. Then, a microdevice loaded with cinnamaldehyde was applied in the in vivo model of Wistar rat. The results showed a reduction in cinnamaldehyde plasma levels and an increase in its concentration in the lumen of the gastrointestinal tract (GIT). The absence of payload release in the stomach, the progressive release throughout the intestine and the prolonged stay of the payload in the GIT-lumen increased the bioavailability of the encapsulated compound at the site of the desired action. These innovative results, based on the specific intestinal controlled delivery, suggest that the M41-payload-L could be a potential hybrid microdevice for the protection and administration of bioactive molecules in the small intestine and colon., This research was funded by the Ministerio de Ciencia, Innovacion y Universidades (Spanish Government))the Agencia Estatal de Investigacion (AEI) and European Union (projects RTI2018-100910-B-C41 and RTI2018-101599-B-C22-AR (MCIU/AEI/FEDER, EU)); the Ministerio de Universidades (Spanish Government) (BG20/00020, A.B. Beatriz Galindo contract); the Agencia Estatal de Investigacion and European Union through FEDER (Fondo Europeo de Desarrollo Regional, AEI/FEDER EU, project SAF2016-78756); and the Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (project PROMETEO 2018/024 and E.P-R. predoctoral grant ACIF/2016/023).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development of Geometry-Controlled All-Orthogonal BODIPY Trimers for Photodynamic Therapy and Phototheragnosis

  • Prieto-Castañeda, A.
  • García-Garrido, F.
  • Díaz-Norambuena, C.
  • Escriche-Navarro, B.
  • García-Fernández, A.
  • Bañuelos, Jorge
  • Rebollar, Esther
  • García-Moreno, I.
  • Martínez-Máñez, R.
  • Moya, Santiago de la
  • Agarrabeitia, A.R.
  • Ortiz, M.J.
6 pags., 4 figs., We have established an easy synthetic protocol for selectively developing all-orthogonal BODIPY trimers with unprecedented geometries on the basis of selecting methyl oxidation versus electrophilic formylation of key dimeric precursors. Photophysical characterization together with biological assays unraveled the most suitable BODIPY-BODIPY geometrical arrangements within the trimer, forcing them to serve as molecular platforms for the development of new, advanced heavy-atom-free photosensitizers for photodynamic therapy and phototheragnosis., The authors acknowledge Spanish MICINN (PID2020-11455GB-C31, -C32, and -C33 and RTI2018-100910-BC41), Spanish Instituto de Salud Carlos III (IFI19/00026), Gobierno Vasco (IT1639-22), and Generalitat Valenciana (PROMETEO 2018/024) for financial support. A.P.-C. thanks Comunidad de Madrid for a research contract. C.D.-N. thanks MICINN for a FPI contract. B.E.-N. thanks the IFI19/00026 project, which is co-funded by the European Union, for a research contract.